id_in_original_dataset,text,labels,txt_len,html_palm2_one_shot,palm2_one_shot_time,html_palm2_five_shot,palm2_five_shot_time,html_palm2_ten_shot,palm2_ten_shot_time,html_palm2_twenty_shot,palm2_twenty_shot_time,gt_labels,palm2_one_shot_labels,palm2_five_shot_labels,palm2_ten_shot_labels,palm2_twenty_shot_labels
10526,"In addition , the frequency at which we have found PAX6 mutations suggests that lesions in PAX6 will account for most cases of aniridia . .",O O O O O O O O O O O O O O O O O O O O O O O B O O,13," In addition , the frequency at which we have found <span style=""background-color: #FFFF00"">PAX6</span> mutations suggests that lesions in <span style=""background-color: #FFFF00"">PAX6</span> will account for most cases of <span style=""background-color: #FFFF00"">aniridia</span> . .",1.2568421363830566," In addition , the frequency at which we have found <span style=""background-color: #FFFF00"">PAX6</span> mutations suggests that lesions in <span style=""background-color: #FFFF00"">PAX6</span> will account for most cases of <span style=""background-color: #FFFF00"">aniridia</span> . .",1.3386709690093994," In addition , the frequency at which we have found <span style=""background-color: #FFFF00"">PAX6</span> mutations suggests that lesions in <span style=""background-color: #FFFF00"">PAX6</span> will account for most cases of <span style=""background-color: #FFFF00"">aniridia</span> . .",1.5489449501037598," In addition , the frequency at which we have found <span style=""background-color: #FFFF00"">PAX6</span> mutations suggests that lesions in <span style=""background-color: #FFFF00"">PAX6</span> will account for most cases of <span style=""background-color: #FFFF00"">aniridia</span> . .",1.7265779972076416,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
5303,Evidence for linkage of bipolar disorder to chromosome 18 with a parent - of - origin effect .,O O O O B I O O O O O O O O O O O O,32," Evidence for linkage of <span style=""background-color: #FFFF00"">bipolar disorder</span> to chromosome 18 with a parent - of - origin effect .",0.7630460262298584," Evidence for linkage of <span style=""background-color: #FFFF00"">bipolar disorder</span> to chromosome 18 with a parent - of - origin effect .",0.8559398651123047," Evidence for linkage of <span style=""background-color: #FFFF00"">bipolar disorder</span> to chromosome 18 with a parent - of - origin effect .",0.9378149509429932," Evidence for linkage of <span style=""background-color: #FFFF00"">bipolar disorder</span> to chromosome 18 with a parent - of - origin effect .",1.1860108375549316,"['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
10443,"In summary , genetic syndromes of either complete or partial LCAT deficiency result in low levels of HDL through preferential hypercatabolism of apoA - II and HDL particles containing apoA - II .",O O O O O O O B I I I I O O O O O O O O O O O O O O O O O O O O O,13," In summary , genetic syndromes of either complete or partial <span style=""background-color: #FFFF00"">LCAT deficiency</span> result in low levels of <span style=""background-color: #FFFF00"">HDL</span> through preferential hypercatabolism of <span style=""background-color: #FFFF00"">apoA - II</span> and <span style=""background-color: #FFFF00"">HDL</span> particles containing <span style=""background-color: #FFFF00"">apoA - II</span> .",1.7244558334350586," In summary , genetic syndromes of either complete or partial <span style=""background-color: #FFFF00"">LCAT</span> deficiency result in low levels of HDL through preferential hypercatabolism of <span style=""background-color: #FFFF00"">apoA - II</span> and HDL particles containing <span style=""background-color: #FFFF00"">apoA - II</span> .",1.3986167907714844," In summary , genetic syndromes of either complete or partial <span style=""background-color: #FFFF00"">LCAT deficiency</span> result in low levels of HDL through preferential hypercatabolism of apoA - II and HDL particles containing apoA - II .",1.1222560405731201," In summary , genetic syndromes of either complete or partial <span style=""background-color: #FFFF00"">LCAT</span> deficiency result in low levels of HDL through preferential hypercatabolism of apoA - II and HDL particles containing apoA - II .",1.3255491256713867,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
2101,The results suggest that the prenatal diagnosis of Wolman disease be made using the radioassay of acid lipase and / or electrophoresis . .,O O O O O O O O B I O O O O O O O O O O O O O O,32," The results suggest that the prenatal diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> be made using the radioassay of <span style=""background-color: #FFFF00"">acid lipase</span> and / or electrophoresis . .",1.0034229755401611," The results suggest that the prenatal diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> be made using the radioassay of acid lipase and / or electrophoresis . .",0.837831974029541," The results suggest that the prenatal diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> be made using the radioassay of acid lipase and / or electrophoresis . .",0.9477250576019287," The results suggest that the prenatal diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> be made using the radioassay of acid lipase and / or electrophoresis . .",1.1665420532226562,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3780,Regional mapping of the phenylalanine hydroxylase gene and the phenylketonuria locus in the human genome .,O O O O O O O O O B O O O O O O,32," Regional mapping of the <span style=""background-color: #FFFF00"">phenylalanine hydroxylase gene</span> and the <span style=""background-color: #FFFF00"">phenylketonuria locus</span> in the human genome .",0.9018371105194092," Regional mapping of the <span style=""background-color: #FFFF00"">phenylalanine hydroxylase</span> gene and the <span style=""background-color: #FFFF00"">phenylketonuria</span> locus in the human genome .",1.0321400165557861," Regional mapping of the <span style=""background-color: #FFFF00"">phenylalanine hydroxylase</span> gene and the <span style=""background-color: #FFFF00"">phenylketonuria</span> locus in the human genome .",1.0525109767913818," Regional mapping of the <span style=""background-color: #FFFF00"">phenylalanine hydroxylase</span> gene and the <span style=""background-color: #FFFF00"">phenylketonuria</span> locus in the human genome .",1.2995083332061768,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']"
2439,This observation indicates that the WT1 exon 9 mutation affecting 394Arg demonstrated in over one - half of the patients with the Denys - Drash syndrome may exhibit incomplete penetrance .,O O O O O O O O O O O O O O O O O O O O O O B I I I O O O O O,32," This observation indicates that the <span style=""background-color: #FFFF00"">WT1 exon 9 mutation</span> affecting <span style=""background-color: #FFFF00"">394Arg</span> demonstrated in over one - half of the patients with the <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> may exhibit incomplete penetrance .",1.2964768409729004," This observation indicates that the <span style=""background-color: #FFFF00"">WT1 exon 9</span> mutation affecting 394Arg demonstrated in over one - half of the patients with the <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> may exhibit incomplete penetrance .",1.2005620002746582," This observation indicates that the <span style=""background-color: #FFFF00"">WT1 exon 9</span> mutation affecting 394Arg demonstrated in over one - half of the patients with the <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> may exhibit incomplete penetrance .",1.3058640956878662," This observation indicates that the <span style=""background-color: #FFFF00"">WT1</span> exon 9 mutation affecting 394Arg demonstrated in over one - half of the patients with the <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> may exhibit incomplete penetrance .",1.6383779048919678,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']"
1064,"The reported frequency of detection of VHL germline mutations has varied from 39 to 80 % ( J . M . Whaley et al . , Am . J . Hum . Genet . , 55 1092 - 1102 , 1994 ; Clinical Research Group for Japan , Hum . Mol . Genet . , 4 2233 - 2237 , 1995 ; F . Chen et al . , Hum . Mutat . , 5 66 - 75 , 1995 ; E . R . Maher et al . , J . Med . Genet . , 33 328 - 332 , 1996 ; B . Zbar , Cancer Surv . , 25 219 - 232 , 1995 ) .",O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,32," The reported frequency of detection of <span style=""background-color: #FFFF00"">VHL</span> germline mutations has varied from 39 to 80 % ( J . M . Whaley et al . , Am . J . Hum . Genet . , 55 1092 - 1102 , 1994 ; Clinical Research Group for Japan , Hum . Mol . Genet . , 4 2233 - 2237 , 1995 ; F . Chen et al . , Hum . Mutat . , 5 66 - 75 , 1995 ; E . R . Maher et al . , J . Med . Genet . , 33 328 - 332 , 1996 ; B . Zbar , Cancer Surv . , 25 219 - 232 , 1995 ) .",2.720021963119507," The reported frequency of detection of <span style=""background-color: #FFFF00"">VHL</span> germline mutations has varied from 39 to 80 % ( J . M . Whaley et al . , Am . J . Hum . Genet . , 55 1092 - 1102 , 1994 ; Clinical Research Group for Japan , Hum . Mol . Genet . , 4 2233 - 2237 , 1995 ; F . Chen et al . , Hum . Mutat . , 5 66 - 75 , 1995 ; E . R . Maher et al . , J . Med . Genet . , 33 328 - 332 , 1996 ; B . Zbar , Cancer Surv . , 25 219 - 232 , 1995 ) .",2.782444715499878," The reported frequency of detection of <span style=""background-color: #FFFF00"">VHL</span> germline mutations has varied from 39 to 80 % ( J . M . Whaley et al . , Am . J . Hum . Genet . , 55 1092 - 1102 , 1994 ; Clinical Research Group for Japan , Hum . Mol . Genet . , 4 2233 - 2237 , 1995 ; F . Chen et al . , Hum . Mutat . , 5 66 - 75 , 1995 ; E . R . Maher et al . , J . Med . Genet . , 33 328 - 332 , 1996 ; B . Zbar , Cancer Surv . , 25 219 - 232 , 1995 ) .",2.9068307876586914," The reported frequency of detection of <span style=""background-color: #FFFF00"">VHL</span> germline mutations has varied from 39 to 80 % ( J . M . Whaley et al . , Am . J . Hum . Genet . , 55 1092 - 1102 , 1994 ; Clinical Research Group for Japan , Hum . Mol . Genet . , 4 2233 - 2237 , 1995 ; F . Chen et al . , Hum . Mutat . , 5 66 - 75 , 1995 ; E . R . Maher et al . , J . Med . Genet . , 33 328 - 332 , 1996 ; B . Zbar , Cancer Surv . , 25 219 - 232 , 1995 ) .",3.2885799407958984,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3375,"These results are distinct from those previously noted in abetalipoproteinemia , which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein . .",O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O,32," These results are distinct from those previously noted in <span style=""background-color: #FFFF00"">abetalipoproteinemia</span> , which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein . .",1.7242109775543213," These results are distinct from those previously noted in <span style=""background-color: #FFFF00"">abetalipoproteinemia</span> , which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein . .",0.9741630554199219," These results are distinct from those previously noted in <span style=""background-color: #FFFF00"">abetalipoproteinemia</span> , which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein . .",1.0789330005645752," These results are distinct from those previously noted in <span style=""background-color: #FFFF00"">abetalipoproteinemia</span> , which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein . .",1.2878210544586182,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9881,These studies suggest that BRCA1 may normally serve as a negative regulator of mammary epithelial cell growth whose function is compromised in breast cancer either by direct mutation or alterations in gene expression . .,O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O,13," These studies suggest that <span style=""background-color: #FFFF00"">BRCA1</span> may normally serve as a negative regulator of <span style=""background-color: #FFFF00"">mammary epithelial cell growth</span> whose function is compromised in <span style=""background-color: #FFFF00"">breast cancer</span> either by direct mutation or alterations in gene expression . .",1.4827537536621094," These studies suggest that <span style=""background-color: #FFFF00"">BRCA1</span> may normally serve as a negative regulator of mammary epithelial cell growth whose function is compromised in <span style=""background-color: #FFFF00"">breast cancer</span> either by direct mutation or alterations in gene expression . .",1.156540870666504," These studies suggest that <span style=""background-color: #FFFF00"">BRCA1</span> may normally serve as a negative regulator of mammary epithelial cell growth whose function is compromised in <span style=""background-color: #FFFF00"">breast cancer</span> either by direct mutation or alterations in gene expression . .",1.2957220077514648," These studies suggest that BRCA1 may normally serve as a negative regulator of mammary epithelial cell growth whose function is compromised in <span style=""background-color: #FFFF00"">breast cancer</span> either by direct mutation or alterations in gene expression . .",1.299654245376587,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
10322,A new missense mutation in exon 1 causing glucose / galactose malabsorption is also described .,O O O O O O O O B I I I O O O O,13," A new missense mutation in exon 1 causing <span style=""background-color: #FFFF00"">glucose / galactose malabsorption</span> is also described .",0.7591447830200195," A new missense mutation in exon 1 causing <span style=""background-color: #FFFF00"">glucose / galactose malabsorption</span> is also described .",0.774310827255249," A new missense mutation in exon 1 causing <span style=""background-color: #FFFF00"">glucose / galactose malabsorption</span> is also described .",0.8919668197631836," A new missense mutation in exon 1 causing <span style=""background-color: #FFFF00"">glucose / galactose malabsorption</span> is also described .",1.1693758964538574,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O']"
7871,"Hence , 41 ( 95 % ) of 43 mutations resulted in truncation of the APC protein .",O O O O O O O O O O O O O O O B O O,13," Hence , 41 ( 95 % ) of 43 mutations resulted in truncation of the <span style=""background-color: #FFFF00"">APC</span> protein .",0.7535700798034668," Hence , 41 ( 95 % ) of 43 mutations resulted in truncation of the <span style=""background-color: #FFFF00"">APC</span> protein .",0.7950162887573242," Hence , 41 ( 95 % ) of 43 mutations resulted in truncation of the <span style=""background-color: #FFFF00"">APC</span> protein .",0.9453349113464355," Hence , 41 ( 95 % ) of 43 mutations resulted in truncation of the <span style=""background-color: #FFFF00"">APC</span> protein .",1.2178750038146973,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
4346,Brain disease and molecular analysis in myotonic dystrophy .,B I O O O O B I O,32," <span style=""background-color: #FFFF00"">Brain disease</span> and molecular analysis in <span style=""background-color: #FFFF00"">myotonic dystrophy</span> .",0.802793025970459," <span style=""background-color: #FFFF00"">Brain disease</span> and molecular analysis in <span style=""background-color: #FFFF00"">myotonic dystrophy</span> .",0.9440021514892578," <span style=""background-color: #FFFF00"">Brain disease</span> and molecular analysis in <span style=""background-color: #FFFF00"">myotonic dystrophy</span> .",1.0047807693481445," <span style=""background-color: #FFFF00"">Brain disease</span> and molecular analysis in <span style=""background-color: #FFFF00"">myotonic dystrophy</span> .",1.3771679401397705,"['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
4054,ALD hemizygotes showed increased levels of hexacosanoate ( C26 fatty acid ) which represented 0 .,B O O O O O O O O O O O O O O O,32," <span style=""background-color: #FFFF00"">ALD</span> hemizygotes showed increased levels of <span style=""background-color: #FFFF00"">hexacosanoate</span> ( <span style=""background-color: #FFFF00"">C26 fatty acid</span> ) which represented 0 .",1.2375187873840332," <span style=""background-color: #FFFF00"">ALD</span> hemizygotes showed increased levels of hexacosanoate ( C26 fatty acid ) which represented 0 .",0.8582701683044434," <span style=""background-color: #FFFF00"">ALD</span> hemizygotes showed increased levels of hexacosanoate ( C26 fatty acid ) which represented 0 .",1.04673171043396," <span style=""background-color: #FFFF00"">ALD</span> hemizygotes showed increased levels of hexacosanoate ( C26 fatty acid ) which represented 0 .",1.2781829833984375,"['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5373,"To investigate mutation origin and mutation - specific phenotypes due to BRCA1 , we constructed a haplotype of nine polymorphic markers within or immediately flanking the BRCA1 locus in a set of 61 breast / ovarian cancer families selected for having one of six recurrent BRCA1 mutations .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I I I O O O O O O O O O O O,32," To investigate mutation origin and mutation - specific phenotypes due to <span style=""background-color: #FFFF00"">BRCA1</span> , we constructed a haplotype of nine polymorphic markers within or immediately flanking the <span style=""background-color: #FFFF00"">BRCA1</span> locus in a set of 61 <span style=""background-color: #FFFF00"">breast</span> / <span style=""background-color: #FFFF00"">ovarian cancer</span> families selected for having one of six recurrent <span style=""background-color: #FFFF00"">BRCA1</span> mutations .",2.0811567306518555," To investigate mutation origin and mutation - specific phenotypes due to <span style=""background-color: #FFFF00"">BRCA1</span> , we constructed a haplotype of nine polymorphic markers within or immediately flanking the <span style=""background-color: #FFFF00"">BRCA1</span> locus in a set of 61 <span style=""background-color: #FFFF00"">breast / ovarian cancer</span> families selected for having one of six recurrent <span style=""background-color: #FFFF00"">BRCA1</span> mutations .",1.8797681331634521," To investigate mutation origin and mutation - specific phenotypes due to <span style=""background-color: #FFFF00"">BRCA1</span> , we constructed a haplotype of nine polymorphic markers within or immediately flanking the <span style=""background-color: #FFFF00"">BRCA1</span> locus in a set of 61 <span style=""background-color: #FFFF00"">breast / ovarian cancer</span> families selected for having one of six recurrent <span style=""background-color: #FFFF00"">BRCA1</span> mutations .",1.8905341625213623," To investigate mutation origin and mutation - specific phenotypes due to <span style=""background-color: #FFFF00"">BRCA1</span> , we constructed a haplotype of nine polymorphic markers within or immediately flanking the <span style=""background-color: #FFFF00"">BRCA1</span> locus in a set of 61 <span style=""background-color: #FFFF00"">breast / ovarian cancer</span> families selected for having one of six recurrent <span style=""background-color: #FFFF00"">BRCA1</span> mutations .",2.3022987842559814,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
5711,Heterozygous mutations in the CD95 ( APO - 1 / Fas ) receptor occur in most individuals with autoimmune lymphoproliferative syndrome ( ALPS ) and dominantly interfere with apoptosis by an unknown mechanism .,O O O O O O O O O O O O O O O O O O B I I O B O O O O O O O O O O O,13," Heterozygous mutations in the <span style=""background-color: #FFFF00"">CD95</span> ( <span style=""background-color: #FFFF00"">APO - 1</span> / <span style=""background-color: #FFFF00"">Fas</span> ) receptor occur in most individuals with <span style=""background-color: #FFFF00"">autoimmune lymphoproliferative syndrome</span> ( <span style=""background-color: #FFFF00"">ALPS</span> ) and dominantly interfere with <span style=""background-color: #FFFF00"">apoptosis</span> by an unknown mechanism .",1.9997329711914062," Heterozygous mutations in the <span style=""background-color: #FFFF00"">CD95 ( APO - 1 / Fas )</span> receptor occur in most individuals with <span style=""background-color: #FFFF00"">autoimmune lymphoproliferative syndrome ( ALPS )</span> and dominantly interfere with apoptosis by an unknown mechanism .",1.3409819602966309," Heterozygous mutations in the <span style=""background-color: #FFFF00"">CD95 ( APO - 1 / Fas )</span> receptor occur in most individuals with <span style=""background-color: #FFFF00"">autoimmune lymphoproliferative syndrome ( ALPS )</span> and dominantly interfere with apoptosis by an unknown mechanism .",1.4002318382263184," <span style=""background-color: #FFFF00"">Heterozygous mutations</span> in the <span style=""background-color: #FFFF00"">CD95 ( APO - 1 / Fas ) receptor</span> occur in most individuals with <span style=""background-color: #FFFF00"">autoimmune lymphoproliferative syndrome</span> ( <span style=""background-color: #FFFF00"">ALPS</span> ) and dominantly interfere with apoptosis by an unknown mechanism .",1.9598603248596191,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
889,Coats ' disease of the retina ( unilateral retinal telangiectasis ) caused by somatic mutation in the NDP gene : a role for norrin in retinal angiogenesis .,B I I O O O O B I I O O O O O O O O O O O O O O O O O O,32," <span style=""background-color: #FFFF00"">Coats' disease</span> of the retina ( <span style=""background-color: #FFFF00"">unilateral retinal telangiectasis</span> ) caused by somatic mutation in the <span style=""background-color: #FFFF00"">NDP</span> gene : a role for <span style=""background-color: #FFFF00"">norrin</span> in retinal angiogenesis .",1.5831689834594727," <span style=""background-color: #FFFF00"">Coats ' disease</span> of the retina ( unilateral retinal telangiectasis ) caused by somatic mutation in the NDP gene : a role for norrin in retinal angiogenesis .",0.9171912670135498," <span style=""background-color: #FFFF00"">Coats ' disease</span> of the retina ( <span style=""background-color: #FFFF00"">unilateral retinal telangiectasis</span> ) caused by somatic mutation in the NDP gene : a role for norrin in retinal angiogenesis .",1.2803280353546143," <span style=""background-color: #FFFF00"">Coats ' disease</span> of the retina ( <span style=""background-color: #FFFF00"">unilateral retinal telangiectasis</span> ) caused by somatic mutation in the NDP gene : a role for norrin in retinal angiogenesis .",1.5693390369415283,"['B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
12487,Five of the cases were observed in children presenting with idiopathic hemolytic uremic syndrome ( HUS ) .,O O O O O O O O O O O B I I O B O O,39," Five of the cases were observed in children presenting with <span style=""background-color: #FFFF00"">idiopathic hemolytic uremic syndrome</span> ( <span style=""background-color: #FFFF00"">HUS</span> ) .",0.9270448684692383," Five of the cases were observed in children presenting with <span style=""background-color: #FFFF00"">idiopathic hemolytic uremic syndrome</span> ( <span style=""background-color: #FFFF00"">HUS</span> ) .",1.0100460052490234," Five of the cases were observed in children presenting with <span style=""background-color: #FFFF00"">idiopathic hemolytic uremic syndrome</span> ( <span style=""background-color: #FFFF00"">HUS</span> ) .",1.0474398136138916," Five of the cases were observed in children presenting with <span style=""background-color: #FFFF00"">idiopathic hemolytic uremic syndrome</span> ( <span style=""background-color: #FFFF00"">HUS</span> ) .",1.3611679077148438,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']"
12563,"The two polymorphisms were localized in noncoding part of the gene 1 ) a C / G polymorphism in the promotor region , 142 bp upstream from the transcriptional initiation site ( - 142C / G ) , and 2 ) a 6 bp deletion polymorphism in the 3 noncoding part of the CPO gene , 574 bp downstream of the last base of the normal termination codon ( + 574 delATTCTT ) .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,39," The two polymorphisms were localized in noncoding part of the gene 1 ) a C / G polymorphism in the <span style=""background-color: #FFFF00"">promotor region</span> , 142 bp upstream from the <span style=""background-color: #FFFF00"">transcriptional initiation site</span> ( - 142C / G ) , and 2 ) a 6 bp deletion polymorphism in the 3 <span style=""background-color: #FFFF00"">noncoding part</span> of the <span style=""background-color: #FFFF00"">CPO gene</span> , 574 bp downstream of the last base of the <span style=""background-color: #FFFF00"">normal termination codon</span> ( + 574 delATTCTT ) .",2.63273024559021," The two polymorphisms were localized in noncoding part of the gene 1 ) a C / G polymorphism in the <span style=""background-color: #FFFF00"">promotor region</span> , 142 bp upstream from the transcriptional initiation site ( - 142C / G ) , and 2 ) a 6 bp deletion polymorphism in the 3 <span style=""background-color: #FFFF00"">noncoding part</span> of the CPO gene , 574 bp downstream of the last base of the normal termination codon ( + 574 delATTCTT ) .",2.328979969024658," The two polymorphisms were localized in noncoding part of the gene 1 ) a C / G polymorphism in the <span style=""background-color: #FFFF00"">promotor region</span> , 142 bp upstream from the transcriptional initiation site ( - 142C / G ) , and 2 ) a 6 bp deletion polymorphism in the 3 <span style=""background-color: #FFFF00"">noncoding part</span> of the CPO gene , 574 bp downstream of the last base of the normal termination codon ( + 574 delATTCTT ) .",1.9916229248046875," The two polymorphisms were localized in noncoding part of the gene 1 ) a C / G polymorphism in the <span style=""background-color: #FFFF00"">promotor</span> region , 142 bp upstream from the transcriptional initiation site ( - 142C / G ) , and 2 ) a 6 bp deletion polymorphism in the 3 <span style=""background-color: #FFFF00"">noncoding</span> part of the CPO gene , 574 bp downstream of the last base of the normal termination codon ( + 574 delATTCTT ) .",2.2176740169525146,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5458,"Analysis of the prevalence of the various mutations among DPD patients has shown that the G - - > A point mutation in the invariant splice donor site is by far the most common ( 52 % ) , whereas the other six mutations are less frequently observed .",O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,13," Analysis of the prevalence of the various mutations among <span style=""background-color: #FFFF00"">DPD</span> patients has shown that the G - - > A point mutation in the invariant splice donor site is by far the most common ( 52 % ) , whereas the other six mutations are less frequently observed .",1.1530358791351318," Analysis of the prevalence of the various mutations among DPD patients has shown that the G - - > A point mutation in the <span style=""background-color: #FFFF00"">invariant splice donor site</span> is by far the most common ( 52 % ) , whereas the other six mutations are less frequently observed .",1.20638108253479," Analysis of the prevalence of the various mutations among DPD patients has shown that the G - - > A point mutation in the invariant splice donor site is by far the most common ( 52 % ) , whereas the other six mutations are less frequently observed .",1.1700243949890137," Analysis of the prevalence of the various mutations among <span style=""background-color: #FFFF00"">DPD</span> patients has shown that the G - - > A point mutation in the invariant splice donor site is by far the most common ( 52 % ) , whereas the other six mutations are less frequently observed .",1.5005531311035156,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
10672,We analyzed DNA samples from women enrolled in a population - based study of early - onset breast cancer to assess the spectrum and frequency of germ - line BRCA1 mutations in young women with breast cancer .,O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O B I O,13," We analyzed DNA samples from women enrolled in a population - based study of early - onset <span style=""background-color: #FFFF00"">breast cancer</span> to assess the spectrum and frequency of germ - line <span style=""background-color: #FFFF00"">BRCA1</span> mutations in young women with <span style=""background-color: #FFFF00"">breast cancer</span> .",1.3779001235961914," We analyzed DNA samples from women enrolled in a population - based study of early - onset <span style=""background-color: #FFFF00"">breast cancer</span> to assess the spectrum and frequency of germ - line <span style=""background-color: #FFFF00"">BRCA1</span> mutations in young women with <span style=""background-color: #FFFF00"">breast cancer</span> .",1.4306881427764893," We analyzed DNA samples from women enrolled in a population - based study of <span style=""background-color: #FFFF00"">early - onset breast cancer</span> to assess the spectrum and frequency of germ - line <span style=""background-color: #FFFF00"">BRCA1</span> mutations in young women with <span style=""background-color: #FFFF00"">breast cancer</span> .",2.0740060806274414," We analyzed DNA samples from women enrolled in a population - based study of <span style=""background-color: #FFFF00"">early - onset breast cancer</span> to assess the spectrum and frequency of germ - line BRCA1 mutations in young women with <span style=""background-color: #FFFF00"">breast cancer</span> .",2.139298677444458,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
2559,"Over time , typical features of PWS developed .",O O O O O O B O O,32," Over time , typical features of <span style=""background-color: #FFFF00"">PWS</span> developed .",0.8846700191497803," Over time , typical features of <span style=""background-color: #FFFF00"">PWS</span> developed .",0.6482317447662354," Over time , typical features of <span style=""background-color: #FFFF00"">PWS</span> developed .",0.7670688629150391," Over time , typical features of <span style=""background-color: #FFFF00"">PWS</span> developed .",1.0678069591522217,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
12583,"Mutations of the human PAX6 gene underlie aniridia ( congenital absence of the iris ) , a rare dominant malformation of the eye .",O O O O O O O B O B I I I I O O O O O B I I I O,39," Mutations of the human <span style=""background-color: #FFFF00"">PAX6</span> gene underlie <span style=""background-color: #FFFF00"">aniridia</span> ( <span style=""background-color: #FFFF00"">congenital absence of the iris</span> ) , a rare dominant malformation of the eye .",1.2710418701171875," Mutations of the human <span style=""background-color: #FFFF00"">PAX6</span> gene underlie <span style=""background-color: #FFFF00"">aniridia</span> ( congenital absence of the iris ) , a rare dominant malformation of the eye .",1.0907187461853027," Mutations of the human <span style=""background-color: #FFFF00"">PAX6</span> gene underlie <span style=""background-color: #FFFF00"">aniridia</span> ( congenital absence of the iris ) , a rare dominant malformation of the eye .",1.3260829448699951," Mutations of the human <span style=""background-color: #FFFF00"">PAX6</span> gene underlie <span style=""background-color: #FFFF00"">aniridia</span> ( congenital absence of the iris ) , a rare dominant malformation of the eye .",1.4443669319152832,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9384,"A chromosome 15 anomaly was observed in 12 of 20 patients , 17 of whom were clinically suspected of having Prader - Willi syndrome ( PWS ) .",O B I I O O O O O O O O O O O O O O O O B I I I O B O O,13," A chromosome 15 anomaly was observed in 12 of 20 patients , 17 of whom were clinically suspected of having <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> ( <span style=""background-color: #FFFF00"">PWS</span> ) .",1.1424999237060547," A chromosome 15 anomaly was observed in 12 of 20 patients , 17 of whom were clinically suspected of having <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> ( <span style=""background-color: #FFFF00"">PWS</span> ) .",1.160918951034546," A chromosome 15 anomaly was observed in 12 of 20 patients , 17 of whom were clinically suspected of having <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> ( <span style=""background-color: #FFFF00"">PWS</span> ) .",1.36592698097229," A chromosome 15 anomaly was observed in 12 of 20 patients , 17 of whom were clinically suspected of having <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> ( <span style=""background-color: #FFFF00"">PWS</span> ) .",1.6164560317993164,"['O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']"
5612,"These selection pressures could be due to infectious diseases , environmental conditions , or other genetic disorders such as anemia .",O O O O O O O B I O O O O O O B I O O B O,13," These selection pressures could be due to <span style=""background-color: #FFFF00"">infectious diseases</span> , <span style=""background-color: #FFFF00"">environmental conditions</span> , or other <span style=""background-color: #FFFF00"">genetic disorders</span> such as <span style=""background-color: #FFFF00"">anemia</span> .",1.5226659774780273," These selection pressures could be due to <span style=""background-color: #FFFF00"">infectious diseases</span> , environmental conditions , or other genetic disorders such as <span style=""background-color: #FFFF00"">anemia</span> .",1.0553860664367676," These selection pressures could be due to <span style=""background-color: #FFFF00"">infectious diseases</span> , environmental conditions , or other genetic disorders such as <span style=""background-color: #FFFF00"">anemia</span> .",1.117879867553711," These selection pressures could be due to <span style=""background-color: #FFFF00"">infectious diseases</span> , <span style=""background-color: #FFFF00"">environmental conditions</span> , or other <span style=""background-color: #FFFF00"">genetic disorders</span> such as <span style=""background-color: #FFFF00"">anemia</span> .",1.6886940002441406,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O']"
3882,These observations provide further evidence for genetic heterogeneity among patients with disorders in purine metabolism involving the HPRT gene .,O O O O O O O O O O O O O O O O O O O O,32," These observations provide further evidence for genetic heterogeneity among patients with disorders in <span style=""background-color: #FFFF00"">purine metabolism</span> involving the <span style=""background-color: #FFFF00"">HPRT gene</span> .",1.0008678436279297," These observations provide further evidence for genetic heterogeneity among patients with disorders in purine metabolism involving the <span style=""background-color: #FFFF00"">HPRT</span> gene .",0.8009548187255859," These observations provide further evidence for genetic heterogeneity among patients with disorders in purine metabolism involving the <span style=""background-color: #FFFF00"">HPRT</span> gene .",0.9044039249420166," These observations provide further evidence for genetic heterogeneity among patients with disorders in purine metabolism involving the <span style=""background-color: #FFFF00"">HPRT</span> gene .",1.1491529941558838,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
35,The serum of a 29 - year old woman with a recent episode of disseminated gonococcal infection and a history of meningococcal meningitis and arthritis as a child was found to lack serum hemolytic complement activity .,O O O O O O O O O O O O O O B I I O O O O B I O B O O O O O O O O O O O O,32," The serum of a 29 - year old woman with a recent episode of <span style=""background-color: #FFFF00"">disseminated gonococcal infection</span> and a history of <span style=""background-color: #FFFF00"">meningococcal meningitis</span> and <span style=""background-color: #FFFF00"">arthritis</span> as a child was found to lack serum hemolytic complement activity .",1.4102559089660645," The serum of a 29 - year old woman with a recent episode of <span style=""background-color: #FFFF00"">disseminated gonococcal infection</span> and a history of <span style=""background-color: #FFFF00"">meningococcal meningitis</span> and <span style=""background-color: #FFFF00"">arthritis</span> as a child was found to lack serum hemolytic complement activity .",1.6400730609893799," The serum of a 29 - year old woman with a recent episode of disseminated <span style=""background-color: #FFFF00"">gonococcal infection</span> and a history of <span style=""background-color: #FFFF00"">meningococcal meningitis</span> and <span style=""background-color: #FFFF00"">arthritis</span> as a child was found to lack serum hemolytic complement activity .",1.5124211311340332," The serum of a 29 - year old woman with a recent episode of disseminated <span style=""background-color: #FFFF00"">gonococcal infection</span> and a history of <span style=""background-color: #FFFF00"">meningococcal meningitis</span> and <span style=""background-color: #FFFF00"">arthritis</span> as a child was found to lack serum hemolytic complement activity .",1.745441198348999,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
4153,"An Irish family is described , in which 2 of 3 brothers had recurrent meningococcal infection .",O O O O O O O O O O O O O O B I O,32," An Irish family is described , in which 2 of 3 brothers had recurrent <span style=""background-color: #FFFF00"">meningococcal infection</span> .",0.6992588043212891," An Irish family is described , in which 2 of 3 brothers had recurrent <span style=""background-color: #FFFF00"">meningococcal infection</span> .",0.7904667854309082," An Irish family is described , in which 2 of 3 brothers had recurrent <span style=""background-color: #FFFF00"">meningococcal infection</span> .",0.8944671154022217," An Irish family is described , in which 2 of 3 brothers had recurrent <span style=""background-color: #FFFF00"">meningococcal infection</span> .",1.1267180442810059,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
5194,"To fill this gap , we sequenced the G6PD gene of 43 G6PD - deficient Chinese whose G6PD was well characterized biochemically .",O O O O O O O O O O O O B I I O O O O O O O O,32," To fill this gap , we sequenced the <span style=""background-color: #FFFF00"">G6PD</span> gene of 43 <span style=""background-color: #FFFF00"">G6PD</span> - deficient Chinese whose <span style=""background-color: #FFFF00"">G6PD</span> was well characterized biochemically .",1.3220181465148926," To fill this gap , we sequenced the <span style=""background-color: #FFFF00"">G6PD</span> gene of 43 <span style=""background-color: #FFFF00"">G6PD</span> - deficient Chinese whose <span style=""background-color: #FFFF00"">G6PD</span> was well characterized biochemically .",1.3249752521514893," To fill this gap , we sequenced the <span style=""background-color: #FFFF00"">G6PD</span> gene of 43 <span style=""background-color: #FFFF00"">G6PD - deficient</span> Chinese whose <span style=""background-color: #FFFF00"">G6PD</span> was well characterized biochemically .",1.38844895362854," To fill this gap , we sequenced the <span style=""background-color: #FFFF00"">G6PD</span> gene of 43 <span style=""background-color: #FFFF00"">G6PD - deficient</span> Chinese whose <span style=""background-color: #FFFF00"">G6PD</span> was well characterized biochemically .",1.6492960453033447,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']"
10611,"The complete sequence and characterization of the structure of the DM kinase gene , as well as the identification of novel polymorphisms within the gene , represent an important step in a further understanding of the genetics of myotonic dystrophy and the molecular biology of the gene . .",O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O,13," The complete sequence and characterization of the structure of the <span style=""background-color: #FFFF00"">DM kinase gene</span> , as well as the identification of novel polymorphisms within the <span style=""background-color: #FFFF00"">gene</span> , represent an important step in a further understanding of the genetics of <span style=""background-color: #FFFF00"">myotonic dystrophy</span> and the molecular biology of the <span style=""background-color: #FFFF00"">gene</span> . .",1.721506118774414," The complete sequence and characterization of the structure of the <span style=""background-color: #FFFF00"">DM kinase</span> gene , as well as the identification of novel polymorphisms within the gene , represent an important step in a further understanding of the genetics of <span style=""background-color: #FFFF00"">myotonic dystrophy</span> and the molecular biology of the gene . .",1.3793470859527588," The complete sequence and characterization of the structure of the <span style=""background-color: #FFFF00"">DM kinase</span> gene , as well as the identification of novel polymorphisms within the gene , represent an important step in a further understanding of the genetics of <span style=""background-color: #FFFF00"">myotonic dystrophy</span> and the molecular biology of the gene . .",1.4574768543243408," The complete sequence and characterization of the structure of the <span style=""background-color: #FFFF00"">DM kinase</span> gene , as well as the identification of novel polymorphisms within the gene , represent an important step in a further understanding of the genetics of <span style=""background-color: #FFFF00"">myotonic dystrophy</span> and the molecular biology of the gene . .",1.6949830055236816,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11217,G6PD activity was detected in samples obtained from biopsies on the quadriceps muscle of seven males and one female .,O O O O O O O O O O O O O O O O O O O O,13, G6PD activity was detected in samples obtained from biopsies on the quadriceps muscle of seven males and one female .,0.5740399360656738, G6PD activity was detected in samples obtained from biopsies on the quadriceps muscle of seven males and one female .,0.6400649547576904, G6PD activity was detected in samples obtained from biopsies on the quadriceps muscle of seven males and one female .,0.7435779571533203," G6PD activity was detected in samples obtained from biopsies on the <span style=""background-color: #FFFF00"">quadriceps muscle</span> of seven males and one female .",1.2475693225860596,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
2118,"One hundred and twenty - six W27 - negative controls matched for race , sex , and age failed to yield a single case .",O O O O O O O O O O O O O O O O O O O O O O O O O,32," One hundred and twenty - six W27 - negative controls matched for race , sex , and age failed to yield a single case .",0.6204485893249512," One hundred and twenty - six W27 - negative controls matched for race , sex , and age failed to yield a single case .",0.7507221698760986," One hundred and twenty - six W27 - negative controls matched for race , sex , and age failed to yield a single case .",0.864264965057373," One hundred and twenty - six W27 - negative controls matched for race , sex , and age failed to yield a single case .",1.047658920288086,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7434,We have expressed an untranslated CUG repeat in an unrelated mRNA in transgenic mice .,O O O O O O O O O O O O O O O,13, We have expressed an untranslated CUG repeat in an unrelated mRNA in transgenic mice .,0.5794839859008789, We have expressed an untranslated CUG repeat in an unrelated mRNA in transgenic mice .,0.5320971012115479, We have expressed an untranslated CUG repeat in an unrelated mRNA in transgenic mice .,0.6612322330474854, We have expressed an untranslated CUG repeat in an unrelated mRNA in transgenic mice .,1.0306050777435303,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
2792,"By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and FMF .",O O O O O O O O O O O O O O O O O O O O B O,32," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the <span style=""background-color: #FFFF00"">SAA</span> gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",1.0416998863220215," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",1.0558722019195557," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",0.9344570636749268," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",1.1794068813323975,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
11062,Deletion of small nuclear ribonucleoprotein polypeptide N ( SNRPN ) in Prader - Willi syndrome detected by fluorescence in situ hybridization : two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q .,O O O O O O O O O O O B I I I O O O O O O O O O O O O O O O O O O O O O,13," Deletion of small nuclear <span style=""background-color: #FFFF00"">ribonucleoprotein polypeptide N</span> ( <span style=""background-color: #FFFF00"">SNRPN</span> ) in <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> detected by fluorescence in situ hybridization : two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q .",1.4050111770629883," Deletion of small nuclear ribonucleoprotein polypeptide N ( <span style=""background-color: #FFFF00"">SNRPN</span> ) in <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> detected by fluorescence in situ hybridization : two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q .",1.2615227699279785," Deletion of small nuclear ribonucleoprotein polypeptide N ( <span style=""background-color: #FFFF00"">SNRPN</span> ) in <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> detected by fluorescence in situ hybridization : two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q .",1.3637781143188477," Deletion of small nuclear ribonucleoprotein polypeptide N ( <span style=""background-color: #FFFF00"">SNRPN</span> ) in <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> detected by fluorescence in situ hybridization : two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q .",1.6102111339569092,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
12617,"Abnormal hepatic copper accumulation is recognized as an inherited disorder in man , mouse , rat and dog .",O B I I O O O O B I O O O O O O O O O,39," Abnormal hepatic <span style=""background-color: #FFFF00"">copper accumulation</span> is recognized as an <span style=""background-color: #FFFF00"">inherited disorder</span> in man , mouse , rat and dog .",1.1443850994110107," Abnormal hepatic copper accumulation is recognized as an inherited disorder in man , mouse , rat and dog .",0.5700092315673828," Abnormal hepatic copper accumulation is recognized as an inherited disorder in <span style=""background-color: #FFFF00"">man</span> , <span style=""background-color: #FFFF00"">mouse</span> , <span style=""background-color: #FFFF00"">rat</span> and <span style=""background-color: #FFFF00"">dog</span> .",1.4273772239685059," <span style=""background-color: #FFFF00"">Abnormal hepatic copper</span> accumulation is recognized as an inherited disorder in man , mouse , rat and dog .",1.1560521125793457,"['O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'B', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3920,G6PD deficiency is heterogeneous in northern Algeria where autochtonous variants seem to prevail .,B I O O O O O O O O O O O O,32," <span style=""background-color: #FFFF00"">G6PD deficiency</span> is heterogeneous in northern <span style=""background-color: #FFFF00"">Algeria</span> where autochtonous variants seem to prevail .",0.9088633060455322," <span style=""background-color: #FFFF00"">G6PD deficiency</span> is heterogeneous in northern Algeria where autochtonous variants seem to prevail .",0.7383289337158203," <span style=""background-color: #FFFF00"">G6PD deficiency</span> is heterogeneous in northern Algeria where autochtonous variants seem to prevail .",0.8769550323486328," <span style=""background-color: #FFFF00"">G6PD deficiency</span> is heterogeneous in northern Algeria where autochtonous variants seem to prevail .",1.2027380466461182,"['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
1256,Our patient illustrates the importance of investigating for underlying ocular and central nervous system pathology whenever midline scalp defects are present . .,O O O O O O O O O O O O O O O O B I I O O O O,32," Our patient illustrates the importance of investigating for underlying <span style=""background-color: #FFFF00"">ocular</span> and <span style=""background-color: #FFFF00"">central nervous system</span> pathology whenever midline scalp defects are present . .",0.9821889400482178, Our patient illustrates the importance of investigating for underlying ocular and central nervous system pathology whenever midline scalp defects are present . .,0.613832950592041, Our patient illustrates the importance of investigating for underlying ocular and central nervous system pathology whenever midline scalp defects are present . .,0.7132060527801514," Our patient illustrates the importance of investigating for underlying <span style=""background-color: #FFFF00"">ocular</span> and <span style=""background-color: #FFFF00"">central nervous system</span> pathology whenever midline scalp defects are present . .",1.3592281341552734,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11733,"Myotonic dystrophy ( DM ) , the most prevalent muscular disorder in adults , is caused by ( CTG ) n - repeat expansion in a gene encoding a protein kinase ( DM protein kinase ; DMPK ) and involves changes in cytoarchitecture and ion homeostasis .",B I O B O O O O O B I O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O,39," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) , the most prevalent <span style=""background-color: #FFFF00"">muscular disorder</span> in adults , is caused by ( <span style=""background-color: #FFFF00"">CTG</span> ) n - repeat expansion in a gene encoding a <span style=""background-color: #FFFF00"">protein kinase</span> ( <span style=""background-color: #FFFF00"">DM protein kinase</span> ; <span style=""background-color: #FFFF00"">DMPK</span> ) and involves changes in <span style=""background-color: #FFFF00"">cytoarchitecture</span> and <span style=""background-color: #FFFF00"">ion homeostasis</span> .",2.6167359352111816," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) , the most prevalent <span style=""background-color: #FFFF00"">muscular disorder</span> in adults , is caused by ( CTG ) n - repeat expansion in a gene encoding a protein kinase ( <span style=""background-color: #FFFF00"">DM protein kinase</span> ; <span style=""background-color: #FFFF00"">DMPK</span> ) and involves changes in cytoarchitecture and ion homeostasis .",1.9409029483795166," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) , the most prevalent <span style=""background-color: #FFFF00"">muscular disorder</span> in adults , is caused by ( CTG ) n - repeat expansion in a gene encoding a protein kinase ( <span style=""background-color: #FFFF00"">DM protein kinase</span> ; <span style=""background-color: #FFFF00"">DMPK</span> ) and involves changes in cytoarchitecture and ion homeostasis .",2.1886909008026123," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) , the most prevalent <span style=""background-color: #FFFF00"">muscular disorder</span> in adults , is caused by ( CTG ) n - repeat expansion in a gene encoding a protein kinase ( <span style=""background-color: #FFFF00"">DM protein kinase</span> ; <span style=""background-color: #FFFF00"">DMPK</span> ) and involves changes in cytoarchitecture and ion homeostasis .",2.4614338874816895,"['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9414,"Molecular , kinetic , and functional studies were carried out on erythrocytes and leukocytes in a Spanish male with G6PD deficiency , congenital nonspherocytic hemolytic anemia ( CNSHA ) , and increased susceptibility to infections .",O O O O O O O O O O O O O O O O O O O B I O B I I I O B O O O O O O O O,13," Molecular , kinetic , and functional studies were carried out on erythrocytes and leukocytes in a Spanish male with <span style=""background-color: #FFFF00"">G6PD deficiency</span> , <span style=""background-color: #FFFF00"">congenital nonspherocytic hemolytic anemia</span> ( <span style=""background-color: #FFFF00"">CNSHA</span> ) , and increased susceptibility to infections .",1.4083380699157715," Molecular , kinetic , and functional studies were carried out on erythrocytes and leukocytes in a Spanish male with <span style=""background-color: #FFFF00"">G6PD deficiency</span> , <span style=""background-color: #FFFF00"">congenital nonspherocytic hemolytic anemia</span> ( <span style=""background-color: #FFFF00"">CNSHA</span> ) , and increased susceptibility to infections .",1.4670631885528564," Molecular , kinetic , and functional studies were carried out on erythrocytes and leukocytes in a Spanish male with <span style=""background-color: #FFFF00"">G6PD deficiency</span> , <span style=""background-color: #FFFF00"">congenital nonspherocytic hemolytic anemia</span> ( <span style=""background-color: #FFFF00"">CNSHA</span> ) , and increased susceptibility to infections .",1.5577473640441895," Molecular , kinetic , and functional studies were carried out on erythrocytes and leukocytes in a Spanish male with <span style=""background-color: #FFFF00"">G6PD deficiency</span> , <span style=""background-color: #FFFF00"">congenital nonspherocytic hemolytic anemia</span> ( <span style=""background-color: #FFFF00"">CNSHA</span> ) , and increased susceptibility to infections .",1.7975459098815918,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3764,"Since the donor of one of these biopsies has a large deletion of the 5 - region of the DMD gene , our results argue against the recent proposal that nebulin is the gene mutated in DMD . .",O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O B O O,32," Since the donor of one of these biopsies has a large deletion of the 5 - region of the <span style=""background-color: #FFFF00"">DMD</span> gene , our results argue against the recent proposal that nebulin is the gene mutated in <span style=""background-color: #FFFF00"">DMD</span> . .",1.2790741920471191," Since the donor of one of these biopsies has a large deletion of the 5 - region of the <span style=""background-color: #FFFF00"">DMD</span> gene , our results argue against the recent proposal that nebulin is the gene mutated in <span style=""background-color: #FFFF00"">DMD</span> . .",1.2636327743530273," Since the donor of one of these biopsies has a large deletion of the 5 - region of the <span style=""background-color: #FFFF00"">DMD</span> gene , our results argue against the recent proposal that nebulin is the gene mutated in <span style=""background-color: #FFFF00"">DMD</span> . .",1.3723721504211426," Since the donor of one of these biopsies has a large deletion of the 5 - region of the <span style=""background-color: #FFFF00"">DMD</span> gene , our results argue against the recent proposal that nebulin is the gene mutated in <span style=""background-color: #FFFF00"">DMD</span> . .",1.5898711681365967,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
2034,"Mice that expressed expanded CUG repeats developed myotonia and myopathy , whereas mice expressing a nonexpanded repeat did not .",O O O O O O O B O B O O O O O O O O O O,32," Mice that expressed expanded <span style=""background-color: #FFFF00"">CUG</span> repeats developed <span style=""background-color: #FFFF00"">myotonia</span> and <span style=""background-color: #FFFF00"">myopathy</span> , whereas mice expressing a nonexpanded repeat did not .",1.1681621074676514," Mice that expressed expanded CUG repeats developed <span style=""background-color: #FFFF00"">myotonia</span> and <span style=""background-color: #FFFF00"">myopathy</span> , whereas mice expressing a nonexpanded repeat did not .",1.0326220989227295," Mice that expressed expanded CUG repeats developed <span style=""background-color: #FFFF00"">myotonia</span> and <span style=""background-color: #FFFF00"">myopathy</span> , whereas mice expressing a nonexpanded repeat did not .",1.124204158782959," Mice that expressed expanded CUG repeats developed <span style=""background-color: #FFFF00"">myotonia</span> and <span style=""background-color: #FFFF00"">myopathy</span> , whereas mice expressing a nonexpanded repeat did not .",1.656867265701294,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9439,( 3 ) Favism has been observed associated with all kinds of variants described here .,O O O B O O O O O O O O O O O O,13," <span style=""background-color: #FFFF00"">Favism</span> has been observed associated with all kinds of variants described here .",0.7371628284454346," ( 3 ) <span style=""background-color: #FFFF00"">Favism</span> has been observed associated with all kinds of variants described here .",0.7772552967071533," ( 3 ) <span style=""background-color: #FFFF00"">Favism</span> has been observed associated with all kinds of variants described here .",0.8696601390838623," ( 3 ) <span style=""background-color: #FFFF00"">Favism</span> has been observed associated with all kinds of variants described here .",1.0978219509124756,"['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9654,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease , and absence of muscle hypertrophy .",O O O O O O O O O O O B I O O O O O O O O B O O B I O O O O B I O,13," No linkage or molecular genetic data are as yet available on <span style=""background-color: #FFFF00"">myotonia levior</span> characterized by milder symptoms and later onset of myotonia than in <span style=""background-color: #FFFF00"">Thomsens disease</span> , and absence of muscle hypertrophy .",1.1473779678344727," No linkage or molecular genetic data are as yet available on <span style=""background-color: #FFFF00"">myotonia levior</span> characterized by milder symptoms and later onset of myotonia than in <span style=""background-color: #FFFF00"">Thomsens disease</span> , and absence of muscle hypertrophy .",1.1692829132080078," No linkage or molecular genetic data are as yet available on <span style=""background-color: #FFFF00"">myotonia levior</span> characterized by milder symptoms and later onset of myotonia than in <span style=""background-color: #FFFF00"">Thomsens disease</span> , and absence of <span style=""background-color: #FFFF00"">muscle hypertrophy</span> .",1.5098750591278076," No linkage or molecular genetic data are as yet available on <span style=""background-color: #FFFF00"">myotonia levior</span> characterized by milder symptoms and later onset of myotonia than in <span style=""background-color: #FFFF00"">Thomsens disease</span> , and absence of <span style=""background-color: #FFFF00"">muscle hypertrophy</span> .",1.8117802143096924,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
8994,Fibroblasts from two obligate SLS heterozygotes had enzyme activities intermediate between that in normal fibroblasts and individuals with SLS .,O O O O B O O O O O O O O O O O O O B O,13," Fibroblasts from two obligate <span style=""background-color: #FFFF00"">SLS</span> heterozygotes had enzyme activities intermediate between that in normal fibroblasts and individuals with <span style=""background-color: #FFFF00"">SLS</span> .",1.0466129779815674," Fibroblasts from two obligate <span style=""background-color: #FFFF00"">SLS</span> heterozygotes had enzyme activities intermediate between that in normal fibroblasts and individuals with <span style=""background-color: #FFFF00"">SLS</span> .",1.058286190032959," Fibroblasts from two obligate <span style=""background-color: #FFFF00"">SLS</span> heterozygotes had enzyme activities intermediate between that in normal fibroblasts and individuals with <span style=""background-color: #FFFF00"">SLS</span> .",1.2798380851745605," <span style=""background-color: #FFFF00"">Fibroblasts</span> from two obligate <span style=""background-color: #FFFF00"">SLS</span> heterozygotes had enzyme activities intermediate between that in normal <span style=""background-color: #FFFF00"">fibroblasts</span> and individuals with <span style=""background-color: #FFFF00"">SLS</span> .",1.7573177814483643,"['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O']"
8179,Carrier detection and prenatal diagnosis of Pelizaeus - Merzbacher disease using a combination of anonymous DNA polymorphisms and the proteolipid protein ( PLP ) gene cDNA .,O O O O O O B I I I O O O O O O O O O O O O O O O O O,13," Carrier detection and prenatal diagnosis of <span style=""background-color: #FFFF00"">Pelizaeus - Merzbacher disease</span> using a combination of anonymous DNA polymorphisms and the <span style=""background-color: #FFFF00"">proteolipid protein ( PLP )</span> gene cDNA .",1.1414968967437744," Carrier detection and prenatal diagnosis of <span style=""background-color: #FFFF00"">Pelizaeus - Merzbacher disease</span> using a combination of anonymous DNA polymorphisms and the proteolipid protein ( <span style=""background-color: #FFFF00"">PLP</span> ) gene cDNA .",1.128330945968628," Carrier detection and prenatal diagnosis of <span style=""background-color: #FFFF00"">Pelizaeus - Merzbacher disease</span> using a combination of anonymous DNA polymorphisms and the proteolipid protein ( <span style=""background-color: #FFFF00"">PLP</span> ) gene cDNA .",1.2284090518951416," Carrier detection and prenatal diagnosis of <span style=""background-color: #FFFF00"">Pelizaeus - Merzbacher disease</span> using a combination of anonymous DNA polymorphisms and the <span style=""background-color: #FFFF00"">proteolipid protein</span> ( <span style=""background-color: #FFFF00"">PLP</span> ) gene cDNA .",1.6327741146087646,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O']"
8139,Our data further support the notion of molecular heterogeneity of galactosemia and suggest that galactosemia mutations and GALT polymorphisms may be useful tools in highlighting different functional domains in human GALT . .,O O O O O O O O O O B O O O B O O O O O O O O O O O O O O O O O O,13," Our data further support the notion of molecular heterogeneity of <span style=""background-color: #FFFF00"">galactosemia</span> and suggest that <span style=""background-color: #FFFF00"">galactosemia</span> mutations and <span style=""background-color: #FFFF00"">GALT</span> polymorphisms may be useful tools in highlighting different functional domains in human <span style=""background-color: #FFFF00"">GALT</span> . .",1.5889437198638916," Our data further support the notion of molecular heterogeneity of <span style=""background-color: #FFFF00"">galactosemia</span> and suggest that <span style=""background-color: #FFFF00"">galactosemia</span> mutations and <span style=""background-color: #FFFF00"">GALT</span> polymorphisms may be useful tools in highlighting different functional domains in human <span style=""background-color: #FFFF00"">GALT</span> . .",1.755674123764038," Our data further support the notion of molecular heterogeneity of <span style=""background-color: #FFFF00"">galactosemia</span> and suggest that <span style=""background-color: #FFFF00"">galactosemia</span> mutations and GALT polymorphisms may be useful tools in highlighting different functional domains in human GALT . .",1.4683611392974854," Our data further support the notion of molecular heterogeneity of <span style=""background-color: #FFFF00"">galactosemia</span> and suggest that <span style=""background-color: #FFFF00"">galactosemia</span> mutations and GALT polymorphisms may be useful tools in highlighting different functional domains in human GALT . .",1.553422212600708,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
6910,"In addition , pedigree analyses suggest the occurrence of an autosomal recessive variant .",O O O O O O O O O O O O O O,13," In addition , pedigree analyses suggest the occurrence of an <span style=""background-color: #FFFF00"">autosomal recessive variant</span> .",0.674274206161499," In addition , pedigree analyses suggest the occurrence of an <span style=""background-color: #FFFF00"">autosomal recessive variant</span> .",0.7043559551239014," In addition , pedigree analyses suggest the occurrence of an <span style=""background-color: #FFFF00"">autosomal recessive</span> variant .",0.8336970806121826," In addition , pedigree analyses suggest the occurrence of an <span style=""background-color: #FFFF00"">autosomal recessive</span> variant .",1.1006839275360107,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']"
8855,"G6PD deficiency in different geographical areas appears to have arisen through independent mutational events , but within the same population it may also be heterogeneous .",B I O O O O O O O O O O O O O O O O O O O O O O O O,13," <span style=""background-color: #FFFF00"">G6PD deficiency</span> in different geographical areas appears to have arisen through independent mutational events , but within the same population it may also be <span style=""background-color: #FFFF00"">heterogeneous</span> .",1.0278818607330322," <span style=""background-color: #FFFF00"">G6PD</span> deficiency in different geographical areas appears to have arisen through independent mutational events , but within the same population it may also be heterogeneous .",0.9156761169433594," <span style=""background-color: #FFFF00"">G6PD deficiency</span> in different geographical areas appears to have arisen through independent mutational events , but within the same population it may also be heterogeneous .",0.9915666580200195," <span style=""background-color: #FFFF00"">G6PD</span> deficiency in different geographical areas appears to have arisen through independent mutational events , but within the same population it may also be heterogeneous .",1.2203161716461182,"['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3430,"A map assignment of OCRL to Xq24 - q26 has been made previously by linkage analysis with DXS42 at Xq24 - q26 ( theta = 0 , z = 5 . 09 ) and with DXS10 at Xq26 ( theta = 0 , z = 6 . 45 ) .",O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,32," A map assignment of OCRL to <span style=""background-color: #FFFF00"">Xq24 - q26</span> has been made previously by linkage analysis with <span style=""background-color: #FFFF00"">DXS42</span> at <span style=""background-color: #FFFF00"">Xq24 - q26</span> ( theta = 0 , z = 5 . 09 ) and with <span style=""background-color: #FFFF00"">DXS10</span> at <span style=""background-color: #FFFF00"">Xq26</span> ( theta = 0 , z = 6 . 45 ) .",2.195136070251465," A map assignment of <span style=""background-color: #FFFF00"">OCRL</span> to <span style=""background-color: #FFFF00"">Xq24 - q26</span> has been made previously by linkage analysis with <span style=""background-color: #FFFF00"">DXS42</span> at <span style=""background-color: #FFFF00"">Xq24 - q26</span> ( theta = 0 , z = 5 . 09 ) and with <span style=""background-color: #FFFF00"">DXS10</span> at <span style=""background-color: #FFFF00"">Xq26</span> ( theta = 0 , z = 6 . 45 ) .",2.5134520530700684," A map assignment of OCRL to <span style=""background-color: #FFFF00"">Xq24 - q26</span> has been made previously by linkage analysis with DXS42 at <span style=""background-color: #FFFF00"">Xq24 - q26</span> ( theta = 0 , z = 5 . 09 ) and with DXS10 at <span style=""background-color: #FFFF00"">Xq26</span> ( theta = 0 , z = 6 . 45 ) .",1.9775047302246094," A map assignment of OCRL to <span style=""background-color: #FFFF00"">Xq24 - q26</span> has been made previously by linkage analysis with DXS42 at <span style=""background-color: #FFFF00"">Xq24 - q26</span> ( theta = 0 , z = 5 . 09 ) and with DXS10 at <span style=""background-color: #FFFF00"">Xq26</span> ( theta = 0 , z = 6 . 45 ) .",2.2479569911956787,"['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7156,Age penetrance is greater for BRCA1 - linked than for BRCA2 - linked cancers in this population .,O O O O O B I I I I I I I I O O O O,13," Age penetrance is greater for <span style=""background-color: #FFFF00"">BRCA1</span> - linked than for <span style=""background-color: #FFFF00"">BRCA2</span> - linked <span style=""background-color: #FFFF00"">cancers</span> in this population .",1.2536871433258057," Age penetrance is greater for <span style=""background-color: #FFFF00"">BRCA1</span> - linked than for <span style=""background-color: #FFFF00"">BRCA2</span> - linked cancers in this population .",1.04264497756958," Age penetrance is greater for <span style=""background-color: #FFFF00"">BRCA1</span> - linked than for <span style=""background-color: #FFFF00"">BRCA2</span> - linked cancers in this population .",1.0905709266662598," Age penetrance is greater for <span style=""background-color: #FFFF00"">BRCA1</span> - linked than for <span style=""background-color: #FFFF00"">BRCA2</span> - linked <span style=""background-color: #FFFF00"">cancers</span> in this population .",1.5913078784942627,"['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O']"
9828,This frequency ( > 57 % ) was much higher than that observed in patients with other disorders of mitochondrial long - chain fatty acid oxidation that may be accompanied by cardiac disease in infants . .,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O,13," This frequency ( > 57 % ) was much higher than that observed in patients with other disorders of <span style=""background-color: #FFFF00"">mitochondrial long - chain fatty acid oxidation</span> that may be accompanied by <span style=""background-color: #FFFF00"">cardiac disease</span> in infants . .",1.162696123123169," This frequency ( > 57 % ) was much higher than that observed in patients with other disorders of mitochondrial long - chain fatty acid oxidation that may be accompanied by <span style=""background-color: #FFFF00"">cardiac disease</span> in infants . .",0.9869658946990967," This frequency ( > 57 % ) was much higher than that observed in patients with other disorders of mitochondrial long - chain fatty acid oxidation that may be accompanied by <span style=""background-color: #FFFF00"">cardiac disease</span> in infants . .",1.1036930084228516," This frequency ( > 57 % ) was much higher than that observed in patients with other disorders of <span style=""background-color: #FFFF00"">mitochondrial long - chain fatty acid oxidation</span> that may be accompanied by <span style=""background-color: #FFFF00"">cardiac disease</span> in infants . .",1.5624101161956787,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O']"
10041,We have cloned cDNAs for the rat gene ( Atp7b ) homologous to the human Wilson disease gene ( ATP7B ) and have used them to identify a partial deletion in the Atp7b gene in the LEC rat .,O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O,13," We have cloned cDNAs for the rat gene ( <span style=""background-color: #FFFF00"">Atp7b</span> ) homologous to the human <span style=""background-color: #FFFF00"">Wilson disease</span> gene ( <span style=""background-color: #FFFF00"">ATP7B</span> ) and have used them to identify a partial deletion in the <span style=""background-color: #FFFF00"">Atp7b</span> gene in the LEC rat .",1.6837360858917236," We have cloned cDNAs for the rat gene ( <span style=""background-color: #FFFF00"">Atp7b</span> ) homologous to the human <span style=""background-color: #FFFF00"">Wilson disease</span> gene ( <span style=""background-color: #FFFF00"">ATP7B</span> ) and have used them to identify a partial deletion in the <span style=""background-color: #FFFF00"">Atp7b</span> gene in the LEC rat .",1.6916611194610596," We have cloned cDNAs for the rat gene ( <span style=""background-color: #FFFF00"">Atp7b</span> ) homologous to the human <span style=""background-color: #FFFF00"">Wilson disease</span> gene ( <span style=""background-color: #FFFF00"">ATP7B</span> ) and have used them to identify a partial deletion in the <span style=""background-color: #FFFF00"">Atp7b</span> gene in the LEC rat .",1.8367056846618652," We have cloned cDNAs for the rat gene ( <span style=""background-color: #FFFF00"">Atp7b</span> ) homologous to the human <span style=""background-color: #FFFF00"">Wilson disease</span> gene ( <span style=""background-color: #FFFF00"">ATP7B</span> ) and have used them to identify a partial deletion in the <span style=""background-color: #FFFF00"">Atp7b</span> gene in the LEC rat .",2.016847848892212,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']"
698,00 for D1S245 .,O O O O,32," <span style=""background-color: #FFFF00"">00</span> for <span style=""background-color: #FFFF00"">D1S245</span> .",0.7705998420715332," 00 for <span style=""background-color: #FFFF00"">D1S245</span> .",0.6478631496429443," 00 for <span style=""background-color: #FFFF00"">D1S245</span> .",0.7819228172302246," 00 for <span style=""background-color: #FFFF00"">D1S245</span> .",0.9835119247436523,"['O', 'O', 'O', 'O']","['B', 'O', 'B', 'O']","['O', 'O', 'B', 'O']","['O', 'O', 'B', 'O']","['O', 'O', 'B', 'O']"
7281,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non - syndromic hearing loss , we compared three common Pendred syndrome allele variants ( L236P , T416P and E384G ) , with three PDS mutations reported only in individuals with non - syndromic hearing loss ( V480D , V653A and I490L / G497S ) .",O O O B O O O O B I O O O B O O O O B I I I I O O O O O B I O O O O O O O O O O O O B O O O O O O B I I I I O O O O O O O O O O,13," To determine whether <span style=""background-color: #FFFF00"">PDS</span> mutations in individuals with <span style=""background-color: #FFFF00"">Pendred syndrome</span> differ functionally from <span style=""background-color: #FFFF00"">PDS</span> mutations in individuals with non - syndromic <span style=""background-color: #FFFF00"">hearing loss</span> , we compared three common <span style=""background-color: #FFFF00"">Pendred syndrome</span> allele variants ( <span style=""background-color: #FFFF00"">L236P</span> , <span style=""background-color: #FFFF00"">T416P</span> and <span style=""background-color: #FFFF00"">E384G</span> ) , with three <span style=""background-color: #FFFF00"">PDS</span> mutations reported only in individuals with non - syndromic <span style=""background-color: #FFFF00"">hearing loss</span> ( <span style=""background-color: #FFFF00"">V480D</span> , <span style=""background-color: #FFFF00"">V653A</span> and <span style=""background-color: #FFFF00"">I490L</span> / <span style=""background-color: #FFFF00"">G497S</span> ) .",4.0971057415008545," To determine whether PDS mutations in individuals with <span style=""background-color: #FFFF00"">Pendred syndrome</span> differ functionally from PDS mutations in individuals with non - syndromic hearing loss , we compared three common <span style=""background-color: #FFFF00"">Pendred syndrome</span> allele variants ( <span style=""background-color: #FFFF00"">L236P</span> , <span style=""background-color: #FFFF00"">T416P</span> and <span style=""background-color: #FFFF00"">E384G</span> ) , with three PDS mutations reported only in individuals with non - syndromic hearing loss ( <span style=""background-color: #FFFF00"">V480D</span> , <span style=""background-color: #FFFF00"">V653A</span> and <span style=""background-color: #FFFF00"">I490L</span> / <span style=""background-color: #FFFF00"">G497S</span> ) .",3.2042691707611084," To determine whether PDS mutations in individuals with <span style=""background-color: #FFFF00"">Pendred syndrome</span> differ functionally from PDS mutations in individuals with non - syndromic hearing loss , we compared three common <span style=""background-color: #FFFF00"">Pendred syndrome</span> allele variants ( L236P , T416P and E384G ) , with three PDS mutations reported only in individuals with non - syndromic hearing loss ( V480D , V653A and I490L / G497S ) .",2.0852606296539307," To determine whether PDS mutations in individuals with <span style=""background-color: #FFFF00"">Pendred syndrome</span> differ functionally from PDS mutations in individuals with non - syndromic hearing loss , we compared three common <span style=""background-color: #FFFF00"">Pendred syndrome</span> allele variants ( L236P , T416P and E384G ) , with three PDS mutations reported only in individuals with non - syndromic hearing loss ( V480D , V653A and I490L / G497S ) .",2.322450876235962,"['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11555,The causes of heterogeneity are not known yet but are likely to include both different mutations at the SJS locus on chromosome 1 and the presence of a second SJS locus .,O O O O O O O O O O O O O O O O O O B O O O O O O O O O O B O O,13," The causes of heterogeneity are not known yet but are likely to include both different mutations at the <span style=""background-color: #FFFF00"">SJS locus</span> on chromosome 1 and the presence of a second <span style=""background-color: #FFFF00"">SJS locus</span> .",1.1403858661651611," The causes of heterogeneity are not known yet but are likely to include both different mutations at the <span style=""background-color: #FFFF00"">SJS</span> locus on chromosome 1 and the presence of a second <span style=""background-color: #FFFF00"">SJS</span> locus .",1.139275074005127," The causes of heterogeneity are not known yet but are likely to include both different mutations at the <span style=""background-color: #FFFF00"">SJS</span> locus on chromosome 1 and the presence of a second <span style=""background-color: #FFFF00"">SJS</span> locus .",1.2343859672546387," The causes of heterogeneity are not known yet but are likely to include both different mutations at the <span style=""background-color: #FFFF00"">SJS</span> locus on chromosome 1 and the presence of a second <span style=""background-color: #FFFF00"">SJS</span> locus .",1.5112199783325195,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
465,"Three congenital anomaly disorders , cat - eye syndrome , der ( ) syndrome and velo - cardio - facial syndrome / DiGeorge syndrome ( VCFS / DGS ) are associated with tetrasomy , trisomy or monosomy , respectively , for part of chromosome 22q11 .",O B I I O B I I I O B I I I O B I I I I I O B I O B O B O O O O O O O O O O O O O O O O O O,32," Three congenital <span style=""background-color: #FFFF00"">anomaly disorders</span> , <span style=""background-color: #FFFF00"">cat - eye syndrome</span> , <span style=""background-color: #FFFF00"">der ( ) syndrome</span> and <span style=""background-color: #FFFF00"">velo - cardio - facial syndrome</span> / <span style=""background-color: #FFFF00"">DiGeorge syndrome</span> ( <span style=""background-color: #FFFF00"">VCFS</span> / <span style=""background-color: #FFFF00"">DGS</span> ) are associated with <span style=""background-color: #FFFF00"">tetrasomy</span> , <span style=""background-color: #FFFF00"">trisomy</span> or <span style=""background-color: #FFFF00"">monosomy</span> , respectively , for part of chromosome 22q11 .",2.8842029571533203," Three congenital anomaly disorders , <span style=""background-color: #FFFF00"">cat - eye syndrome</span> , der ( ) syndrome and <span style=""background-color: #FFFF00"">velo - cardio - facial syndrome</span> / <span style=""background-color: #FFFF00"">DiGeorge syndrome</span> ( <span style=""background-color: #FFFF00"">VCFS</span> / <span style=""background-color: #FFFF00"">DGS</span> ) are associated with tetrasomy , trisomy or monosomy , respectively , for part of chromosome 22q11 .",2.0463619232177734," Three congenital anomaly disorders , <span style=""background-color: #FFFF00"">cat - eye syndrome</span> , <span style=""background-color: #FFFF00"">der ( ) syndrome</span> and <span style=""background-color: #FFFF00"">velo - cardio - facial syndrome / DiGeorge syndrome</span> ( <span style=""background-color: #FFFF00"">VCFS / DGS</span> ) are associated with tetrasomy , trisomy or monosomy , respectively , for part of chromosome 22q11 .",1.9172608852386475," Three congenital anomaly disorders , <span style=""background-color: #FFFF00"">cat - eye syndrome</span> , <span style=""background-color: #FFFF00"">der ( ) syndrome</span> and <span style=""background-color: #FFFF00"">velo - cardio - facial syndrome / DiGeorge syndrome</span> ( <span style=""background-color: #FFFF00"">VCFS / DGS</span> ) are associated with tetrasomy , trisomy or monosomy , respectively , for part of chromosome 22q11 .",2.067106008529663,"['O', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
737,Index cases for the present study were found two different ways through a series of consecutive ovarian cancers ( n = 16 ) and through our family cancer clinic ( n = 14 ) .,O O O O O O O O O O O O O O O O B I O O O O O O O O O B O O O O O O O,32," Index cases for the present study were found two different ways through a series of consecutive <span style=""background-color: #FFFF00"">ovarian cancers</span> ( n = 16 ) and through our family <span style=""background-color: #FFFF00"">cancer</span> clinic ( n = 14 ) .",1.1262807846069336," Index cases for the present study were found two different ways through a series of consecutive <span style=""background-color: #FFFF00"">ovarian cancers</span> ( n = 16 ) and through our family cancer clinic ( n = 14 ) .",1.0158541202545166," Index cases for the present study were found two different ways through a series of consecutive <span style=""background-color: #FFFF00"">ovarian cancers</span> ( n = 16 ) and through our family cancer clinic ( n = 14 ) .",1.196653127670288," Index cases for the present study were found two different ways through a series of consecutive <span style=""background-color: #FFFF00"">ovarian cancers</span> ( n = 16 ) and through our family <span style=""background-color: #FFFF00"">cancer</span> clinic ( n = 14 ) .",1.6041381359100342,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
12170,"In individuals with mutations in either region 2 or region 3 , the average number of adenomas tended to be lower than those in individuals with mutations in region 1 , although age at diagnosis was similar .",O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O,39," In individuals with mutations in either region 2 or region 3 , the average number of adenomas tended to be lower than those in individuals with mutations in region 1 , although age at diagnosis was similar .",0.8816587924957275," In individuals with mutations in either region 2 or region 3 , the average number of adenomas tended to be lower than those in individuals with mutations in region 1 , although age at diagnosis was similar .",0.8309328556060791," In individuals with mutations in either region 2 or region 3 , the average number of adenomas tended to be lower than those in individuals with mutations in region 1 , although age at diagnosis was similar .",0.9210481643676758," In individuals with mutations in either region 2 or region 3 , the average number of adenomas tended to be lower than those in individuals with mutations in region 1 , although age at diagnosis was similar .",1.19486403465271,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
2351,We have utilized backcross analysis in mice to verify and define more precisely the location of the Pdeb locus 6 .,O O O O O O O O O O O O O O O O O O O O O,32," We have utilized backcross analysis in mice to verify and define more precisely the location of the <span style=""background-color: #FFFF00"">Pdeb</span> locus 6 .",0.8464241027832031," We have utilized backcross analysis in mice to verify and define more precisely the location of the <span style=""background-color: #FFFF00"">Pdeb</span> locus 6 .",0.8206980228424072," We have utilized backcross analysis in mice to verify and define more precisely the location of the <span style=""background-color: #FFFF00"">Pdeb</span> locus 6 .",0.9006991386413574," We have utilized backcross analysis in mice to verify and define more precisely the location of the <span style=""background-color: #FFFF00"">Pdeb</span> locus 6 .",1.1984808444976807,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']"
5675,Hereditary hemochromatosis ( HH ) is a common autosomal recessive genetic disorder of iron metabolism .,B I O B O O O O B I I I O O O O,13," <span style=""background-color: #FFFF00"">Hereditary hemochromatosis</span> ( <span style=""background-color: #FFFF00"">HH</span> ) is a common <span style=""background-color: #FFFF00"">autosomal recessive genetic disorder</span> of <span style=""background-color: #FFFF00"">iron metabolism</span> .",1.3187389373779297," <span style=""background-color: #FFFF00"">Hereditary hemochromatosis</span> ( <span style=""background-color: #FFFF00"">HH</span> ) is a common autosomal recessive genetic disorder of iron metabolism .",0.989940881729126," <span style=""background-color: #FFFF00"">Hereditary hemochromatosis</span> ( <span style=""background-color: #FFFF00"">HH</span> ) is a common autosomal recessive genetic disorder of iron metabolism .",1.0996379852294922," <span style=""background-color: #FFFF00"">Hereditary hemochromatosis</span> ( <span style=""background-color: #FFFF00"">HH</span> ) is a common autosomal recessive genetic disorder of iron metabolism .",1.295659065246582,"['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
4118,Glucose - 6 - phosphate dehydrogenase ( G6PD ) deficiency in RBCs was found significantly more frequently in 210 male cataractous patients than in 672 control subjects of Sardinian origin .,B I I I I I I I I I O O O O O O O O O O B O O O O O O O O O O,32," <span style=""background-color: #FFFF00"">Glucose - 6 - phosphate dehydrogenase</span> ( <span style=""background-color: #FFFF00"">G6PD</span> ) <span style=""background-color: #FFFF00"">deficiency</span> in <span style=""background-color: #FFFF00"">RBCs</span> was found significantly more frequently in 210 male <span style=""background-color: #FFFF00"">cataractous</span> patients than in 672 control subjects of <span style=""background-color: #FFFF00"">Sardinian</span> origin .",1.996448040008545," Glucose - 6 - phosphate dehydrogenase ( <span style=""background-color: #FFFF00"">G6PD</span> ) deficiency in RBCs was found significantly more frequently in 210 male cataractous patients than in 672 control subjects of Sardinian origin .",1.9747109413146973," <span style=""background-color: #FFFF00"">Glucose - 6 - phosphate dehydrogenase</span> ( <span style=""background-color: #FFFF00"">G6PD</span> ) deficiency in RBCs was found significantly more frequently in 210 male cataractous patients than in 672 control subjects of Sardinian origin .",1.3363068103790283," <span style=""background-color: #FFFF00"">Glucose - 6 - phosphate dehydrogenase</span> ( <span style=""background-color: #FFFF00"">G6PD</span> ) deficiency in RBCs was found significantly more frequently in 210 male <span style=""background-color: #FFFF00"">cataractous</span> patients than in 672 control subjects of Sardinian origin .",1.8441178798675537,"['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3495,In BMD families no recombinants were observed in the 16 informative meioses studied .,O B O O O O O O O O O O O O,32," In <span style=""background-color: #FFFF00"">BMD</span> families no recombinants were observed in the 16 informative meioses studied .",0.7778401374816895," In <span style=""background-color: #FFFF00"">BMD</span> families no recombinants were observed in the 16 informative meioses studied .",0.7764058113098145," In <span style=""background-color: #FFFF00"">BMD</span> families no recombinants were observed in the 16 informative meioses studied .",0.9412212371826172," In <span style=""background-color: #FFFF00"">BMD</span> families no recombinants were observed in the 16 informative meioses studied .",1.118217945098877,"['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5305,"We have studied 28 nuclear families selected for apparent unilineal transmission of the BPAD phenotype , by using 31 polymorphic markers spanning chromosome 18 .",O O O O O O O O O O O O O B O O O O O O O O O O O,32," We have studied 28 nuclear families selected for apparent unilineal transmission of the <span style=""background-color: #FFFF00"">BPAD</span> phenotype , by using 31 polymorphic markers spanning chromosome 18 .",1.0685710906982422," We have studied 28 nuclear families selected for apparent unilineal transmission of the <span style=""background-color: #FFFF00"">BPAD</span> phenotype , by using 31 polymorphic markers spanning chromosome 18 .",1.0379478931427002," We have studied 28 nuclear families selected for apparent unilineal transmission of the <span style=""background-color: #FFFF00"">BPAD</span> phenotype , by using 31 polymorphic markers spanning chromosome 18 .",1.0291540622711182," We have studied 28 nuclear families selected for apparent unilineal transmission of the <span style=""background-color: #FFFF00"">BPAD</span> phenotype , by using 31 polymorphic markers spanning chromosome 18 .",1.2756919860839844,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
1897,The Wiskott - Aldrich syndrome ( WAS ) is caused by defects in the WAS protein ( WASP ) gene on the X chromosome .,O B I I I O B O O O O O O O B O O O O O O O O O O,32," The <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is caused by defects in the <span style=""background-color: #FFFF00"">WAS protein</span> ( <span style=""background-color: #FFFF00"">WASP</span> ) gene on the X chromosome .",1.372617244720459," The <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is caused by defects in the <span style=""background-color: #FFFF00"">WAS</span> protein ( <span style=""background-color: #FFFF00"">WASP</span> ) gene on the X chromosome .",1.460010051727295," The <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is caused by defects in the <span style=""background-color: #FFFF00"">WAS</span> protein ( <span style=""background-color: #FFFF00"">WASP</span> ) gene on the X chromosome .",1.572436809539795," The <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is caused by defects in the <span style=""background-color: #FFFF00"">WAS</span> protein ( <span style=""background-color: #FFFF00"">WASP</span> ) gene on the X chromosome .",1.777216911315918,"['O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
8191,Exclusion of linkage between familial Mediterranean fever and the human serum amyloid A ( SAA ) gene cluster .,O O O O B I I O O O O O O O O O O O O,13," Exclusion of linkage between <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> and the human serum <span style=""background-color: #FFFF00"">amyloid A ( SAA )</span> gene cluster .",0.9210779666900635," Exclusion of linkage between <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> and the human serum amyloid A ( <span style=""background-color: #FFFF00"">SAA</span> ) gene cluster .",0.9686000347137451," Exclusion of linkage between <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> and the human serum amyloid A ( <span style=""background-color: #FFFF00"">SAA</span> ) gene cluster .",1.054715871810913," Exclusion of linkage between <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> and the human serum amyloid A ( <span style=""background-color: #FFFF00"">SAA</span> ) gene cluster .",1.2885980606079102,"['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O']"
4202,One PAX6 mutation found in the PST region was associated with cataracts in an aniridia family .,O O O O O O O O O O O B O O B O O,32," One <span style=""background-color: #FFFF00"">PAX6</span> mutation found in the <span style=""background-color: #FFFF00"">PST</span> region was associated with <span style=""background-color: #FFFF00"">cataracts</span> in an <span style=""background-color: #FFFF00"">aniridia</span> family .",1.3166007995605469," One <span style=""background-color: #FFFF00"">PAX6</span> mutation found in the PST region was associated with cataracts in an aniridia family .",0.7820370197296143," One <span style=""background-color: #FFFF00"">PAX6</span> mutation found in the PST region was associated with <span style=""background-color: #FFFF00"">cataracts</span> in an <span style=""background-color: #FFFF00"">aniridia</span> family .",1.4285881519317627," One <span style=""background-color: #FFFF00"">PAX6</span> mutation found in the PST region was associated with <span style=""background-color: #FFFF00"">cataracts</span> in an <span style=""background-color: #FFFF00"">aniridia</span> family .",1.48809814453125,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O']"
9045,In the nondeficient polymorphic African variant G6PD A we have found a single point mutation .,O O O O O O O O O O O O O O O O,13," In the nondeficient polymorphic <span style=""background-color: #FFFF00"">African variant G6PD</span> A we have found a single point mutation .",0.7292730808258057," In the nondeficient polymorphic African variant <span style=""background-color: #FFFF00"">G6PD A</span> we have found a single point mutation .",0.8007950782775879," In the nondeficient polymorphic African variant <span style=""background-color: #FFFF00"">G6PD A</span> we have found a single point mutation .",0.9012892246246338," In the nondeficient polymorphic African variant <span style=""background-color: #FFFF00"">G6PD A</span> we have found a single point mutation .",1.1930911540985107,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7160,"To facilitate our understanding of the normal function of MEFV , we extended our previous studies .",O O O O O O O O O O O O O O O O O,13," To facilitate our understanding of the normal function of <span style=""background-color: #FFFF00"">MEFV</span> , we extended our previous studies .",0.6781718730926514," To facilitate our understanding of the normal function of <span style=""background-color: #FFFF00"">MEFV</span> , we extended our previous studies .",0.7459981441497803," To facilitate our understanding of the normal function of MEFV , we extended our previous studies .",0.7839100360870361," To facilitate our understanding of the normal function of MEFV , we extended our previous studies .",0.931696891784668,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
8842,Linkage analysis with flanking markers was used to assess OCRL carrier status in women at risk .,O O O O O O O O O B O O O O O O O,13," Linkage analysis with flanking markers was used to assess <span style=""background-color: #FFFF00"">OCRL</span> carrier status in women at risk .",0.6967761516571045," Linkage analysis with flanking markers was used to assess <span style=""background-color: #FFFF00"">OCRL</span> carrier status in women at risk .",0.7301843166351318," Linkage analysis with flanking markers was used to assess <span style=""background-color: #FFFF00"">OCRL</span> carrier status in women at risk .",0.8687949180603027," Linkage analysis with flanking markers was used to assess <span style=""background-color: #FFFF00"">OCRL</span> carrier status in women at risk .",1.0920538902282715,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9526,"Defects in enzymes of the beta - oxidation pathway cause sudden , unexplained death in childhood , acute hepatic encephalopathy or liver failure , skeletal myopathy , and cardiomyopathy .",O O O O O O O O O O B I I I O O O O B I O B I O B I O O B O,13," Defects in enzymes of the <span style=""background-color: #FFFF00"">beta - oxidation pathway</span> cause sudden , unexplained death in childhood , acute hepatic encephalopathy or <span style=""background-color: #FFFF00"">liver failure</span> , <span style=""background-color: #FFFF00"">skeletal myopathy</span> , and <span style=""background-color: #FFFF00"">cardiomyopathy</span> .",1.454375982284546," Defects in enzymes of the beta - oxidation pathway cause sudden , unexplained death in childhood , acute hepatic encephalopathy or liver failure , <span style=""background-color: #FFFF00"">skeletal myopathy</span> , and <span style=""background-color: #FFFF00"">cardiomyopathy</span> .",1.188124179840088," Defects in enzymes of the beta - oxidation pathway cause sudden , unexplained death in childhood , acute hepatic encephalopathy or <span style=""background-color: #FFFF00"">liver failure</span> , <span style=""background-color: #FFFF00"">skeletal myopathy</span> , and <span style=""background-color: #FFFF00"">cardiomyopathy</span> .",1.424666166305542," Defects in enzymes of the beta - oxidation pathway cause sudden , unexplained death in childhood , acute hepatic encephalopathy or <span style=""background-color: #FFFF00"">liver failure</span> , <span style=""background-color: #FFFF00"">skeletal myopathy</span> , and <span style=""background-color: #FFFF00"">cardiomyopathy</span> .",1.6602959632873535,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'O']"
8640,Linkage analysis of the apolipoprotein C2 gene and myotonic dystrophy on human chromosome 19 reveals linkage disequilibrium in a French - Canadian population .,O O O O O O O O B I O O O O O O O O O O O O O O,13," Linkage analysis of the <span style=""background-color: #FFFF00"">apolipoprotein C2</span> gene and <span style=""background-color: #FFFF00"">myotonic dystrophy</span> on human chromosome 19 reveals linkage disequilibrium in a <span style=""background-color: #FFFF00"">French - Canadian</span> population .",1.2396430969238281," Linkage analysis of the <span style=""background-color: #FFFF00"">apolipoprotein C2</span> gene and <span style=""background-color: #FFFF00"">myotonic dystrophy</span> on human chromosome 19 reveals linkage disequilibrium in a French - Canadian population .",1.166839838027954," Linkage analysis of the apolipoprotein C2 gene and <span style=""background-color: #FFFF00"">myotonic dystrophy</span> on human chromosome 19 reveals linkage disequilibrium in a French - Canadian population .",1.0412118434906006," Linkage analysis of the <span style=""background-color: #FFFF00"">apolipoprotein C2</span> gene and <span style=""background-color: #FFFF00"">myotonic dystrophy</span> on human chromosome 19 reveals linkage disequilibrium in a French - Canadian population .",1.437695026397705,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
4618,"The genetic instability observed in the tumor and cell line DNA , together with the germ - line mutation in a mismatch - repair gene , suggest that the MSH2 gene is involved in the onset and / or progression in a subset of ovarian cancer . .",O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O,32," The genetic instability observed in the tumor and cell line <span style=""background-color: #FFFF00"">DNA</span> , together with the germ - line mutation in a <span style=""background-color: #FFFF00"">mismatch - repair gene</span> , suggest that the <span style=""background-color: #FFFF00"">MSH2 gene</span> is involved in the onset and / or progression in a subset of <span style=""background-color: #FFFF00"">ovarian cancer</span> . .",1.731274127960205," The genetic instability observed in the tumor and cell line DNA , together with the germ - line mutation in a <span style=""background-color: #FFFF00"">mismatch - repair</span> gene , suggest that the <span style=""background-color: #FFFF00"">MSH2</span> gene is involved in the onset and / or progression in a subset of ovarian cancer . .",1.2907581329345703," The genetic instability observed in the tumor and cell line DNA , together with the germ - line mutation in a <span style=""background-color: #FFFF00"">mismatch - repair</span> gene , suggest that the MSH2 gene is involved in the onset and / or progression in a subset of ovarian cancer . .",1.3033571243286133," The genetic instability observed in the <span style=""background-color: #FFFF00"">tumor</span> and cell line DNA , together with the germ - line mutation in a <span style=""background-color: #FFFF00"">mismatch - repair</span> gene , suggest that the MSH2 gene is involved in the onset and / or progression in a subset of <span style=""background-color: #FFFF00"">ovarian cancer</span> . .",1.9535632133483887,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']"
5120,"Aniridia is a congenital malformation of the eye , chiefly characterised by iris hypoplasia , which can cause blindness .",B O O B I I I I O O O O B I O O O O B O,32," <span style=""background-color: #FFFF00"">Aniridia</span> is a congenital malformation of the eye , chiefly characterised by <span style=""background-color: #FFFF00"">iris hypoplasia</span> , which can cause <span style=""background-color: #FFFF00"">blindness</span> .",1.7411303520202637," <span style=""background-color: #FFFF00"">Aniridia</span> is a congenital malformation of the eye , chiefly characterised by iris hypoplasia , which can cause blindness .",0.8480887413024902," <span style=""background-color: #FFFF00"">Aniridia</span> is a congenital malformation of the eye , chiefly characterised by iris hypoplasia , which can cause blindness .",0.9286532402038574," <span style=""background-color: #FFFF00"">Aniridia</span> is a congenital malformation of the eye , chiefly characterised by iris hypoplasia , which can cause blindness .",1.1753599643707275,"['B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
10150,"A high risk of colorectal cancer was predicted when an interstitial deletion of the long arm of chromosome 5 , del ( 5 ) ( q15q22 . 3 ) , was detected in her lymphocytes and deletion of the MCC and APC genes confirmed by molecular analysis .",O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O,13," A high risk of <span style=""background-color: #FFFF00"">colorectal cancer</span> was predicted when an interstitial deletion of the long arm of chromosome 5 , del ( 5 ) ( q15q22 . 3 ) , was detected in her lymphocytes and deletion of the <span style=""background-color: #FFFF00"">MCC</span> and <span style=""background-color: #FFFF00"">APC</span> genes confirmed by molecular analysis .",1.5138750076293945," A high risk of <span style=""background-color: #FFFF00"">colorectal cancer</span> was predicted when an interstitial deletion of the long arm of chromosome 5 , del ( 5 ) ( q15q22 . 3 ) , was detected in her lymphocytes and deletion of the <span style=""background-color: #FFFF00"">MCC</span> and <span style=""background-color: #FFFF00"">APC</span> genes confirmed by molecular analysis .",1.6060810089111328," A high risk of colorectal cancer was predicted when an interstitial deletion of the long arm of chromosome 5 , del ( 5 ) ( q15q22 . 3 ) , was detected in her lymphocytes and deletion of the <span style=""background-color: #FFFF00"">MCC</span> and <span style=""background-color: #FFFF00"">APC</span> genes confirmed by molecular analysis .",1.5098187923431396," A high risk of <span style=""background-color: #FFFF00"">colorectal cancer</span> was predicted when an interstitial deletion of the long arm of chromosome 5 , del ( 5 ) ( q15q22 . 3 ) , was detected in her lymphocytes and deletion of the MCC and <span style=""background-color: #FFFF00"">APC</span> genes confirmed by molecular analysis .",1.8156158924102783,"['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']"
9660,Whole genomic hprt clones were used in Southern analysis to screen the integrity of the hprt gene in a family that includes a patient with HPRT enzyme deficiency causal to Lesch - Nyhan syndrome .,O O O O O O O O O O O O O O O O O O O O O O O O O B I I O O B I I I O,13," Whole genomic <span style=""background-color: #FFFF00"">hprt</span> clones were used in Southern analysis to screen the integrity of the <span style=""background-color: #FFFF00"">hprt</span> gene in a family that includes a patient with <span style=""background-color: #FFFF00"">HPRT enzyme deficiency</span> causal to <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> .",1.5689959526062012," Whole genomic <span style=""background-color: #FFFF00"">hprt</span> clones were used in Southern analysis to screen the integrity of the <span style=""background-color: #FFFF00"">hprt</span> gene in a family that includes a patient with <span style=""background-color: #FFFF00"">HPRT enzyme deficiency</span> causal to <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> .",1.5745360851287842," Whole genomic hprt clones were used in Southern analysis to screen the integrity of the hprt gene in a family that includes a patient with <span style=""background-color: #FFFF00"">HPRT enzyme deficiency</span> causal to <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> .",1.300889015197754," Whole genomic hprt clones were used in Southern analysis to screen the integrity of the hprt gene in a family that includes a patient with <span style=""background-color: #FFFF00"">HPRT enzyme deficiency</span> causal to <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> .",1.540776014328003,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O']"
6995,Fragile X syndrome is a common cause of mental retardation involving loss of expression of the FMR1 gene .,B I I O O O O O B I O O O O O O O O O,13," <span style=""background-color: #FFFF00"">Fragile X syndrome</span> is a common cause of <span style=""background-color: #FFFF00"">mental retardation</span> involving loss of expression of the <span style=""background-color: #FFFF00"">FMR1 gene</span> .",1.124791145324707," <span style=""background-color: #FFFF00"">Fragile X syndrome</span> is a common cause of mental retardation involving loss of expression of the <span style=""background-color: #FFFF00"">FMR1</span> gene .",0.9838862419128418," <span style=""background-color: #FFFF00"">Fragile X syndrome</span> is a common cause of mental retardation involving loss of expression of the <span style=""background-color: #FFFF00"">FMR1</span> gene .",1.33160400390625," <span style=""background-color: #FFFF00"">Fragile X syndrome</span> is a common cause of mental retardation involving loss of expression of the <span style=""background-color: #FFFF00"">FMR1</span> gene .",1.2847609519958496,"['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
12012,"A hot spot for PTEN mutation in CD was identified in exon 5 that contains the PTPase core motif , with 13 of 30 ( 43 % ) CD mutations identified in this exon .",O O O O O O O B O O O O O O O O O O O O O O O O O O O O B O O O O O O,39," A hot spot for <span style=""background-color: #FFFF00"">PTEN</span> mutation in <span style=""background-color: #FFFF00"">CD</span> was identified in exon 5 that contains the <span style=""background-color: #FFFF00"">PTPase core motif</span> , with 13 of 30 ( 43 % ) <span style=""background-color: #FFFF00"">CD</span> mutations identified in this exon .",1.54231595993042," A hot spot for <span style=""background-color: #FFFF00"">PTEN</span> mutation in CD was identified in exon 5 that contains the PTPase core motif , with 13 of 30 ( 43 % ) CD mutations identified in this exon .",1.0414588451385498," A hot spot for <span style=""background-color: #FFFF00"">PTEN</span> mutation in CD was identified in exon 5 that contains the PTPase core motif , with 13 of 30 ( 43 % ) CD mutations identified in this exon .",1.1839861869812012," A hot spot for <span style=""background-color: #FFFF00"">PTEN</span> mutation in <span style=""background-color: #FFFF00"">CD</span> was identified in exon 5 that contains the PTPase core motif , with 13 of 30 ( 43 % ) <span style=""background-color: #FFFF00"">CD</span> mutations identified in this exon .",1.8478710651397705,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']"
5134,"Immunohistochemical analysis of muscle dystrophin and haplotype analysis of the DMD locus revealed that the X chromosome carrying the DMD gene was transmitted from the healthy maternal grandfather to his three daughters , including the probands mother .",O O O O O O O O O O B O O O O O O O O B O O O O O O O O O O O O O O O O O O,32," Immunohistochemical analysis of muscle <span style=""background-color: #FFFF00"">dystrophin</span> and haplotype analysis of the <span style=""background-color: #FFFF00"">DMD</span> locus revealed that the X chromosome carrying the <span style=""background-color: #FFFF00"">DMD</span> gene was transmitted from the healthy maternal grandfather to his three daughters , including the probands mother .",1.4782278537750244," Immunohistochemical analysis of muscle <span style=""background-color: #FFFF00"">dystrophin</span> and haplotype analysis of the <span style=""background-color: #FFFF00"">DMD</span> locus revealed that the X chromosome carrying the <span style=""background-color: #FFFF00"">DMD</span> gene was transmitted from the healthy maternal grandfather to his three daughters , including the probands mother .",1.448274850845337," Immunohistochemical analysis of <span style=""background-color: #FFFF00"">muscle dystrophin</span> and haplotype analysis of the <span style=""background-color: #FFFF00"">DMD</span> locus revealed that the X chromosome carrying the <span style=""background-color: #FFFF00"">DMD</span> gene was transmitted from the healthy maternal grandfather to his three daughters , including the probands mother .",1.553220272064209," Immunohistochemical analysis of muscle <span style=""background-color: #FFFF00"">dystrophin</span> and haplotype analysis of the <span style=""background-color: #FFFF00"">DMD</span> locus revealed that the X chromosome carrying the <span style=""background-color: #FFFF00"">DMD</span> gene was transmitted from the healthy maternal grandfather to his three daughters , including the probands mother .",1.8211660385131836,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3111,"To ascertain the molecular mechanism that causes murine C5 deficiency , genomic and cDNA libraries were constructed from mouse liver DNA and mRNA employing the congenic strains B10 .",O O O O O O O O B I O O O O O O O O O O O O O O O O O O O,32," To ascertain the molecular mechanism that causes murine <span style=""background-color: #FFFF00"">C5 deficiency</span> , genomic and cDNA libraries were constructed from mouse liver DNA and mRNA employing the congenic strains <span style=""background-color: #FFFF00"">B10</span> .",1.0891587734222412," To ascertain the molecular mechanism that causes murine <span style=""background-color: #FFFF00"">C5 deficiency</span> , genomic and cDNA libraries were constructed from mouse liver DNA and mRNA employing the congenic strains B10 .",0.9301269054412842," To ascertain the molecular mechanism that causes <span style=""background-color: #FFFF00"">murine C5 deficiency</span> , genomic and cDNA libraries were constructed from mouse liver DNA and mRNA employing the congenic strains B10 .",1.0370759963989258," To ascertain the molecular mechanism that causes murine <span style=""background-color: #FFFF00"">C5 deficiency</span> , genomic and cDNA libraries were constructed from mouse liver DNA and mRNA employing the congenic strains B10 .",1.2598650455474854,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3903,Complement deficiency and nephritis .,B I O B O,32," <span style=""background-color: #FFFF00"">Complement deficiency</span> and <span style=""background-color: #FFFF00"">nephritis</span> .",0.8086159229278564," <span style=""background-color: #FFFF00"">Complement deficiency</span> and nephritis .",0.6454119682312012," <span style=""background-color: #FFFF00"">Complement deficiency</span> and nephritis .",0.7208449840545654," <span style=""background-color: #FFFF00"">Complement deficiency</span> and nephritis .",0.96142578125,"['B', 'I', 'O', 'B', 'O']","['B', 'I', 'O', 'B', 'O']","['B', 'I', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O']"
12406,"2 respectively , regions prone to amplification in some human cancers .",O O O O O O O O O O B O,39," 2 respectively , regions prone to amplification in some <span style=""background-color: #FFFF00"">human cancers</span> .",0.634840726852417," 2 respectively , regions prone to amplification in some human cancers .",0.5226249694824219," 2 respectively , regions prone to amplification in some <span style=""background-color: #FFFF00"">human cancers</span> .",0.7964539527893066," 2 respectively , regions prone to amplification in some <span style=""background-color: #FFFF00"">human cancers</span> .",1.0368061065673828,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
11699,Recent studies suggest that vascular endothelial growth factor ( VEGF ) mRNA is upregulated in RCC - and von Hippel - Lindau disease - associated tumors .,O O O O O O O O O O O O O O O B I I I I I I I I I I O,13," Recent studies suggest that <span style=""background-color: #FFFF00"">vascular endothelial growth factor</span> ( <span style=""background-color: #FFFF00"">VEGF</span> ) mRNA is upregulated in <span style=""background-color: #FFFF00"">RCC</span> - and <span style=""background-color: #FFFF00"">von Hippel - Lindau disease</span> - associated tumors .",1.477769136428833," Recent studies suggest that vascular endothelial growth factor ( <span style=""background-color: #FFFF00"">VEGF</span> ) mRNA is upregulated in <span style=""background-color: #FFFF00"">RCC</span> - and <span style=""background-color: #FFFF00"">von Hippel - Lindau disease</span> - associated tumors .",1.2970542907714844," Recent studies suggest that <span style=""background-color: #FFFF00"">vascular endothelial growth factor</span> ( <span style=""background-color: #FFFF00"">VEGF</span> ) mRNA is upregulated in <span style=""background-color: #FFFF00"">RCC</span> - and <span style=""background-color: #FFFF00"">von Hippel - Lindau disease</span> - associated tumors .",1.5574331283569336," Recent studies suggest that <span style=""background-color: #FFFF00"">vascular endothelial growth factor</span> ( <span style=""background-color: #FFFF00"">VEGF</span> ) mRNA is upregulated in <span style=""background-color: #FFFF00"">RCC</span> - and <span style=""background-color: #FFFF00"">von Hippel - Lindau disease</span> - associated <span style=""background-color: #FFFF00"">tumors</span> .",1.995643138885498,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'B', 'O']"
3776,Phenylketonuria ( PKU ) is caused by a genetic deficiency of the enzyme phenylalanine hydroxylase ( PAH ) .,B O B O O O O O O B I I I I I O O O O,32," <span style=""background-color: #FFFF00"">Phenylketonuria</span> ( <span style=""background-color: #FFFF00"">PKU</span> ) is caused by a genetic deficiency of the enzyme <span style=""background-color: #FFFF00"">phenylalanine hydroxylase</span> ( <span style=""background-color: #FFFF00"">PAH</span> ) .",1.4221389293670654," <span style=""background-color: #FFFF00"">Phenylketonuria</span> ( <span style=""background-color: #FFFF00"">PKU</span> ) is caused by a genetic deficiency of the enzyme <span style=""background-color: #FFFF00"">phenylalanine hydroxylase</span> ( <span style=""background-color: #FFFF00"">PAH</span> ) .",1.3660390377044678," <span style=""background-color: #FFFF00"">Phenylketonuria</span> ( <span style=""background-color: #FFFF00"">PKU</span> ) is caused by a genetic deficiency of the enzyme <span style=""background-color: #FFFF00"">phenylalanine hydroxylase</span> ( <span style=""background-color: #FFFF00"">PAH</span> ) .",1.4719371795654297," <span style=""background-color: #FFFF00"">Phenylketonuria</span> ( <span style=""background-color: #FFFF00"">PKU</span> ) is caused by a genetic deficiency of the enzyme <span style=""background-color: #FFFF00"">phenylalanine hydroxylase</span> ( <span style=""background-color: #FFFF00"">PAH</span> ) .",1.8842430114746094,"['B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']"
10154,This family further confirms the cytogenetic mapping of both MCC and APC genes to 5q22 and comparison with other recent cases suggests that both genes and their closely linked markers lie within the 5q22 .,O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O,13," This family further confirms the cytogenetic mapping of both <span style=""background-color: #FFFF00"">MCC</span> and <span style=""background-color: #FFFF00"">APC</span> genes to 5q22 and comparison with other recent cases suggests that both genes and their closely linked markers lie within the 5q22 .",1.160297155380249," This family further confirms the cytogenetic mapping of both <span style=""background-color: #FFFF00"">MCC</span> and <span style=""background-color: #FFFF00"">APC</span> genes to 5q22 and comparison with other recent cases suggests that both genes and their closely linked markers lie within the 5q22 .",1.2485380172729492," This family further confirms the cytogenetic mapping of both <span style=""background-color: #FFFF00"">MCC</span> and <span style=""background-color: #FFFF00"">APC</span> genes to 5q22 and comparison with other recent cases suggests that both genes and their closely linked markers lie within the 5q22 .",1.3431916236877441," This family further confirms the cytogenetic mapping of both <span style=""background-color: #FFFF00"">MCC</span> and <span style=""background-color: #FFFF00"">APC</span> genes to 5q22 and comparison with other recent cases suggests that both genes and their closely linked markers lie within the 5q22 .",1.5734138488769531,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
12465,Molecular study and neuropsychological analysis were performed concurrently on 49 patients with Duchenne muscular dystrophy ( DMD ) in order to find a molecular explanation for the cognitive impairment observed in most DMD patients .,O O O O O O O O O O O O B I I O B O O O O O O O O O O B I O O O B O O,39," Molecular study and neuropsychological analysis were performed concurrently on 49 patients with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) in order to find a molecular explanation for the cognitive impairment observed in most <span style=""background-color: #FFFF00"">DMD</span> patients .",1.3643627166748047," Molecular study and neuropsychological analysis were performed concurrently on 49 patients with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) in order to find a molecular explanation for the cognitive impairment observed in most <span style=""background-color: #FFFF00"">DMD</span> patients .",1.4609029293060303," Molecular study and neuropsychological analysis were performed concurrently on 49 patients with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) in order to find a molecular explanation for the cognitive impairment observed in most <span style=""background-color: #FFFF00"">DMD</span> patients .",1.5184118747711182," Molecular study and neuropsychological analysis were performed concurrently on 49 patients with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) in order to find a molecular explanation for the cognitive impairment observed in most <span style=""background-color: #FFFF00"">DMD</span> patients .",1.8503007888793945,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
2596,A C - - greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with Pelizaeus - merzbacher disease ( PMD ) .,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I I I O B O O,32," A C - - greater than G transversion has been found in exon 3 of the <span style=""background-color: #FFFF00"">PLP gene</span> of affected males and their mother in a single sibship with <span style=""background-color: #FFFF00"">Pelizaeus - merzbacher disease</span> ( <span style=""background-color: #FFFF00"">PMD</span> ) .",1.3809161186218262," A C - - greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with <span style=""background-color: #FFFF00"">Pelizaeus - merzbacher disease</span> ( <span style=""background-color: #FFFF00"">PMD</span> ) .",1.2486069202423096," A C - - greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with <span style=""background-color: #FFFF00"">Pelizaeus - merzbacher disease</span> ( <span style=""background-color: #FFFF00"">PMD</span> ) .",1.430931806564331," A C - - greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with <span style=""background-color: #FFFF00"">Pelizaeus - merzbacher disease</span> ( <span style=""background-color: #FFFF00"">PMD</span> ) .",1.7392010688781738,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']"
8292,The Lesch - Nyhan syndrome is a severe X chromosome - linked human disease caused by a virtual absence of hypoxanthine - guanine phosphoribosyltransferase ( HPRT ) activity .,O B I I I O O O B I I I I I O O O O B I I I I I I I I I O,13," The <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> is a severe X <span style=""background-color: #FFFF00"">chromosome - linked human disease</span> caused by a virtual absence of <span style=""background-color: #FFFF00"">hypoxanthine - guanine phosphoribosyltransferase</span> ( <span style=""background-color: #FFFF00"">HPRT</span> ) activity .",1.6163339614868164," The <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> is a severe X chromosome - linked human disease caused by a virtual absence of <span style=""background-color: #FFFF00"">hypoxanthine - guanine phosphoribosyltransferase ( HPRT )</span> activity .",1.1833291053771973," The <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> is a severe X chromosome - linked human disease caused by a virtual absence of <span style=""background-color: #FFFF00"">hypoxanthine - guanine phosphoribosyltransferase ( HPRT )</span> activity .",1.3539221286773682," The <span style=""background-color: #FFFF00"">Lesch - Nyhan syndrome</span> is a severe X chromosome - linked human disease caused by a virtual absence of <span style=""background-color: #FFFF00"">hypoxanthine - guanine phosphoribosyltransferase</span> ( <span style=""background-color: #FFFF00"">HPRT</span> ) activity .",1.7430651187896729,"['O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O']"
1412,"11 ( 1 - LOD support interval . 04 - . 19 ) , compared with HLODs of 0 in the remaining 281 families .",O O O O O O O O O O O O O O O O O O O O O O O O O,32," 11 ( 1 - <span style=""background-color: #FFFF00"">LOD support interval</span> . 04 - . 19 ) , compared with <span style=""background-color: #FFFF00"">HLODs</span> of 0 in the remaining 281 families .",1.1116700172424316," 11 ( 1 - LOD support interval . 04 - . 19 ) , compared with HLODs of 0 in the remaining 281 families .",0.8404479026794434," 11 ( 1 - LOD support interval . 04 - . 19 ) , compared with HLODs of 0 in the remaining 281 families .",0.8889009952545166," 11 ( 1 - LOD support interval . 04 - . 19 ) , compared with HLODs of 0 in the remaining 281 families .",1.205190896987915,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11701,"VEGF promoter - luciferase constructs were transiently cotransfected with a wild - type VHL ( wt - VHL ) vector in several cell lines , including 293 embryonic kidney and RCC cell lines .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O,13," VEGF promoter - luciferase constructs were transiently cotransfected with a wild - type <span style=""background-color: #FFFF00"">VHL</span> ( <span style=""background-color: #FFFF00"">wt - VHL</span> ) vector in several cell lines , including 293 <span style=""background-color: #FFFF00"">embryonic kidney</span> and <span style=""background-color: #FFFF00"">RCC</span> cell lines .",1.6064519882202148," VEGF promoter - luciferase constructs were transiently cotransfected with a wild - type VHL ( wt - VHL ) vector in several cell lines , including 293 embryonic kidney and RCC cell lines .",0.9814682006835938," VEGF promoter - luciferase constructs were transiently cotransfected with a wild - type VHL ( wt - VHL ) vector in several cell lines , including 293 embryonic kidney and RCC cell lines .",1.0553579330444336," <span style=""background-color: #FFFF00"">VEGF</span> promoter - luciferase constructs were transiently cotransfected with a wild - type VHL ( wt - VHL ) vector in several cell lines , including 293 embryonic kidney and <span style=""background-color: #FFFF00"">RCC</span> cell lines .",1.604367733001709,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']"
11216,"Muscle expression of G6PD deficiency has been investigated in Mediterranean , Seattle - like and A - variants .",O O O B I O O O O O O O O O O O O O O,13," <span style=""background-color: #FFFF00"">Muscle</span> expression of <span style=""background-color: #FFFF00"">G6PD deficiency</span> has been investigated in <span style=""background-color: #FFFF00"">Mediterranean</span> , <span style=""background-color: #FFFF00"">Seattle</span> - like and <span style=""background-color: #FFFF00"">A</span> - variants .",1.4953773021697998," Muscle expression of <span style=""background-color: #FFFF00"">G6PD deficiency</span> has been investigated in Mediterranean , Seattle - like and A - variants .",0.8258700370788574," <span style=""background-color: #FFFF00"">Muscle expression</span> of <span style=""background-color: #FFFF00"">G6PD deficiency</span> has been investigated in Mediterranean , Seattle - like and A - variants .",1.074232816696167," <span style=""background-color: #FFFF00"">Muscle</span> expression of <span style=""background-color: #FFFF00"">G6PD deficiency</span> has been investigated in <span style=""background-color: #FFFF00"">Mediterranean</span> , <span style=""background-color: #FFFF00"">Seattle - like</span> and <span style=""background-color: #FFFF00"">A - variants</span> .",1.902583122253418,"['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O']"
9431,"Subjects were from multiple geographic regions within Spain , and all suffered from hemolytic anemia , either acute ( 34 cases ) or chronic nonspherocytic ( 2 cases ) .",O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O,13," Subjects were from multiple geographic regions within Spain , and all suffered from <span style=""background-color: #FFFF00"">hemolytic anemia</span> , either acute ( 34 cases ) or chronic <span style=""background-color: #FFFF00"">nonspherocytic</span> ( 2 cases ) .",1.0882649421691895," Subjects were from multiple geographic regions within Spain , and all suffered from <span style=""background-color: #FFFF00"">hemolytic anemia</span> , either acute ( 34 cases ) or chronic nonspherocytic ( 2 cases ) .",0.9796650409698486," Subjects were from multiple geographic regions within Spain , and all suffered from <span style=""background-color: #FFFF00"">hemolytic anemia</span> , either acute ( 34 cases ) or chronic nonspherocytic ( 2 cases ) .",1.0633158683776855," Subjects were from multiple geographic regions within Spain , and all suffered from <span style=""background-color: #FFFF00"">hemolytic anemia</span> , either acute ( 34 cases ) or chronic nonspherocytic ( 2 cases ) .",1.293781042098999,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
2677,"Linkage analysis between the aniridia phenotype and ACP1 does not support the original linkage results , excluding linkage up to theta = 0 .",O O O O B O O O O O O O O O O O O O O O O O O O,32," Linkage analysis between the <span style=""background-color: #FFFF00"">aniridia</span> phenotype and <span style=""background-color: #FFFF00"">ACP1</span> does not support the original linkage results , excluding linkage up to theta = 0 .",1.0384173393249512," Linkage analysis between the <span style=""background-color: #FFFF00"">aniridia</span> phenotype and ACP1 does not support the original linkage results , excluding linkage up to theta = 0 .",0.8413097858428955," Linkage analysis between the <span style=""background-color: #FFFF00"">aniridia</span> phenotype and ACP1 does not support the original linkage results , excluding linkage up to theta = 0 .",0.9970297813415527," Linkage analysis between the <span style=""background-color: #FFFF00"">aniridia</span> phenotype and ACP1 does not support the original linkage results , excluding linkage up to theta = 0 .",1.2427630424499512,"['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7487,Cytogenetic investigations in families with ataxia - telangiectasia .,O O O O O B I I O,13," Cytogenetic investigations in families with <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> .",0.7244586944580078," Cytogenetic investigations in families with <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> .",0.7620229721069336," Cytogenetic investigations in families with <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> .",0.8251571655273438," <span style=""background-color: #FFFF00"">Cytogenetic investigations</span> in families with <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> .",1.2589497566223145,"['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'B', 'I', 'I', 'O']"
4625,"PAX6 gene dosage effect in a family with congenital cataracts , aniridia , anophthalmia and central nervous system defects .",O O O O O O O O B I O B O B O B I I I O,32," <span style=""background-color: #FFFF00"">PAX6</span> gene dosage effect in a family with <span style=""background-color: #FFFF00"">congenital cataracts</span> , <span style=""background-color: #FFFF00"">aniridia</span> , <span style=""background-color: #FFFF00"">anophthalmia</span> and <span style=""background-color: #FFFF00"">central nervous system defects</span> .",1.5894489288330078," <span style=""background-color: #FFFF00"">PAX6</span> gene dosage effect in a family with congenital cataracts , aniridia , anophthalmia and central nervous system defects .",0.8733210563659668," <span style=""background-color: #FFFF00"">PAX6</span> gene dosage effect in a family with congenital cataracts , aniridia , anophthalmia and central nervous system defects .",0.9720978736877441," <span style=""background-color: #FFFF00"">PAX6</span> gene dosage effect in a family with congenital cataracts , <span style=""background-color: #FFFF00"">aniridia</span> , <span style=""background-color: #FFFF00"">anophthalmia</span> and central nervous system defects .",1.5910580158233643,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'O', 'B', 'I', 'I', 'I', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'O', 'B', 'I', 'I', 'I', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']"
6425,Juvenile retinoschisis is an X - linked recessive disease caused by mutations in the XLRS1 gene .,B I O O B I I I I O O O O O O O O,13," <span style=""background-color: #FFFF00"">Juvenile retinoschisis</span> is an X - linked recessive <span style=""background-color: #FFFF00"">disease</span> caused by mutations in the <span style=""background-color: #FFFF00"">XLRS1 gene</span> .",1.1649501323699951," <span style=""background-color: #FFFF00"">Juvenile retinoschisis</span> is an X - linked recessive disease caused by mutations in the <span style=""background-color: #FFFF00"">XLRS1</span> gene .",0.9673459529876709," <span style=""background-color: #FFFF00"">Juvenile retinoschisis</span> is an X - linked recessive disease caused by mutations in the <span style=""background-color: #FFFF00"">XLRS1</span> gene .",1.071923017501831," <span style=""background-color: #FFFF00"">Juvenile retinoschisis</span> is an X - linked recessive disease caused by mutations in the <span style=""background-color: #FFFF00"">XLRS1</span> gene .",1.3165040016174316,"['B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
12392,Deficiency of arylsulfatase A ( ARSA ) enzyme activity causes metachromatic leukodystrophy ( MLD ) .,B I I I O O O O O O B I O B O O,39," Deficiency of <span style=""background-color: #FFFF00"">arylsulfatase A</span> ( <span style=""background-color: #FFFF00"">ARSA</span> ) enzyme activity causes <span style=""background-color: #FFFF00"">metachromatic leukodystrophy</span> ( <span style=""background-color: #FFFF00"">MLD</span> ) .",1.4399690628051758," Deficiency of <span style=""background-color: #FFFF00"">arylsulfatase A</span> ( <span style=""background-color: #FFFF00"">ARSA</span> ) enzyme activity causes <span style=""background-color: #FFFF00"">metachromatic leukodystrophy</span> ( <span style=""background-color: #FFFF00"">MLD</span> ) .",1.422076940536499," Deficiency of <span style=""background-color: #FFFF00"">arylsulfatase A ( ARSA )</span> enzyme activity causes <span style=""background-color: #FFFF00"">metachromatic leukodystrophy ( MLD )</span> .",1.0916399955749512," <span style=""background-color: #FFFF00"">Deficiency</span> of <span style=""background-color: #FFFF00"">arylsulfatase A</span> ( <span style=""background-color: #FFFF00"">ARSA</span> ) enzyme activity causes <span style=""background-color: #FFFF00"">metachromatic leukodystrophy</span> ( <span style=""background-color: #FFFF00"">MLD</span> ) .",1.9670779705047607,"['B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['B', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']"
8193,"By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and FMF .",O O O O O O O O O O O O O O O O O O O O B O,13," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the <span style=""background-color: #FFFF00"">SAA</span> gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",0.9539542198181152," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",0.9053130149841309," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",0.9400629997253418," By haplotype analysis , our data indicate a minimum crossover frequency of 22 % between the SAA gene marker and <span style=""background-color: #FFFF00"">FMF</span> .",1.1794872283935547,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
10512,The RB1 gene from 12 human retinoblastoma tumors has been analyzed exon - by - exon with the single - strand conformation polymorphism technique .,O O O O O O B I O O O O O O O O O O O O O O O O O,13," The <span style=""background-color: #FFFF00"">RB1</span> gene from 12 human <span style=""background-color: #FFFF00"">retinoblastoma</span> tumors has been analyzed exon - by - exon with the single - strand conformation polymorphism technique .",1.0153939723968506," The <span style=""background-color: #FFFF00"">RB1</span> gene from 12 human <span style=""background-color: #FFFF00"">retinoblastoma</span> tumors has been analyzed exon - by - exon with the single - strand conformation polymorphism technique .",1.0386130809783936," The <span style=""background-color: #FFFF00"">RB1</span> gene from 12 human <span style=""background-color: #FFFF00"">retinoblastoma</span> tumors has been analyzed exon - by - exon with the single - strand conformation polymorphism technique .",1.293929100036621," The <span style=""background-color: #FFFF00"">RB1</span> gene from 12 human <span style=""background-color: #FFFF00"">retinoblastoma</span> <span style=""background-color: #FFFF00"">tumors</span> has been analyzed exon - by - exon with the single - strand conformation polymorphism technique .",2.000901222229004,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'B', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
10756,"The recently cloned human breast and ovarian cancer susceptibility gene , BRCA1 , is located on human chromosome 17q21 .",O O O O B I I I O O O O O O O O O O O O,13," The recently cloned human <span style=""background-color: #FFFF00"">breast and ovarian cancer susceptibility gene</span> , <span style=""background-color: #FFFF00"">BRCA1</span> , is located on human chromosome 17q21 .",1.14127516746521," The recently cloned human breast and ovarian cancer susceptibility gene , <span style=""background-color: #FFFF00"">BRCA1</span> , is located on human chromosome 17q21 .",0.9138398170471191," The recently cloned human breast and ovarian cancer susceptibility gene , <span style=""background-color: #FFFF00"">BRCA1</span> , is located on human chromosome 17q21 .",0.9675168991088867," The recently cloned human <span style=""background-color: #FFFF00"">breast and ovarian cancer susceptibility gene</span> , <span style=""background-color: #FFFF00"">BRCA1</span> , is located on human chromosome 17q21 .",1.5401279926300049,"['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7947,In the second family the mutation in codon 675 is a G - - - - T transversion that converts a glutamine ( GAA ) to a stop ( TAA ) codon .,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,13," In the second family the mutation in codon 675 is a G - - - - T transversion that converts a <span style=""background-color: #FFFF00"">glutamine</span> ( <span style=""background-color: #FFFF00"">GAA</span> ) to a <span style=""background-color: #FFFF00"">stop</span> ( <span style=""background-color: #FFFF00"">TAA</span> ) codon .",1.5347230434417725," In the second family the mutation in codon 675 is a G - - - - T transversion that converts a <span style=""background-color: #FFFF00"">glutamine</span> ( GAA ) to a stop ( TAA ) codon .",1.0559539794921875," In the second family the mutation in codon 675 is a G - - - - T transversion that converts a <span style=""background-color: #FFFF00"">glutamine</span> ( GAA ) to a stop ( TAA ) codon .",1.0908310413360596," In the second family the mutation in codon 675 is a G - - - - T transversion that converts a <span style=""background-color: #FFFF00"">glutamine</span> ( GAA ) to a stop ( TAA ) codon .",1.4650120735168457,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7497,"Electrophoresis of cell extracts revealed the absence of the A form of acid lipase , consistent with the diagnosis of Wolman disease .",O O O O O O O O O O O O O O O O O O O O B I O,13," Electrophoresis of cell extracts revealed the absence of the A form of <span style=""background-color: #FFFF00"">acid lipase</span> , consistent with the diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> .",0.9788098335266113," Electrophoresis of cell extracts revealed the absence of the A form of acid lipase , consistent with the diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> .",0.9284751415252686," Electrophoresis of cell extracts revealed the absence of the A form of acid lipase , consistent with the diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> .",1.0448768138885498," Electrophoresis of cell extracts revealed the absence of the A form of acid lipase , consistent with the diagnosis of <span style=""background-color: #FFFF00"">Wolman disease</span> .",1.1825342178344727,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
6108,Morphological abnormalities resembling cirrhosis developed in the majority of the livers from homozygous mutants older than 7 months of age .,B I O B O O O O O O O O O O O O O O O O O,13," Morphological abnormalities resembling <span style=""background-color: #FFFF00"">cirrhosis</span> developed in the majority of the livers from homozygous mutants older than 7 months of age .",0.7798168659210205," Morphological abnormalities resembling <span style=""background-color: #FFFF00"">cirrhosis</span> developed in the majority of the livers from homozygous mutants older than 7 months of age .",0.8552980422973633," Morphological abnormalities resembling <span style=""background-color: #FFFF00"">cirrhosis</span> developed in the majority of the livers from homozygous mutants older than 7 months of age .",0.915212869644165," Morphological abnormalities resembling <span style=""background-color: #FFFF00"">cirrhosis</span> developed in the majority of the livers from homozygous mutants older than 7 months of age .",1.1234149932861328,"['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11941,"Using this approach , an abnormally spliced transcript was identified that contains an extra 264 bases upstream from exon 32 , resulting in a premature termination codon 27 bp downstream from the cryptic splice site .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,39," Using this approach , an abnormally spliced transcript was identified that contains an extra 264 bases upstream from exon 32 , resulting in a premature termination codon 27 bp downstream from the cryptic splice site .",0.7930722236633301," Using this approach , an abnormally spliced transcript was identified that contains an extra 264 bases upstream from exon 32 , resulting in a premature termination codon 27 bp downstream from the cryptic splice site .",0.8692529201507568," Using this approach , an abnormally spliced transcript was identified that contains an extra 264 bases upstream from exon 32 , resulting in a premature termination codon 27 bp downstream from the cryptic splice site .",0.9915649890899658," Using this approach , an abnormally spliced transcript was identified that contains an extra 264 bases upstream from exon 32 , resulting in a premature termination codon 27 bp downstream from the cryptic splice site .",1.3919060230255127,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
8368,Glucose - 6 - phosphate dehydrogenase ( G6PD ) deficiency appears to be fairly common in Mexico .,B I I I I I I I I I O O O O O O O O,13," <span style=""background-color: #FFFF00"">Glucose - 6 - phosphate dehydrogenase</span> ( <span style=""background-color: #FFFF00"">G6PD</span> ) <span style=""background-color: #FFFF00"">deficiency</span> appears to be fairly common in Mexico .",1.1118340492248535," <span style=""background-color: #FFFF00"">Glucose - 6 - phosphate dehydrogenase</span> ( <span style=""background-color: #FFFF00"">G6PD</span> ) deficiency appears to be fairly common in Mexico .",0.9807281494140625," <span style=""background-color: #FFFF00"">Glucose - 6 - phosphate dehydrogenase</span> ( <span style=""background-color: #FFFF00"">G6PD</span> ) deficiency appears to be fairly common in Mexico .",1.089237928390503," <span style=""background-color: #FFFF00"">Glucose - 6 - phosphate dehydrogenase</span> ( <span style=""background-color: #FFFF00"">G6PD</span> ) deficiency appears to be fairly common in Mexico .",1.3102028369903564,"['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
12009,Constitutive DNA from 37 CD families and seven BZS families was screened for germline PTEN mutations .,O O O O B O O O B O O O O O O O O,39," Constitutive DNA from 37 CD families and seven BZS families was screened for germline <span style=""background-color: #FFFF00"">PTEN</span> mutations .",0.7440710067749023," Constitutive DNA from 37 CD families and seven BZS families was screened for germline <span style=""background-color: #FFFF00"">PTEN</span> mutations .",0.8194129467010498," Constitutive DNA from 37 CD families and seven BZS families was screened for germline <span style=""background-color: #FFFF00"">PTEN</span> mutations .",0.9023768901824951," Constitutive DNA from 37 <span style=""background-color: #FFFF00"">CD</span> families and seven <span style=""background-color: #FFFF00"">BZS</span> families was screened for germline PTEN mutations .",1.5597939491271973,"['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
764,"To address the molecular basis of disease in Zellweger syndrome patients from CG1 , we examined all 24 PEX1 exons in four patients , including both patients that have mutations in PMP70 .",O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O,32," To address the molecular basis of disease in <span style=""background-color: #FFFF00"">Zellweger syndrome</span> patients from <span style=""background-color: #FFFF00"">CG1</span> , we examined all 24 <span style=""background-color: #FFFF00"">PEX1</span> exons in four patients , including both patients that have mutations in <span style=""background-color: #FFFF00"">PMP70</span> .",1.6078770160675049," To address the molecular basis of disease in <span style=""background-color: #FFFF00"">Zellweger syndrome</span> patients from CG1 , we examined all 24 PEX1 exons in four patients , including both patients that have mutations in <span style=""background-color: #FFFF00"">PMP70</span> .",1.2830090522766113," To address the molecular basis of disease in <span style=""background-color: #FFFF00"">Zellweger syndrome</span> patients from CG1 , we examined all 24 PEX1 exons in four patients , including both patients that have mutations in PMP70 .",1.171138048171997," To address the molecular basis of disease in <span style=""background-color: #FFFF00"">Zellweger syndrome</span> patients from CG1 , we examined all 24 PEX1 exons in four patients , including both patients that have mutations in PMP70 .",1.5640487670898438,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11101,"In conclusion , we demonstrated that a point mutation in a lariat branchpoint consensus sequence causes a null allele in a patient with FED .",O O O O O O O O O O O O O O O O O O O O O O O B O,13," In conclusion , we demonstrated that a point mutation in a lariat branchpoint consensus sequence causes a null allele in a patient with <span style=""background-color: #FFFF00"">FED</span> .",1.0486149787902832," In conclusion , we demonstrated that a point mutation in a lariat branchpoint consensus sequence causes a null allele in a patient with <span style=""background-color: #FFFF00"">FED</span> .",0.9060280323028564," In conclusion , we demonstrated that a point mutation in a lariat branchpoint consensus sequence causes a null allele in a patient with <span style=""background-color: #FFFF00"">FED</span> .",0.9541020393371582," In conclusion , we demonstrated that a point mutation in a lariat <span style=""background-color: #FFFF00"">branchpoint</span> consensus sequence causes a null allele in a patient with <span style=""background-color: #FFFF00"">FED</span> .",1.484058141708374,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
11429,"The ATM gene is responsible for the autosomal recessive disorder ataxia - telangiectasia ( A - T ) , characterized by cerebellar degeneration , immunodeficiency and cancer predisposition .",O O O O O O O B I I B I I O B I I O O O O B I O B O B I O,13," The <span style=""background-color: #FFFF00"">ATM</span> gene is responsible for the <span style=""background-color: #FFFF00"">autosomal recessive disorder</span> <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) , characterized by <span style=""background-color: #FFFF00"">cerebellar degeneration</span> , <span style=""background-color: #FFFF00"">immunodeficiency</span> and <span style=""background-color: #FFFF00"">cancer predisposition</span> .",2.0691869258880615," The <span style=""background-color: #FFFF00"">ATM</span> gene is responsible for the autosomal recessive disorder <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) , characterized by cerebellar degeneration , immunodeficiency and cancer predisposition .",1.3923542499542236," The <span style=""background-color: #FFFF00"">ATM</span> gene is responsible for the autosomal recessive disorder <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) , characterized by cerebellar degeneration , immunodeficiency and cancer predisposition .",1.4314732551574707," The <span style=""background-color: #FFFF00"">ATM</span> gene is responsible for the <span style=""background-color: #FFFF00"">autosomal recessive disorder</span> <span style=""background-color: #FFFF00"">ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) , characterized by <span style=""background-color: #FFFF00"">cerebellar degeneration</span> , <span style=""background-color: #FFFF00"">immunodeficiency</span> and <span style=""background-color: #FFFF00"">cancer predisposition</span> .",2.4570629596710205,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'I', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'I', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'B', 'I', 'O']"
8237,"Finally , since none of the 98 PKU patients tested were found to carry this particular deletion , our study suggests that this molecular event probably occurred recently on the background of a haplotype 2 gene in Portugal . .",O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,13," Finally , since none of the 98 <span style=""background-color: #FFFF00"">PKU</span> patients tested were found to carry this particular deletion , our study suggests that this molecular event probably occurred recently on the background of a haplotype 2 gene in Portugal . .",1.0032730102539062," Finally , since none of the 98 <span style=""background-color: #FFFF00"">PKU</span> patients tested were found to carry this particular deletion , our study suggests that this molecular event probably occurred recently on the background of a haplotype 2 gene in Portugal . .",1.0680887699127197," Finally , since none of the 98 <span style=""background-color: #FFFF00"">PKU</span> patients tested were found to carry this particular deletion , our study suggests that this molecular event probably occurred recently on the background of a haplotype 2 gene in Portugal . .",1.1514220237731934," Finally , since none of the 98 <span style=""background-color: #FFFF00"">PKU</span> patients tested were found to carry this particular deletion , our study suggests that this molecular event probably occurred recently on the background of a haplotype 2 gene in Portugal . .",1.442410945892334,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3086,First case of C9 deficiency in Europe .,O O O B I O O O,32," First case of <span style=""background-color: #FFFF00"">C9 deficiency</span> in Europe .",0.6047928333282471," First case of <span style=""background-color: #FFFF00"">C9 deficiency</span> in Europe .",0.6368520259857178," First case of <span style=""background-color: #FFFF00"">C9 deficiency</span> in Europe .",0.7908411026000977," First case of <span style=""background-color: #FFFF00"">C9 deficiency</span> in Europe .",1.0512373447418213,"['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']"
6178,The presence of normally spliced transcripts was correlated with a milder phenotype .,O O O O O O O O O O O O O,13, The presence of normally spliced transcripts was correlated with a milder phenotype .,0.45296692848205566, The presence of normally spliced transcripts was correlated with a milder phenotype .,0.530280351638794," The presence of normally spliced transcripts was correlated with a milder <span style=""background-color: #FFFF00"">phenotype</span> .",0.8130061626434326," The presence of normally spliced transcripts was correlated with a milder <span style=""background-color: #FFFF00"">phenotype</span> .",1.0838432312011719,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
3893,"This constant introduction of new mutations would be expected to result in a heterogeneous collection of genetic lesions , some of which may be novel .",O O O O O O O O O O O O O O O O B I O O O O O O O O,32," This constant introduction of new mutations would be expected to result in a <span style=""background-color: #FFFF00"">heterogeneous collection</span> of <span style=""background-color: #FFFF00"">genetic lesions</span> , some of which may be <span style=""background-color: #FFFF00"">novel</span> .",1.176185131072998," This constant introduction of new mutations would be expected to result in a heterogeneous collection of genetic lesions , some of which may be novel .",0.6581768989562988," This constant introduction of new mutations would be expected to result in a heterogeneous collection of genetic lesions , some of which may be novel .",0.7460699081420898," This constant introduction of new mutations would be expected to result in a heterogeneous collection of genetic lesions , some of which may be novel .",0.9852950572967529,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9757,Mutations in the gene for X - linked adrenoleukodystrophy in patients with different clinical phenotypes .,O O O O O B I I I O O O O O O O,13," Mutations in the gene for <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> in patients with different clinical phenotypes .",0.7755188941955566," Mutations in the gene for <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> in patients with different clinical phenotypes .",0.7977659702301025," Mutations in the gene for <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> in patients with different clinical phenotypes .",0.8426148891448975," Mutations in the gene for <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> in patients with different clinical phenotypes .",1.155245065689087,"['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5052,"BACKGROUND Recently , mutations in the retinal degeneration slow ( rds ) gene which codes for peripherin - rds have been implicated as a cause of autosomal dominant retinitis pigmentosa .",O O O O O O B I O O O O O O O O O O O O O O O O O O B I I I O,32," BACKGROUND Recently , mutations in the <span style=""background-color: #FFFF00"">retinal degeneration slow</span> ( <span style=""background-color: #FFFF00"">rds</span> ) gene which codes for <span style=""background-color: #FFFF00"">peripherin - rds</span> have been implicated as a cause of <span style=""background-color: #FFFF00"">autosomal dominant retinitis pigmentosa</span> .",1.5081770420074463," BACKGROUND Recently , mutations in the <span style=""background-color: #FFFF00"">retinal degeneration slow ( rds )</span> gene which codes for <span style=""background-color: #FFFF00"">peripherin - rds</span> have been implicated as a cause of <span style=""background-color: #FFFF00"">autosomal dominant retinitis pigmentosa</span> .",1.4188189506530762," BACKGROUND Recently , mutations in the <span style=""background-color: #FFFF00"">retinal degeneration slow ( rds )</span> gene which codes for <span style=""background-color: #FFFF00"">peripherin - rds</span> have been implicated as a cause of <span style=""background-color: #FFFF00"">autosomal dominant retinitis pigmentosa</span> .",1.4574902057647705," BACKGROUND Recently , mutations in the <span style=""background-color: #FFFF00"">retinal degeneration slow</span> ( <span style=""background-color: #FFFF00"">rds</span> ) gene which codes for <span style=""background-color: #FFFF00"">peripherin - rds</span> have been implicated as a cause of autosomal dominant <span style=""background-color: #FFFF00"">retinitis pigmentosa</span> .",1.903876781463623,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
10743,"In addition , the neuroepithelium in Brca1 - deficient embryos appeared disorganized , with signs of both rapid proliferation and excessive cell death . .",O O O O O O B I I O O O O O O O O O O O O O O O O,13," In addition , the neuroepithelium in <span style=""background-color: #FFFF00"">Brca1</span> - deficient embryos appeared disorganized , with signs of both rapid proliferation and excessive cell death . .",0.9783329963684082," In addition , the neuroepithelium in <span style=""background-color: #FFFF00"">Brca1</span> - deficient embryos appeared disorganized , with signs of both rapid proliferation and excessive cell death . .",0.8877761363983154," In addition , the neuroepithelium in <span style=""background-color: #FFFF00"">Brca1 - deficient</span> embryos appeared disorganized , with signs of both rapid proliferation and excessive cell death . .",1.0509202480316162," In addition , the neuroepithelium in <span style=""background-color: #FFFF00"">Brca1</span> - deficient embryos appeared disorganized , with signs of both rapid proliferation and excessive cell death . .",1.3115789890289307,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7046,Founder mutations in the BRCA1 gene in Polish families with breast - ovarian cancer .,O O O O O O O O O O B I I I O,13," Founder mutations in the <span style=""background-color: #FFFF00"">BRCA1</span> gene in Polish families with <span style=""background-color: #FFFF00"">breast</span> - <span style=""background-color: #FFFF00"">ovarian cancer</span> .",1.073113203048706," Founder mutations in the <span style=""background-color: #FFFF00"">BRCA1</span> gene in Polish families with <span style=""background-color: #FFFF00"">breast - ovarian cancer</span> .",0.9020371437072754," Founder mutations in the <span style=""background-color: #FFFF00"">BRCA1</span> gene in Polish families with <span style=""background-color: #FFFF00"">breast - ovarian cancer</span> .",1.019582986831665," <span style=""background-color: #FFFF00"">Founder mutations</span> in the <span style=""background-color: #FFFF00"">BRCA1</span> gene in Polish families with <span style=""background-color: #FFFF00"">breast - ovarian cancer</span> .",1.4697577953338623,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['B', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']"
9191,Type I von Willebrand disease ( vWD ) is characterized by equally low plasma concentrations of von Willebrand factor antigen ( vWF Ag ) and ristocetin cofactor ( RiCof ) and by the presence of all vWF multimers in sodium dodecyl sulfate ( SDS ) - agarose gel electrophoresis .,B I I I I O B O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,13," <span style=""background-color: #FFFF00"">Type I von Willebrand disease</span> ( <span style=""background-color: #FFFF00"">vWD</span> ) is characterized by equally low plasma concentrations of <span style=""background-color: #FFFF00"">von Willebrand factor antigen</span> ( <span style=""background-color: #FFFF00"">vWF Ag</span> ) and <span style=""background-color: #FFFF00"">ristocetin cofactor</span> ( <span style=""background-color: #FFFF00"">RiCof</span> ) and by the presence of all <span style=""background-color: #FFFF00"">vWF multimers</span> in <span style=""background-color: #FFFF00"">sodium dodecyl sulfate</span> ( <span style=""background-color: #FFFF00"">SDS</span> ) - <span style=""background-color: #FFFF00"">agarose gel electrophoresis</span> .",2.9392247200012207," Type I <span style=""background-color: #FFFF00"">von Willebrand disease</span> ( <span style=""background-color: #FFFF00"">vWD</span> ) is characterized by equally low plasma concentrations of <span style=""background-color: #FFFF00"">von Willebrand factor antigen</span> ( <span style=""background-color: #FFFF00"">vWF Ag</span> ) and <span style=""background-color: #FFFF00"">ristocetin cofactor</span> ( <span style=""background-color: #FFFF00"">RiCof</span> ) and by the presence of all <span style=""background-color: #FFFF00"">vWF</span> multimers in <span style=""background-color: #FFFF00"">sodium dodecyl sulfate</span> ( <span style=""background-color: #FFFF00"">SDS</span> ) - agarose gel electrophoresis .",2.803447961807251," <span style=""background-color: #FFFF00"">Type I von Willebrand disease</span> ( <span style=""background-color: #FFFF00"">vWD</span> ) is characterized by equally low plasma concentrations of <span style=""background-color: #FFFF00"">von Willebrand factor antigen</span> ( <span style=""background-color: #FFFF00"">vWF Ag</span> ) and <span style=""background-color: #FFFF00"">ristocetin cofactor</span> ( <span style=""background-color: #FFFF00"">RiCof</span> ) and by the presence of all <span style=""background-color: #FFFF00"">vWF multimers</span> in <span style=""background-color: #FFFF00"">sodium dodecyl sulfate</span> ( <span style=""background-color: #FFFF00"">SDS</span> ) - <span style=""background-color: #FFFF00"">agarose gel electrophoresis</span> .",3.1481430530548096," <span style=""background-color: #FFFF00"">Type I von Willebrand disease</span> ( <span style=""background-color: #FFFF00"">vWD</span> ) is characterized by equally low plasma concentrations of <span style=""background-color: #FFFF00"">von Willebrand factor antigen</span> ( <span style=""background-color: #FFFF00"">vWF Ag</span> ) and <span style=""background-color: #FFFF00"">ristocetin cofactor</span> ( <span style=""background-color: #FFFF00"">RiCof</span> ) and by the presence of all <span style=""background-color: #FFFF00"">vWF</span> multimers in sodium dodecyl sulfate ( <span style=""background-color: #FFFF00"">SDS</span> ) - agarose gel electrophoresis .",2.893131971359253,"['B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'O']","['B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']"
11327,BACKGROUND Allelic loss of chromosome 18q predicts a poor outcome in patients with stage II colorectal cancer .,O O O O O O O O O O O O O B I I I O,13," Allelic loss of chromosome <span style=""background-color: #FFFF00"">18q</span> predicts a poor outcome in patients with stage II <span style=""background-color: #FFFF00"">colorectal cancer</span> .",0.9579887390136719," BACKGROUND Allelic loss of chromosome <span style=""background-color: #FFFF00"">18q</span> predicts a poor outcome in patients with stage II colorectal cancer .",0.8613498210906982," BACKGROUND Allelic loss of chromosome <span style=""background-color: #FFFF00"">18q</span> predicts a poor outcome in patients with stage II <span style=""background-color: #FFFF00"">colorectal cancer</span> .",1.0954468250274658," BACKGROUND Allelic loss of chromosome <span style=""background-color: #FFFF00"">18q</span> predicts a poor outcome in patients with stage II <span style=""background-color: #FFFF00"">colorectal cancer</span> .",1.3587379455566406,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
8234,The absence of PAH activity results in typical PKU while persistence of a residual enzyme activity gives rise to variant forms of the disease .,O O O O O O O O B O O O O O O O O O O O O O O O O,13," The absence of <span style=""background-color: #FFFF00"">PAH</span> activity results in typical <span style=""background-color: #FFFF00"">PKU</span> while persistence of a residual enzyme activity gives rise to variant forms of the <span style=""background-color: #FFFF00"">disease</span> .",1.3357172012329102," The absence of PAH activity results in typical <span style=""background-color: #FFFF00"">PKU</span> while persistence of a residual enzyme activity gives rise to variant forms of the disease .",0.9274969100952148," The absence of PAH activity results in typical <span style=""background-color: #FFFF00"">PKU</span> while persistence of a residual enzyme activity gives rise to variant forms of the disease .",1.042917013168335," The absence of PAH activity results in typical <span style=""background-color: #FFFF00"">PKU</span> while persistence of a residual enzyme activity gives rise to variant forms of the disease .",1.2137558460235596,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
12014,Germline PTEN mutations were identified in four of seven ( 57 % ) BZS families studied .,O O O O O O O O O O O O O B O O O,39," Germline <span style=""background-color: #FFFF00"">PTEN</span> mutations were identified in four of seven ( 57 % ) <span style=""background-color: #FFFF00"">BZS</span> families studied .",0.9633197784423828," Germline <span style=""background-color: #FFFF00"">PTEN</span> mutations were identified in four of seven ( 57 % ) BZS families studied .",0.83060622215271," <span style=""background-color: #FFFF00"">Germline PTEN</span> mutations were identified in four of seven ( 57 % ) BZS families studied .",0.9332799911499023," <span style=""background-color: #FFFF00"">Germline PTEN</span> mutations were identified in four of seven ( 57 % ) BZS families studied .",1.1506779193878174,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']","['O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
8072,The structural gene for this human enzyme ( AGA ) has been assigned to the region 4q21 - - - - qter .,O O O O O O O O O O O O O O O O O O O O O O O,13," The structural gene for this human enzyme ( <span style=""background-color: #FFFF00"">AGA</span> ) has been assigned to the region 4q21 - - - - qter .",0.8192429542541504," The structural gene for this human enzyme ( <span style=""background-color: #FFFF00"">AGA</span> ) has been assigned to the region 4q21 - - - - qter .",0.8996639251708984," The structural gene for this human enzyme ( <span style=""background-color: #FFFF00"">AGA</span> ) has been assigned to the region 4q21 - - - - qter .",1.0445408821105957," The structural gene for this human enzyme ( <span style=""background-color: #FFFF00"">AGA</span> ) has been assigned to the region 4q21 - - - - qter .",1.2709722518920898,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7353,Study of the voltage - gated sodium channel beta 1 subunit gene ( SCN1B ) in the benign familial infantile convulsions syndrome ( BFIC ) .,O O O O O O O O O O O O O O O O O B I I I I O B O O,13," Study of the voltage - gated sodium channel beta 1 subunit gene ( <span style=""background-color: #FFFF00"">SCN1B</span> ) in the <span style=""background-color: #FFFF00"">benign familial infantile convulsions syndrome</span> ( <span style=""background-color: #FFFF00"">BFIC</span> ) .",1.2356421947479248," Study of the voltage - gated sodium channel beta 1 subunit gene ( <span style=""background-color: #FFFF00"">SCN1B</span> ) in the <span style=""background-color: #FFFF00"">benign familial infantile convulsions syndrome</span> ( <span style=""background-color: #FFFF00"">BFIC</span> ) .",1.3214290142059326," Study of the voltage - gated sodium channel beta 1 subunit gene ( <span style=""background-color: #FFFF00"">SCN1B</span> ) in the <span style=""background-color: #FFFF00"">benign familial infantile convulsions syndrome</span> ( <span style=""background-color: #FFFF00"">BFIC</span> ) .",1.4303131103515625," Study of the voltage - gated sodium channel beta 1 subunit gene ( <span style=""background-color: #FFFF00"">SCN1B</span> ) in the <span style=""background-color: #FFFF00"">benign familial infantile convulsions syndrome</span> ( <span style=""background-color: #FFFF00"">BFIC</span> ) .",1.593522071838379,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O']"
2368,"Although Kaposi sarcoma can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with HIV , we postulate that longevity in the face of mild immunosuppression was the major factor in the development of Kaposi sarcoma in this patient . .",O B I O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O B I O O O O O,32," Although <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with <span style=""background-color: #FFFF00"">HIV</span> , we postulate that longevity in the face of mild immunosuppression was the major factor in the development of <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> in this patient . .",1.5334479808807373," Although <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with <span style=""background-color: #FFFF00"">HIV</span> , we postulate that longevity in the face of mild immunosuppression was the major factor in the development of <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> in this patient . .",1.584867000579834," Although <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with HIV , we postulate that longevity in the face of mild immunosuppression was the major factor in the development of <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> in this patient . .",1.5442719459533691," Although <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with HIV , we postulate that longevity in the face of mild immunosuppression was the major factor in the development of <span style=""background-color: #FFFF00"">Kaposi sarcoma</span> in this patient . .",1.7241861820220947,"['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']"
10986,Myotonic dystrophy ( DM ) is commonly associated with CTG repeat expansions within the gene for DM - protein kinase ( DMPK ) .,B I O B O O O O O O O O O O O O O O O O O O O O,13," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) is commonly associated with <span style=""background-color: #FFFF00"">CTG repeat expansions</span> within the gene for <span style=""background-color: #FFFF00"">DM - protein kinase</span> ( <span style=""background-color: #FFFF00"">DMPK</span> ) .",1.580125093460083," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) is commonly associated with CTG repeat expansions within the gene for <span style=""background-color: #FFFF00"">DM - protein kinase</span> ( <span style=""background-color: #FFFF00"">DMPK</span> ) .",1.5985620021820068," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) is commonly associated with CTG repeat expansions within the gene for <span style=""background-color: #FFFF00"">DM - protein kinase</span> ( <span style=""background-color: #FFFF00"">DMPK</span> ) .",1.6116881370544434," <span style=""background-color: #FFFF00"">Myotonic dystrophy</span> ( <span style=""background-color: #FFFF00"">DM</span> ) is commonly associated with CTG repeat expansions within the gene for <span style=""background-color: #FFFF00"">DM - protein kinase</span> ( <span style=""background-color: #FFFF00"">DMPK</span> ) .",2.0530972480773926,"['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']","['B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O']"
6471,"In addition , germline mosaicism of the VHL gene was identified in one family .",O O O O O O O B O O O O O O O,13," In addition , germline mosaicism of the <span style=""background-color: #FFFF00"">VHL</span> gene was identified in one family .",0.6883039474487305," In addition , germline mosaicism of the <span style=""background-color: #FFFF00"">VHL</span> gene was identified in one family .",0.9037830829620361," In addition , germline mosaicism of the <span style=""background-color: #FFFF00"">VHL</span> gene was identified in one family .",0.8558149337768555," In addition , germline mosaicism of the <span style=""background-color: #FFFF00"">VHL</span> gene was identified in one family .",1.0807271003723145,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11122,"The Emery - Dreifuss muscular dystrophy protein , emerin , is a nuclear membrane protein .",O B I I I I O O O O O O O O O O,13," The <span style=""background-color: #FFFF00"">Emery - Dreifuss muscular dystrophy</span> protein , <span style=""background-color: #FFFF00"">emerin</span> , is a <span style=""background-color: #FFFF00"">nuclear membrane</span> protein .",1.0984280109405518," The <span style=""background-color: #FFFF00"">Emery - Dreifuss muscular dystrophy</span> protein , <span style=""background-color: #FFFF00"">emerin</span> , is a nuclear membrane protein .",1.003558874130249," The <span style=""background-color: #FFFF00"">Emery - Dreifuss muscular dystrophy</span> protein , <span style=""background-color: #FFFF00"">emerin</span> , is a nuclear membrane protein .",1.1367437839508057," The <span style=""background-color: #FFFF00"">Emery - Dreifuss muscular dystrophy</span> protein , <span style=""background-color: #FFFF00"">emerin</span> , is a nuclear membrane protein .",1.4063680171966553,"['O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5112,"Mutations were found in all tumors , and one - third of the tumors had independent mutations in both alleles neither of which were found in the germ line , confirming their true sporadic nature .",O O O O O B O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O,32," Mutations were found in all tumors , and one - third of the tumors had independent mutations in both alleles neither of which were found in the germ line , confirming their true <span style=""background-color: #FFFF00"">sporadic nature</span> .",1.039067029953003," Mutations were found in all tumors , and one - third of the tumors had independent mutations in both alleles neither of which were found in the germ line , confirming their true sporadic nature .",1.0774168968200684," Mutations were found in all tumors , and one - third of the tumors had independent mutations in both alleles neither of which were found in the germ line , confirming their true sporadic nature .",1.0229899883270264," Mutations were found in all <span style=""background-color: #FFFF00"">tumors</span> , and one - third of the <span style=""background-color: #FFFF00"">tumors</span> had independent mutations in both alleles neither of which were found in the germ line , confirming their true sporadic nature .",1.7501959800720215,"['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7310,"Mutations in Prph2 have been shown to result in a variety of photoreceptor dystrophies , including autosomal dominant retinitis pigmentosa and macular dystrophy .",O O O O O O O O O O O O B I O O B I I I O B I O,13," Mutations in <span style=""background-color: #FFFF00"">Prph2</span> have been shown to result in a variety of <span style=""background-color: #FFFF00"">photoreceptor dystrophies</span> , including <span style=""background-color: #FFFF00"">autosomal dominant retinitis pigmentosa</span> and <span style=""background-color: #FFFF00"">macular dystrophy</span> .",1.542253017425537," Mutations in <span style=""background-color: #FFFF00"">Prph2</span> have been shown to result in a variety of <span style=""background-color: #FFFF00"">photoreceptor dystrophies</span> , including <span style=""background-color: #FFFF00"">autosomal dominant retinitis pigmentosa</span> and <span style=""background-color: #FFFF00"">macular dystrophy</span> .",1.5284960269927979," Mutations in Prph2 have been shown to result in a variety of <span style=""background-color: #FFFF00"">photoreceptor dystrophies</span> , including <span style=""background-color: #FFFF00"">autosomal dominant retinitis pigmentosa</span> and <span style=""background-color: #FFFF00"">macular dystrophy</span> .",1.4507310390472412," Mutations in Prph2 have been shown to result in a variety of <span style=""background-color: #FFFF00"">photoreceptor dystrophies</span> , including <span style=""background-color: #FFFF00"">autosomal dominant retinitis pigmentosa</span> and <span style=""background-color: #FFFF00"">macular dystrophy</span> .",1.7382888793945312,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'O']"
6016,3 3 .,O O O,13," <span style=""background-color: #FFFF00"">3 3</span> .",0.5566530227661133," <span style=""background-color: #FFFF00"">3 3</span> .",0.5966620445251465," <span style=""background-color: #FFFF00"">3 3</span> .",0.6732358932495117, 3 3 .,0.8488290309906006,"['O', 'O', 'O']","['B', 'I', 'O']","['B', 'I', 'O']","['B', 'I', 'O']","['O', 'O', 'O']"
10614,This report describes the autosomal inheritance of a hemophilia A phenotype due to a mutation of vWF that results in defective factor VIII binding .,O O O O O O O O B I O O O O O O O O O O O O O O O,13," This report describes the <span style=""background-color: #FFFF00"">autosomal inheritance</span> of a <span style=""background-color: #FFFF00"">hemophilia A</span> phenotype due to a mutation of <span style=""background-color: #FFFF00"">vWF</span> that results in defective <span style=""background-color: #FFFF00"">factor VIII</span> binding .",1.4069240093231201," This report describes the autosomal inheritance of a <span style=""background-color: #FFFF00"">hemophilia A</span> phenotype due to a mutation of vWF that results in defective factor VIII binding .",0.9831738471984863," This report describes the autosomal inheritance of a <span style=""background-color: #FFFF00"">hemophilia A</span> phenotype due to a mutation of vWF that results in defective factor VIII binding .",1.0499598979949951," This report describes the autosomal inheritance of a <span style=""background-color: #FFFF00"">hemophilia A</span> phenotype due to a mutation of vWF that results in defective factor VIII binding .",1.2403101921081543,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3148,A 47 - year - old woman with paroxysmal nocturnal haemoglobinuria ( PNH ) was found to have an inherited deficiency in the ninth complement component ( C9 ) .,O O O O O O O O B I I O B O O O O O O B I I I I I I O O O O,32," A 47 - year - old woman with <span style=""background-color: #FFFF00"">paroxysmal nocturnal haemoglobinuria</span> ( <span style=""background-color: #FFFF00"">PNH</span> ) was found to have an <span style=""background-color: #FFFF00"">inherited deficiency</span> in the ninth <span style=""background-color: #FFFF00"">complement component</span> ( <span style=""background-color: #FFFF00"">C9</span> ) .",1.890470027923584," A 47 - year - old woman with <span style=""background-color: #FFFF00"">paroxysmal nocturnal haemoglobinuria</span> ( <span style=""background-color: #FFFF00"">PNH</span> ) was found to have an inherited deficiency in the ninth complement component ( <span style=""background-color: #FFFF00"">C9</span> ) .",1.3588132858276367," A 47 - year - old woman with <span style=""background-color: #FFFF00"">paroxysmal nocturnal haemoglobinuria</span> ( <span style=""background-color: #FFFF00"">PNH</span> ) was found to have an inherited deficiency in the ninth complement component ( <span style=""background-color: #FFFF00"">C9</span> ) .",1.4700911045074463," A 47 - year - old woman with <span style=""background-color: #FFFF00"">paroxysmal nocturnal haemoglobinuria</span> ( <span style=""background-color: #FFFF00"">PNH</span> ) was found to have an inherited deficiency in the ninth complement component ( <span style=""background-color: #FFFF00"">C9</span> ) .",1.8817479610443115,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
6665,"The osteolytic lesions , which develop usually in the long bones during early adulthood , show increased osteoblast and osteoclast activity .",O B I O O O O O O O O O O O O O O O O O O O,13," The osteolytic lesions , which develop usually in the long bones during early adulthood , show increased <span style=""background-color: #FFFF00"">osteoblast</span> and <span style=""background-color: #FFFF00"">osteoclast</span> activity .",1.0446069240570068," The osteolytic lesions , which develop usually in the long bones during early adulthood , show increased osteoblast and osteoclast activity .",0.6668860912322998," The osteolytic lesions , which develop usually in the long bones during early adulthood , show increased osteoblast and osteoclast activity .",0.7899298667907715," The osteolytic lesions , which develop usually in the long bones during early adulthood , show increased <span style=""background-color: #FFFF00"">osteoblast</span> and <span style=""background-color: #FFFF00"">osteoclast</span> activity .",1.3798131942749023,"['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O']"
6397,We report on a boy with a maternal uniparental disomy for chromosome 14 ( UPD ( 14 ) ) .,O O O O O O O B I I I I I O B O O O O O,13," We report on a boy with a maternal <span style=""background-color: #FFFF00"">uniparental disomy</span> for chromosome <span style=""background-color: #FFFF00"">14</span> ( <span style=""background-color: #FFFF00"">UPD ( 14 )</span> ) .",1.1456949710845947," We report on a boy with a maternal <span style=""background-color: #FFFF00"">uniparental disomy</span> for chromosome 14 ( UPD ( 14 ) ) .",0.9040019512176514," We report on a boy with a maternal <span style=""background-color: #FFFF00"">uniparental disomy</span> for chromosome 14 ( <span style=""background-color: #FFFF00"">UPD ( 14 )</span> ) .",1.1130030155181885," We report on a boy with a maternal <span style=""background-color: #FFFF00"">uniparental disomy</span> for chromosome 14 ( <span style=""background-color: #FFFF00"">UPD ( 14 )</span> ) .",1.3438279628753662,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O']"
8256,The results from a multiply informative crossover localize the NDP gene proximal to DXS7 .,O O O O O O O O O B O O O O O,13," The results from a multiply informative crossover localize the <span style=""background-color: #FFFF00"">NDP</span> gene proximal to <span style=""background-color: #FFFF00"">DXS7</span> .",0.925274133682251," The results from a multiply informative crossover localize the <span style=""background-color: #FFFF00"">NDP</span> gene proximal to <span style=""background-color: #FFFF00"">DXS7</span> .",0.9293019771575928," The results from a multiply informative crossover localize the <span style=""background-color: #FFFF00"">NDP</span> gene proximal to DXS7 .",0.9225931167602539," The results from a multiply informative crossover localize the <span style=""background-color: #FFFF00"">NDP</span> gene proximal to DXS7 .",1.1314928531646729,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']"
6494,These data suggest that an early event in the pathogenesis of SCA3 / MJD may be an altered conformation of ataxin - 3 within the nucleus that exposes the polyglutamine domain . .,O O O O O O O O O O O B O B O O O O O O O O O O O O O O O O O O O,13," These data suggest that an early event in the pathogenesis of <span style=""background-color: #FFFF00"">SCA3</span> / <span style=""background-color: #FFFF00"">MJD</span> may be an altered conformation of <span style=""background-color: #FFFF00"">ataxin - 3</span> within the nucleus that exposes the <span style=""background-color: #FFFF00"">polyglutamine domain</span> . .",1.5325489044189453," These data suggest that an early event in the pathogenesis of <span style=""background-color: #FFFF00"">SCA3</span> / <span style=""background-color: #FFFF00"">MJD</span> may be an altered conformation of <span style=""background-color: #FFFF00"">ataxin - 3</span> within the nucleus that exposes the polyglutamine domain . .",1.3824481964111328," These data suggest that an early event in the pathogenesis of <span style=""background-color: #FFFF00"">SCA3 / MJD</span> may be an altered conformation of <span style=""background-color: #FFFF00"">ataxin - 3</span> within the nucleus that exposes the polyglutamine domain . .",1.3367550373077393," These data suggest that an early event in the pathogenesis of <span style=""background-color: #FFFF00"">SCA3 / MJD</span> may be an altered conformation of <span style=""background-color: #FFFF00"">ataxin - 3</span> within the nucleus that exposes the <span style=""background-color: #FFFF00"">polyglutamine</span> domain . .",1.767611026763916,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']"
1359,Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase ( DMPK ) isoforms with distinct properties .,O O O O O O O O O B I O O O O O O O O O O,32," Constitutive and regulated modes of splicing produce six major <span style=""background-color: #FFFF00"">myotonic dystrophy protein kinase</span> ( <span style=""background-color: #FFFF00"">DMPK</span> ) isoforms with distinct properties .",1.0356900691986084," Constitutive and regulated modes of splicing produce six major <span style=""background-color: #FFFF00"">myotonic dystrophy protein kinase ( DMPK )</span> isoforms with distinct properties .",1.0570378303527832," Constitutive and regulated modes of splicing produce six major <span style=""background-color: #FFFF00"">myotonic dystrophy protein kinase ( DMPK )</span> isoforms with distinct properties .",0.9381749629974365," <span style=""background-color: #FFFF00"">Constitutive</span> and regulated modes of splicing produce six major <span style=""background-color: #FFFF00"">myotonic dystrophy protein kinase</span> ( <span style=""background-color: #FFFF00"">DMPK</span> ) isoforms with distinct properties .",1.8556406497955322,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']"
12025,Complement component C6 deficiency ( C6D ) was diagnosed in a 16 - year - old African - American male with meningococcal meningitis .,B I I I O B O O O O O O O O O O O O O O O B I O,39," <span style=""background-color: #FFFF00"">Complement component C6 deficiency</span> ( <span style=""background-color: #FFFF00"">C6D</span> ) was diagnosed in a 16 - year - old <span style=""background-color: #FFFF00"">African - American</span> male with <span style=""background-color: #FFFF00"">meningococcal meningitis</span> .",1.4469032287597656," <span style=""background-color: #FFFF00"">Complement component C6 deficiency</span> ( <span style=""background-color: #FFFF00"">C6D</span> ) was diagnosed in a 16 - year - old African - American male with <span style=""background-color: #FFFF00"">meningococcal meningitis</span> .",1.2874889373779297," <span style=""background-color: #FFFF00"">Complement component C6 deficiency</span> ( <span style=""background-color: #FFFF00"">C6D</span> ) was diagnosed in a 16 - year - old African - American male with meningococcal meningitis .",1.3578310012817383," <span style=""background-color: #FFFF00"">Complement component C6 deficiency</span> ( <span style=""background-color: #FFFF00"">C6D</span> ) was diagnosed in a 16 - year - old African - American male with <span style=""background-color: #FFFF00"">meningococcal meningitis</span> .",1.623950719833374,"['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
7945,In one family a C - - - - T transition in codon 661 converts an arginine ( CGG ) to a tryptophan ( TGG ) codon .,O O O O O O O O O O O O O O O O O O O O O O O O O O O O,13," In one family a <span style=""background-color: #FFFF00"">C - - - - T transition</span> in codon 661 converts an <span style=""background-color: #FFFF00"">arginine</span> ( <span style=""background-color: #FFFF00"">CGG</span> ) to a <span style=""background-color: #FFFF00"">tryptophan</span> ( <span style=""background-color: #FFFF00"">TGG</span> ) codon .",1.6640970706939697," In one family a C - <span style=""background-color: #FFFF00"">- - - T</span> transition in codon 661 converts an <span style=""background-color: #FFFF00"">arginine</span> ( CGG ) to a <span style=""background-color: #FFFF00"">tryptophan</span> ( TGG ) codon .",1.336867094039917," In one family a C - - - - T transition in codon 661 converts an <span style=""background-color: #FFFF00"">arginine</span> ( CGG ) to a <span style=""background-color: #FFFF00"">tryptophan</span> ( TGG ) codon .",1.2643139362335205," In one family a C - - - - T transition in codon 661 converts an <span style=""background-color: #FFFF00"">arginine</span> ( CGG ) to a <span style=""background-color: #FFFF00"">tryptophan</span> ( TGG ) codon .",1.484067678451538,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']"
2264,The gene responsible for Huntington disease has been localized to a 2 .,O O O O B I O O O O O O O,32," The gene responsible for <span style=""background-color: #FFFF00"">Huntington disease</span> has been localized to a 2 .",0.6821928024291992," The gene responsible for <span style=""background-color: #FFFF00"">Huntington disease</span> has been localized to a 2 .",0.7453789710998535," The gene responsible for <span style=""background-color: #FFFF00"">Huntington disease</span> has been localized to a 2 .",0.8179478645324707," The gene responsible for <span style=""background-color: #FFFF00"">Huntington disease</span> has been localized to a 2 .",1.3411450386047363,"['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
2630,von Willebrand disease type B : a missense mutation selectively abolishes ristocetin - induced von Willebrand factor binding to platelet glycoprotein Ib .,B I I I I O O O O O O O O O B I O O O O O O O,32," <span style=""background-color: #FFFF00"">von Willebrand disease</span> type B : a missense mutation selectively abolishes ristocetin - induced <span style=""background-color: #FFFF00"">von Willebrand factor</span> binding to platelet glycoprotein Ib .",1.0611562728881836," <span style=""background-color: #FFFF00"">von Willebrand disease</span> type B : a missense mutation selectively abolishes ristocetin - induced <span style=""background-color: #FFFF00"">von Willebrand factor</span> binding to platelet glycoprotein Ib .",1.100003957748413," <span style=""background-color: #FFFF00"">von Willebrand disease type B</span> : a missense mutation selectively abolishes ristocetin - induced <span style=""background-color: #FFFF00"">von Willebrand factor</span> binding to platelet glycoprotein Ib .",1.2098093032836914," <span style=""background-color: #FFFF00"">von Willebrand disease</span> type B : a missense mutation selectively abolishes ristocetin - induced <span style=""background-color: #FFFF00"">von Willebrand factor</span> binding to platelet glycoprotein Ib .",1.4265050888061523,"['B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']"
5637,Mutational analysis and genotype - phenotype correlation of 29 unrelated Japanese patients with X - linked adrenoleukodystrophy .,O O O O O O O O O O O O O B I I I O,13," <span style=""background-color: #FFFF00"">Mutational analysis</span> and genotype - phenotype correlation of 29 unrelated <span style=""background-color: #FFFF00"">Japanese</span> patients with <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> .",1.1830461025238037," Mutational analysis and genotype - phenotype correlation of 29 unrelated Japanese patients with <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> .",0.8707900047302246," Mutational analysis and genotype - phenotype correlation of 29 unrelated Japanese patients with <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> .",1.0095679759979248," Mutational analysis and genotype - phenotype correlation of 29 unrelated Japanese patients with <span style=""background-color: #FFFF00"">X - linked adrenoleukodystrophy</span> .",1.1964530944824219,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']"
11816,"A new tumor suppressor gene , PTEN / MMAC1 , was isolated recently at this region of chromosome 10q23 and found to be inactivated by mutation in three prostate cancer cell lines .",O O B O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O,39," A new <span style=""background-color: #FFFF00"">tumor suppressor gene</span> , <span style=""background-color: #FFFF00"">PTEN</span> / <span style=""background-color: #FFFF00"">MMAC1</span> , was isolated recently at this region of chromosome <span style=""background-color: #FFFF00"">10q23</span> and found to be inactivated by mutation in three <span style=""background-color: #FFFF00"">prostate cancer</span> cell lines .",1.715132236480713," A new tumor suppressor gene , <span style=""background-color: #FFFF00"">PTEN / MMAC1</span> , was isolated recently at this region of chromosome 10q23 and found to be inactivated by mutation in three <span style=""background-color: #FFFF00"">prostate cancer</span> cell lines .",1.2366416454315186," A new tumor suppressor gene , <span style=""background-color: #FFFF00"">PTEN / MMAC1</span> , was isolated recently at this region of chromosome 10q23 and found to be inactivated by mutation in three <span style=""background-color: #FFFF00"">prostate cancer</span> cell lines .",1.3351621627807617," A new <span style=""background-color: #FFFF00"">tumor suppressor gene</span> , <span style=""background-color: #FFFF00"">PTEN / MMAC1</span> , was isolated recently at this region of chromosome 10q23 and found to be inactivated by mutation in three <span style=""background-color: #FFFF00"">prostate cancer</span> cell lines .",2.0141050815582275,"['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']","['O', 'O', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O']"
769,"Wiskott - Aldrich syndrome ( WAS ) is an X - linked recessive immunodeficiency characterized by thrombocytopenia , eczema , and recurrent infections , and caused by mutations in the WAS protein ( WASP ) gene .",B I I I O B O O O B I I I I O O B O B O O O O O O O O O O O B O O O O O O,32," <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is an X - linked recessive <span style=""background-color: #FFFF00"">immunodeficiency</span> characterized by <span style=""background-color: #FFFF00"">thrombocytopenia</span> , <span style=""background-color: #FFFF00"">eczema</span> , and recurrent infections , and caused by mutations in the <span style=""background-color: #FFFF00"">WAS protein</span> ( <span style=""background-color: #FFFF00"">WASP</span> ) gene .",2.1626369953155518," <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is an X - linked recessive immunodeficiency characterized by thrombocytopenia , eczema , and recurrent infections , and caused by mutations in the <span style=""background-color: #FFFF00"">WAS protein</span> ( <span style=""background-color: #FFFF00"">WASP</span> ) gene .",1.629652976989746," <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is an X - linked recessive immunodeficiency characterized by thrombocytopenia , eczema , and recurrent infections , and caused by mutations in the <span style=""background-color: #FFFF00"">WAS protein ( WASP )</span> gene .",1.5071711540222168," <span style=""background-color: #FFFF00"">Wiskott - Aldrich syndrome</span> ( <span style=""background-color: #FFFF00"">WAS</span> ) is an X - linked recessive immunodeficiency characterized by thrombocytopenia , eczema , and recurrent infections , and caused by mutations in the <span style=""background-color: #FFFF00"">WAS protein</span> ( <span style=""background-color: #FFFF00"">WASP</span> ) gene .",2.0867629051208496,"['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O']"
12247,Somatic instability of the CTG repeat in mice transgenic for the myotonic dystrophy region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities .,O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O,39," Somatic instability of the CTG repeat in mice transgenic for the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities .",0.9057469367980957," <span style=""background-color: #FFFF00"">Somatic instability</span> of the CTG repeat in mice transgenic for the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities .",1.1842429637908936," Somatic instability of the CTG repeat in mice transgenic for the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities .",1.0384440422058105," <span style=""background-color: #FFFF00"">Somatic instability</span> of the CTG repeat in mice transgenic for the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities .",1.534433126449585,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
630,"van der Woude syndrome ( VWS ) , which has been mapped to 1q32 - 41 , is characterized by pits and / or sinuses of the lower lip , cleft lip / palate ( CL / P ) , cleft palate ( CP ) , bifid uvula , and hypodontia ( H ) .",B I I I O B O O O O O O O O O O O O O O B I I I I I I I I O B I I I O B I I O O B I O B O O B I O O B O B O O,32," <span style=""background-color: #FFFF00"">van der Woude syndrome</span> ( <span style=""background-color: #FFFF00"">VWS</span> ) , which has been mapped to 1q32 - 41 , is characterized by pits and / or sinuses of the lower lip , <span style=""background-color: #FFFF00"">cleft lip / palate</span> ( <span style=""background-color: #FFFF00"">CL / P</span> ) , <span style=""background-color: #FFFF00"">cleft palate</span> ( <span style=""background-color: #FFFF00"">CP</span> ) , bifid uvula , and <span style=""background-color: #FFFF00"">hypodontia</span> ( <span style=""background-color: #FFFF00"">H</span> ) .",2.622436046600342," <span style=""background-color: #FFFF00"">van der Woude syndrome</span> ( <span style=""background-color: #FFFF00"">VWS</span> ) , which has been mapped to 1q32 - 41 , is characterized by pits and / or sinuses of the lower lip , <span style=""background-color: #FFFF00"">cleft lip / palate</span> ( <span style=""background-color: #FFFF00"">CL / P</span> ) , <span style=""background-color: #FFFF00"">cleft palate</span> ( <span style=""background-color: #FFFF00"">CP</span> ) , bifid uvula , and <span style=""background-color: #FFFF00"">hypodontia</span> ( <span style=""background-color: #FFFF00"">H</span> ) .",2.931795835494995," <span style=""background-color: #FFFF00"">van der Woude syndrome</span> ( <span style=""background-color: #FFFF00"">VWS</span> ) , which has been mapped to 1q32 - 41 , is characterized by pits and / or sinuses of the lower lip , <span style=""background-color: #FFFF00"">cleft lip / palate</span> ( <span style=""background-color: #FFFF00"">CL / P</span> ) , <span style=""background-color: #FFFF00"">cleft palate</span> ( <span style=""background-color: #FFFF00"">CP</span> ) , bifid uvula , and hypodontia ( <span style=""background-color: #FFFF00"">H</span> ) .",2.622501850128174," <span style=""background-color: #FFFF00"">van der Woude syndrome</span> ( <span style=""background-color: #FFFF00"">VWS</span> ) , which has been mapped to 1q32 - 41 , is characterized by pits and / or sinuses of the lower lip , <span style=""background-color: #FFFF00"">cleft lip / palate</span> ( <span style=""background-color: #FFFF00"">CL / P</span> ) , <span style=""background-color: #FFFF00"">cleft palate</span> ( <span style=""background-color: #FFFF00"">CP</span> ) , bifid uvula , and hypodontia ( <span style=""background-color: #FFFF00"">H</span> ) .",2.8574631214141846,"['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'O', 'B', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
10116,These findings provide direct evidence that XK is responsible for McLeod syndrome . .,O O O O O O O O O O B I O O,13," These findings provide direct evidence that XK is responsible for <span style=""background-color: #FFFF00"">McLeod syndrome</span> . .",0.6470420360565186," These findings provide direct evidence that XK is responsible for <span style=""background-color: #FFFF00"">McLeod syndrome</span> . .",0.7544360160827637," These findings provide direct evidence that XK is responsible for <span style=""background-color: #FFFF00"">McLeod syndrome</span> . .",0.8804829120635986," These findings provide direct evidence that XK is responsible for <span style=""background-color: #FFFF00"">McLeod syndrome</span> . .",1.2335247993469238,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']"
2562,Genetic heterogeneity in X - linked amelogenesis imperfecta .,O O O B I I I I O,32," <span style=""background-color: #FFFF00"">Genetic heterogeneity</span> in <span style=""background-color: #FFFF00"">X - linked amelogenesis imperfecta</span> .",0.9629528522491455," <span style=""background-color: #FFFF00"">Genetic heterogeneity</span> in X - linked <span style=""background-color: #FFFF00"">amelogenesis imperfecta</span> .",1.046433925628662," <span style=""background-color: #FFFF00"">Genetic heterogeneity</span> in X - linked <span style=""background-color: #FFFF00"">amelogenesis imperfecta</span> .",1.0472221374511719," <span style=""background-color: #FFFF00"">Genetic heterogeneity</span> in X - linked <span style=""background-color: #FFFF00"">amelogenesis imperfecta</span> .",1.2438609600067139,"['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['B', 'I', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
1713,Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts .,O O O O O O O O O O O B O,32," Heterozygous loss of Six5 in mice is sufficient to cause <span style=""background-color: #FFFF00"">ocular cataracts</span> .",1.125096082687378," Heterozygous loss of <span style=""background-color: #FFFF00"">Six5</span> in mice is sufficient to cause ocular cataracts .",0.8723969459533691," Heterozygous loss of <span style=""background-color: #FFFF00"">Six5</span> in mice is sufficient to cause ocular cataracts .",0.9555308818817139," <span style=""background-color: #FFFF00"">Heterozygous loss</span> of Six5 in mice is sufficient to cause <span style=""background-color: #FFFF00"">ocular cataracts</span> .",1.3330450057983398,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
4590,These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to MJD .,O O O O O O O O O O O O O O O O O O B O,32," These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to <span style=""background-color: #FFFF00"">MJD</span> .",0.822537899017334," These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to <span style=""background-color: #FFFF00"">MJD</span> .",1.0553791522979736," These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to <span style=""background-color: #FFFF00"">MJD</span> .",0.9918308258056641," These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to <span style=""background-color: #FFFF00"">MJD</span> .",1.1062977313995361,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
11388,"The BARD1 / BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility , indicating that BARD1 may be involved in mediating tumour suppression by BRCA1 . .",O O O O O O O O O O O O O O B I O O O O O O O O O O B O O O O O,13," The <span style=""background-color: #FFFF00"">BARD1</span> / <span style=""background-color: #FFFF00"">BRCA1</span> interaction is disrupted by <span style=""background-color: #FFFF00"">BRCA1</span> missense mutations that segregate with <span style=""background-color: #FFFF00"">breast cancer</span> susceptibility , indicating that <span style=""background-color: #FFFF00"">BARD1</span> may be involved in mediating tumour suppression by <span style=""background-color: #FFFF00"">BRCA1</span> . .",2.0170300006866455," The BARD1 / <span style=""background-color: #FFFF00"">BRCA1</span> interaction is disrupted by <span style=""background-color: #FFFF00"">BRCA1</span> missense mutations that segregate with <span style=""background-color: #FFFF00"">breast cancer</span> susceptibility , indicating that BARD1 may be involved in mediating tumour suppression by <span style=""background-color: #FFFF00"">BRCA1</span> . .",1.6192820072174072," The <span style=""background-color: #FFFF00"">BARD1 / BRCA1</span> interaction is disrupted by <span style=""background-color: #FFFF00"">BRCA1</span> missense mutations that segregate with <span style=""background-color: #FFFF00"">breast cancer</span> susceptibility , indicating that <span style=""background-color: #FFFF00"">BARD1</span> may be involved in mediating tumour suppression by <span style=""background-color: #FFFF00"">BRCA1</span> . .",2.055500030517578," The <span style=""background-color: #FFFF00"">BARD1 / BRCA1</span> interaction is disrupted by <span style=""background-color: #FFFF00"">BRCA1</span> missense mutations that segregate with <span style=""background-color: #FFFF00"">breast cancer</span> susceptibility , indicating that <span style=""background-color: #FFFF00"">BARD1</span> may be involved in mediating <span style=""background-color: #FFFF00"">tumour</span> suppression by <span style=""background-color: #FFFF00"">BRCA1</span> . .",2.4858500957489014,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O']"
10558,"In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever ( FMF ) , a family is presented with 6 out of 9 siblings affected by FMF .",O O O O O O O O O O O O O O O B I I O B O O O O O O O O O O O O O O B O,13," In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> ( <span style=""background-color: #FFFF00"">FMF</span> ) , a family is presented with 6 out of 9 siblings affected by <span style=""background-color: #FFFF00"">FMF</span> .",1.3981666564941406," In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> ( <span style=""background-color: #FFFF00"">FMF</span> ) , a family is presented with 6 out of 9 siblings affected by <span style=""background-color: #FFFF00"">FMF</span> .",1.4708831310272217," In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> ( <span style=""background-color: #FFFF00"">FMF</span> ) , a family is presented with 6 out of 9 siblings affected by <span style=""background-color: #FFFF00"">FMF</span> .",1.583333969116211," In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of <span style=""background-color: #FFFF00"">familial Mediterranean fever</span> ( <span style=""background-color: #FFFF00"">FMF</span> ) , a family is presented with 6 out of 9 siblings affected by <span style=""background-color: #FFFF00"">FMF</span> .",1.968454122543335,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
9362,"Here prediction and exclusion of DMD gene transmission may be possible , the accuracy being dependent on the closeness of the linkage of the DNA marker ( s ) to the DMD gene ; an illustrative case is reported .",O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O,13," Here prediction and exclusion of <span style=""background-color: #FFFF00"">DMD</span> gene transmission may be possible , the accuracy being dependent on the closeness of the linkage of the <span style=""background-color: #FFFF00"">DNA</span> marker ( s ) to the <span style=""background-color: #FFFF00"">DMD</span> gene ; an illustrative case is reported .",1.3824760913848877," Here prediction and exclusion of <span style=""background-color: #FFFF00"">DMD</span> gene transmission may be possible , the accuracy being dependent on the closeness of the linkage of the DNA marker ( s ) to the <span style=""background-color: #FFFF00"">DMD</span> gene ; an illustrative case is reported .",1.231842041015625," Here prediction and exclusion of <span style=""background-color: #FFFF00"">DMD</span> gene transmission may be possible , the accuracy being dependent on the closeness of the linkage of the DNA marker ( s ) to the <span style=""background-color: #FFFF00"">DMD</span> gene ; an illustrative case is reported .",1.3513038158416748," Here prediction and exclusion of <span style=""background-color: #FFFF00"">DMD</span> gene transmission may be possible , the accuracy being dependent on the closeness of the linkage of the DNA marker ( s ) to the <span style=""background-color: #FFFF00"">DMD</span> gene ; an illustrative case is reported .",1.8159737586975098,"['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
4604,High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation .,O O O O O O O O O O O O O O B I O O,32," High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> mutation .",0.744520902633667," High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> mutation .",0.9184529781341553," High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> mutation .",0.9342000484466553," <span style=""background-color: #FFFF00"">High resolution genetic</span> analysis suggests one ancestral predisposing haplotype for the origin of the <span style=""background-color: #FFFF00"">myotonic dystrophy</span> mutation .",1.32590913772583,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']"
9833,"This study examines several biological properties of C5 - deficient ( C5D ) human serum , particularly sera obtained from two C5D homozygotes .",O O O O O O O B I I O B O O O O O O O O O B O O,13," This study examines several biological properties of <span style=""background-color: #FFFF00"">C5</span> - deficient ( <span style=""background-color: #FFFF00"">C5D</span> ) human serum , particularly sera obtained from two <span style=""background-color: #FFFF00"">C5D</span> homozygotes .",1.2938239574432373," This study examines several biological properties of <span style=""background-color: #FFFF00"">C5 - deficient</span> ( <span style=""background-color: #FFFF00"">C5D</span> ) human serum , particularly sera obtained from two <span style=""background-color: #FFFF00"">C5D</span> homozygotes .",1.3382699489593506," This study examines several biological properties of <span style=""background-color: #FFFF00"">C5 - deficient</span> ( <span style=""background-color: #FFFF00"">C5D</span> ) human serum , particularly sera obtained from two <span style=""background-color: #FFFF00"">C5D</span> homozygotes .",1.5765409469604492," This study examines several biological properties of <span style=""background-color: #FFFF00"">C5 - deficient</span> ( <span style=""background-color: #FFFF00"">C5D</span> ) human serum , particularly sera obtained from two <span style=""background-color: #FFFF00"">C5D</span> homozygotes .",1.8653430938720703,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
3152,Gross haemoglobinuria and jaundice occurred only after receiving postoperative transfusion of whole blood .,O B O B O O O O O O O O O O,32," Gross <span style=""background-color: #FFFF00"">haemoglobinuria</span> and <span style=""background-color: #FFFF00"">jaundice</span> occurred only after receiving postoperative transfusion of whole blood .",0.9910638332366943, Gross haemoglobinuria and jaundice occurred only after receiving postoperative transfusion of whole blood .,0.5248167514801025, Gross haemoglobinuria and jaundice occurred only after receiving postoperative transfusion of whole blood .,0.6650848388671875, Gross haemoglobinuria and jaundice occurred only after receiving postoperative transfusion of whole blood .,0.9034929275512695,"['O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
2997,A de novo unbalanced reciprocal translocation identified as paternal in origin in the Prader - Willi syndrome .,O O O O O O O O O O O O O B I I I O,32," A de novo unbalanced reciprocal translocation identified as paternal in origin in the <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> .",0.707056999206543," A de novo unbalanced reciprocal translocation identified as paternal in origin in the <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> .",0.7577383518218994," A de novo unbalanced reciprocal translocation identified as paternal in origin in the <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> .",0.9488587379455566," A de novo unbalanced reciprocal translocation identified as paternal in origin in the <span style=""background-color: #FFFF00"">Prader - Willi syndrome</span> .",1.0850670337677002,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']"
11520,"We report about Dr . Kniest , who first described the condition in 1952 , and his patient , who , at the age of 50 years is severely handicapped with short stature , restricted joint mobility , and blindness but is mentally alert and leads an active life .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O B I O B I I O O B O O O O O O O O O O,13," We report about Dr . <span style=""background-color: #FFFF00"">Kniest</span> , who first described the condition in 1952 , and his patient , who , at the age of 50 years is severely handicapped with short stature , restricted joint mobility , and <span style=""background-color: #FFFF00"">blindness</span> but is mentally alert and leads an active life .",1.349073886871338," We report about Dr . Kniest , who first described the condition in 1952 , and his patient , who , at the age of 50 years is severely handicapped with short stature , restricted joint mobility , and blindness but is mentally alert and leads an active life .",1.015467643737793," We report about Dr . Kniest , who first described the condition in 1952 , and his patient , who , at the age of 50 years is severely handicapped with short stature , restricted joint mobility , and blindness but is mentally alert and leads an active life .",1.122021198272705," We report about Dr . Kniest , who first described the condition in 1952 , and his patient , who , at the age of 50 years is severely handicapped with <span style=""background-color: #FFFF00"">short stature</span> , restricted joint mobility , and <span style=""background-color: #FFFF00"">blindness</span> but is mentally alert and leads an active life .",1.7145700454711914,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7142,CONTEXT Most hereditary ovarian cancers are associated with germline mutations in BRCA1 or BRCA2 .,O O B I I O O O O O O O O O O,13," Most hereditary ovarian cancers are associated with germline mutations in <span style=""background-color: #FFFF00"">BRCA1</span> or <span style=""background-color: #FFFF00"">BRCA2</span> .",0.8938450813293457," Most hereditary ovarian cancers are associated with germline mutations in <span style=""background-color: #FFFF00"">BRCA1</span> or <span style=""background-color: #FFFF00"">BRCA2</span> .",0.9366559982299805," Most hereditary ovarian cancers are associated with germline mutations in <span style=""background-color: #FFFF00"">BRCA1</span> or <span style=""background-color: #FFFF00"">BRCA2</span> .",1.0637733936309814," Most hereditary <span style=""background-color: #FFFF00"">ovarian cancers</span> are associated with germline mutations in <span style=""background-color: #FFFF00"">BRCA1</span> or <span style=""background-color: #FFFF00"">BRCA2</span> .",1.4964349269866943,"['O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O']"
0,"Identification of APC2 , a homologue of the adenomatous polyposis coli tumour suppressor .",O O O O O O O O B I I I O O,32," Identification of <span style=""background-color: #FFFF00"">APC2</span> , a homologue of the <span style=""background-color: #FFFF00"">adenomatous polyposis coli tumour suppressor</span> .",1.0519909858703613," Identification of <span style=""background-color: #FFFF00"">APC2</span> , a homologue of the <span style=""background-color: #FFFF00"">adenomatous polyposis coli tumour suppressor</span> .",1.046537160873413," Identification of <span style=""background-color: #FFFF00"">APC2</span> , a homologue of the <span style=""background-color: #FFFF00"">adenomatous polyposis coli tumour suppressor</span> .",1.0559439659118652," Identification of <span style=""background-color: #FFFF00"">APC2</span> , a homologue of the <span style=""background-color: #FFFF00"">adenomatous polyposis coli tumour</span> suppressor .",1.4340412616729736,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O']"
9665,"Disturbances of enamel formation occur in amelogenesis imperfecta , a clinically heterogenous group of inherited disorders characterised by defective enamel biomineralisation .",O O O O O O B I O O O O O O B I O O O O O O,13," Disturbances of enamel formation occur in <span style=""background-color: #FFFF00"">amelogenesis imperfecta</span> , a clinically heterogenous group of <span style=""background-color: #FFFF00"">inherited disorders</span> characterised by defective enamel biomineralisation .",1.051002025604248," Disturbances of enamel formation occur in <span style=""background-color: #FFFF00"">amelogenesis imperfecta</span> , a clinically heterogenous group of inherited disorders characterised by defective enamel biomineralisation .",0.8914921283721924," Disturbances of enamel formation occur in <span style=""background-color: #FFFF00"">amelogenesis imperfecta</span> , a clinically heterogenous group of inherited disorders characterised by defective enamel biomineralisation .",1.0539708137512207," <span style=""background-color: #FFFF00"">Disturbances</span> of enamel formation occur in <span style=""background-color: #FFFF00"">amelogenesis imperfecta</span> , a clinically heterogenous group of inherited disorders characterised by defective enamel biomineralisation .",1.53497314453125,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
50,"In addition , a significant excess risk of basal cell carcinoma was seen ( standardized incidence ratio 35 , 95 % confidence interval 7 . 2 to 102 ) .",O O O O O O O O B I I O O O O O O O O O O O O O O O O O O O,32," In addition , a significant excess risk of <span style=""background-color: #FFFF00"">basal cell carcinoma</span> was seen ( standardized incidence ratio 35 , 95 % confidence interval 7 . 2 to 102 ) .",0.9976060390472412," In addition , a significant excess risk of <span style=""background-color: #FFFF00"">basal cell carcinoma</span> was seen ( standardized incidence ratio 35 , 95 % confidence interval 7 . 2 to 102 ) .",1.0242791175842285," In addition , a significant excess risk of <span style=""background-color: #FFFF00"">basal cell carcinoma</span> was seen ( standardized incidence ratio 35 , 95 % confidence interval 7 . 2 to 102 ) .",1.2135519981384277," In addition , a significant excess risk of <span style=""background-color: #FFFF00"">basal cell carcinoma</span> was seen ( standardized incidence ratio 35 , 95 % confidence interval 7 . 2 to 102 ) .",1.3572959899902344,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
12186,"Mice harbouring an intragenic deletion in Snrpn are phenotypically normal , suggesting that mutations of SNRPN are not sufficient to induce PWS .",O O O O O O O O O O O O O O O O O O O O O B O,39," Mice harbouring an intragenic deletion in <span style=""background-color: #FFFF00"">Snrpn</span> are phenotypically normal , suggesting that mutations of <span style=""background-color: #FFFF00"">SNRPN</span> are not sufficient to induce <span style=""background-color: #FFFF00"">PWS</span> .",1.1913809776306152," Mice harbouring an intragenic deletion in <span style=""background-color: #FFFF00"">Snrpn</span> are phenotypically normal , suggesting that mutations of <span style=""background-color: #FFFF00"">SNRPN</span> are not sufficient to induce <span style=""background-color: #FFFF00"">PWS</span> .",1.3974699974060059," Mice harbouring an intragenic deletion in <span style=""background-color: #FFFF00"">Snrpn</span> are phenotypically normal , suggesting that mutations of <span style=""background-color: #FFFF00"">SNRPN</span> are not sufficient to induce <span style=""background-color: #FFFF00"">PWS</span> .",1.3998839855194092," Mice harbouring an intragenic deletion in Snrpn are phenotypically normal , suggesting that mutations of SNRPN are not sufficient to induce <span style=""background-color: #FFFF00"">PWS</span> .",1.2200279235839844,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
561,"All but two of these previously described mutations cause in - frame deletions in type II collagen , either by small deletions in the gene or splice site alterations .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,32," All but two of these previously described mutations cause in - frame deletions in <span style=""background-color: #FFFF00"">type II collagen</span> , either by small deletions in the <span style=""background-color: #FFFF00"">gene</span> or <span style=""background-color: #FFFF00"">splice site alterations</span> .",1.20048189163208," All but two of these previously described mutations cause in - frame deletions in <span style=""background-color: #FFFF00"">type II collagen</span> , either by small deletions in the gene or splice site alterations .",0.8797838687896729," All but two of these previously described mutations cause in - frame deletions in type II collagen , either by small deletions in the gene or splice site alterations .",0.7949137687683105," All but two of these previously described mutations cause in - frame deletions in type II <span style=""background-color: #FFFF00"">collagen</span> , either by small deletions in the gene or splice site alterations .",1.2502777576446533,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
10495,"Detailed analysis of genomic deletions in Norrie patients shows that they are heterogeneous , both in size and in position .",O O O O O O B O O O O O O O O O O O O O O,13," Detailed analysis of genomic deletions in <span style=""background-color: #FFFF00"">Norrie</span> patients shows that they are heterogeneous , both in size and in position .",0.8455700874328613," Detailed analysis of genomic deletions in <span style=""background-color: #FFFF00"">Norrie</span> patients shows that they are heterogeneous , both in size and in position .",0.7902820110321045," Detailed analysis of genomic deletions in <span style=""background-color: #FFFF00"">Norrie</span> patients shows that they are heterogeneous , both in size and in position .",0.9760310649871826," Detailed analysis of genomic deletions in <span style=""background-color: #FFFF00"">Norrie</span> patients shows that they are heterogeneous , both in size and in position .",1.369614839553833,"['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3991,"TSD carrier frequencies were then examined by single country and single region of origin in 28 , 029 Jews within this sample for whom such data were available for analysis .",B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,32," TSD carrier frequencies were then examined by single country and single region of origin in 28 , 029 Jews within this sample for whom such data were available for analysis .",0.7775359153747559," TSD carrier frequencies were then examined by single country and single region of origin in 28 , 029 Jews within this sample for whom such data were available for analysis .",1.0171918869018555," TSD carrier frequencies were then examined by single country and single region of origin in 28 , 029 Jews within this sample for whom such data were available for analysis .",0.8865149021148682," <span style=""background-color: #FFFF00"">TSD</span> carrier frequencies were then examined by single country and single region of origin in 28 , 029 Jews within this sample for whom such data were available for analysis .",1.3093271255493164,"['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9153,"A portion of the Duchenne muscular dystrophy ( DMD ) gene transcript from human fetal skeletal muscle and mouse adult heart was sequenced , representing approximately 25 percent of the total , 14 - kb DMD transcript .",O O O O B I I O B O O O O O O O O O O O O O O O O O O O O O O O O O O B O O,13," A portion of the <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) gene transcript from human fetal skeletal muscle and mouse adult heart was sequenced , representing approximately 25 percent of the total , 14 - kb <span style=""background-color: #FFFF00"">DMD</span> transcript .",1.4396040439605713," A portion of the <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) gene transcript from human fetal skeletal muscle and mouse adult heart was sequenced , representing approximately 25 percent of the total , 14 - kb <span style=""background-color: #FFFF00"">DMD</span> transcript .",1.4766790866851807," A portion of the <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) gene transcript from human fetal skeletal muscle and mouse adult heart was sequenced , representing approximately 25 percent of the total , 14 - kb <span style=""background-color: #FFFF00"">DMD</span> transcript .",1.668384075164795," A portion of the <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) gene transcript from human fetal skeletal muscle and mouse adult heart was sequenced , representing approximately 25 percent of the total , 14 - kb <span style=""background-color: #FFFF00"">DMD</span> transcript .",1.9144408702850342,"['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
5845,We previously reported evidence of linkage to the 1q24 - 25 region ( HPC1 ) in 91 North American and Swedish families each with multiple cases of prostate cancer ( Smith et al . 1996 ) .,O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O,13," We previously reported evidence of linkage to the 1q24 - 25 region ( <span style=""background-color: #FFFF00"">HPC1</span> ) in 91 North American and Swedish families each with multiple cases of <span style=""background-color: #FFFF00"">prostate cancer</span> ( Smith et al . 1996 ) .",1.493427038192749," We previously reported evidence of linkage to the 1q24 - 25 region ( <span style=""background-color: #FFFF00"">HPC1</span> ) in 91 North American and Swedish families each with multiple cases of <span style=""background-color: #FFFF00"">prostate cancer</span> ( Smith et al . 1996 ) .",1.430582046508789," We previously reported evidence of linkage to the <span style=""background-color: #FFFF00"">1q24 - 25 region</span> ( <span style=""background-color: #FFFF00"">HPC1</span> ) in 91 North American and Swedish families each with multiple cases of <span style=""background-color: #FFFF00"">prostate cancer</span> ( Smith et al . 1996 ) .",1.6679160594940186," We previously reported evidence of linkage to the 1q24 - 25 region ( <span style=""background-color: #FFFF00"">HPC1</span> ) in 91 North American and Swedish families each with multiple cases of <span style=""background-color: #FFFF00"">prostate cancer</span> ( Smith et al . 1996 ) .",1.877159833908081,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
9091,"A controlled , double - blind therapeutic trial with the drug mazindol , a growth hormone inhibitor , was performed in a pair of 7 1 / 2 year - old monozygotic twins , with Duchenne muscular dystrophy ( DMD ) .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I I O B O O,13," A controlled , double - blind therapeutic trial with the drug mazindol , a growth hormone inhibitor , was performed in a pair of 7 1 / 2 year - old monozygotic twins , with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) .",1.2931060791015625," A controlled , double - blind therapeutic trial with the drug mazindol , a growth hormone inhibitor , was performed in a pair of 7 1 / 2 year - old monozygotic twins , with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) .",1.3911879062652588," A controlled , double - blind therapeutic trial with the drug mazindol , a growth hormone inhibitor , was performed in a pair of 7 1 / 2 year - old monozygotic twins , with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) .",1.508728265762329," A controlled , double - blind therapeutic trial with the drug mazindol , a growth hormone inhibitor , was performed in a pair of 7 1 / 2 year - old monozygotic twins , with <span style=""background-color: #FFFF00"">Duchenne muscular dystrophy</span> ( <span style=""background-color: #FFFF00"">DMD</span> ) .",1.7578842639923096,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O']"
10914,We report details of a family with classic Li - Fraumeni syndrome in which there is a mutation in codon 344 of the tumour suppressor gene TP53 .,O O O O O O O O B I I I O O O O O O O O O O O B O O O O,13," We report details of a family with classic <span style=""background-color: #FFFF00"">Li - Fraumeni syndrome</span> in which there is a mutation in codon 344 of the <span style=""background-color: #FFFF00"">tumour suppressor gene TP53</span> .",1.0825579166412354," We report details of a family with classic <span style=""background-color: #FFFF00"">Li - Fraumeni syndrome</span> in which there is a mutation in codon 344 of the tumour suppressor gene TP53 .",0.9558751583099365," We report details of a family with classic <span style=""background-color: #FFFF00"">Li - Fraumeni syndrome</span> in which there is a mutation in codon 344 of the <span style=""background-color: #FFFF00"">tumour suppressor gene TP53</span> .",1.2389159202575684," We report details of a family with classic <span style=""background-color: #FFFF00"">Li - Fraumeni syndrome</span> in which there is a mutation in codon 344 of the <span style=""background-color: #FFFF00"">tumour suppressor gene TP53</span> .",1.4575908184051514,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']"
475,Functional consequences of mutations in the early growth response 2 gene ( EGR2 ) correlate with severity of human myelinopathies .,O O O O O O O O O O O O O O O O O O O B O,32," Functional consequences of mutations in the <span style=""background-color: #FFFF00"">early growth response 2 gene</span> ( <span style=""background-color: #FFFF00"">EGR2</span> ) correlate with severity of human <span style=""background-color: #FFFF00"">myelinopathies</span> .",1.4281890392303467," Functional consequences of mutations in the <span style=""background-color: #FFFF00"">early growth response 2 gene</span> ( <span style=""background-color: #FFFF00"">EGR2</span> ) correlate with severity of human <span style=""background-color: #FFFF00"">myelinopathies</span> .",1.321263313293457," Functional consequences of mutations in the <span style=""background-color: #FFFF00"">early growth response 2 gene</span> ( <span style=""background-color: #FFFF00"">EGR2</span> ) correlate with severity of human <span style=""background-color: #FFFF00"">myelinopathies</span> .",1.3011188507080078," Functional consequences of mutations in the <span style=""background-color: #FFFF00"">early growth response 2</span> gene ( <span style=""background-color: #FFFF00"">EGR2</span> ) correlate with severity of human <span style=""background-color: #FFFF00"">myelinopathies</span> .",1.603592872619629,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
1536,"Interestingly , all patients with cardiac involvement were homozygous for one of these mutations R59H , Y591C , Y591N , or IVS14 - 2A > G .",O O O O O B I O O O O O O O O O O O O O O O O O O O O,32," Interestingly , all patients with <span style=""background-color: #FFFF00"">cardiac involvement</span> were homozygous for one of these mutations <span style=""background-color: #FFFF00"">R59H</span> , <span style=""background-color: #FFFF00"">Y591C</span> , <span style=""background-color: #FFFF00"">Y591N</span> , or <span style=""background-color: #FFFF00"">IVS14 - 2A > G</span> .",2.0061209201812744," Interestingly , all patients with cardiac involvement were homozygous for one of these mutations <span style=""background-color: #FFFF00"">R59H</span> , <span style=""background-color: #FFFF00"">Y591C</span> , <span style=""background-color: #FFFF00"">Y591N</span> , or <span style=""background-color: #FFFF00"">IVS14 - 2A > G</span> .",1.6149852275848389," Interestingly , all patients with <span style=""background-color: #FFFF00"">cardiac involvement</span> were homozygous for one of these mutations <span style=""background-color: #FFFF00"">R59H</span> , <span style=""background-color: #FFFF00"">Y591C</span> , <span style=""background-color: #FFFF00"">Y591N</span> , or <span style=""background-color: #FFFF00"">IVS14 - 2A > G</span> .",2.0538361072540283," Interestingly , all patients with <span style=""background-color: #FFFF00"">cardiac</span> involvement were homozygous for one of these mutations <span style=""background-color: #FFFF00"">R59H</span> , <span style=""background-color: #FFFF00"">Y591C</span> , <span style=""background-color: #FFFF00"">Y591N</span> , or <span style=""background-color: #FFFF00"">IVS14 - 2A > G</span> .",2.1737518310546875,"['O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O']"
2136,A germ line mutation within the coding sequence for the putative 5 - phosphoribosyl - 1 - pyrophosphate binding site of hypoxanthine - guanine phosphoribosyltransferase ( HPRT ) in a Lesch - Nyhan patient : missense mutations within a functionally important region probably cause disease .,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I I O O O O O O O O O O O O O,32," A germ line mutation within the coding sequence for the putative 5 - <span style=""background-color: #FFFF00"">phosphoribosyl</span> - 1 - <span style=""background-color: #FFFF00"">pyrophosphate</span> binding site of <span style=""background-color: #FFFF00"">hypoxanthine</span> - <span style=""background-color: #FFFF00"">guanine phosphoribosyltransferase</span> ( <span style=""background-color: #FFFF00"">HPRT</span> ) in a <span style=""background-color: #FFFF00"">Lesch</span> - <span style=""background-color: #FFFF00"">Nyhan</span> patient : missense mutations within a functionally important region probably cause <span style=""background-color: #FFFF00"">disease</span> .",2.614415168762207," A germ line mutation within the coding sequence for the putative 5 - phosphoribosyl - 1 - pyrophosphate binding site of <span style=""background-color: #FFFF00"">hypoxanthine - guanine phosphoribosyltransferase</span> ( <span style=""background-color: #FFFF00"">HPRT</span> ) in a <span style=""background-color: #FFFF00"">Lesch - Nyhan</span> patient : missense mutations within a functionally important region probably cause disease .",1.6798820495605469," A germ line mutation within the coding sequence for the putative 5 - phosphoribosyl - 1 - pyrophosphate binding site of <span style=""background-color: #FFFF00"">hypoxanthine - guanine phosphoribosyltransferase</span> ( <span style=""background-color: #FFFF00"">HPRT</span> ) in a <span style=""background-color: #FFFF00"">Lesch - Nyhan</span> patient : missense mutations within a functionally important region probably cause disease .",1.9308762550354004," A germ line mutation within the coding sequence for the putative 5 - phosphoribosyl - 1 - pyrophosphate binding site of <span style=""background-color: #FFFF00"">hypoxanthine - guanine phosphoribosyltransferase</span> ( <span style=""background-color: #FFFF00"">HPRT</span> ) in a <span style=""background-color: #FFFF00"">Lesch - Nyhan</span> patient : missense mutations within a functionally important region probably cause <span style=""background-color: #FFFF00"">disease</span> .",2.196446180343628,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
6998,"As a step toward understanding the function of FMR1 and the determination of the potential for therapeutic approaches to fragile X syndrome , yeast artificial chromosome ( YAC ) transgenic mice were generated in order to determine whether the Fmr1 knockout mouse phenotype could be rescued .",O O O O O O O O O O O O O O O O O O O B I I O O O O O O O O O O O O O O O O O O O O O O O O O,13," As a step toward understanding the function of <span style=""background-color: #FFFF00"">FMR1</span> and the determination of the potential for therapeutic approaches to <span style=""background-color: #FFFF00"">fragile X syndrome</span> , yeast artificial chromosome ( <span style=""background-color: #FFFF00"">YAC</span> ) transgenic mice were generated in order to determine whether the <span style=""background-color: #FFFF00"">Fmr1</span> knockout mouse phenotype could be rescued .",1.686215877532959," As a step toward understanding the function of <span style=""background-color: #FFFF00"">FMR1</span> and the determination of the potential for therapeutic approaches to <span style=""background-color: #FFFF00"">fragile X syndrome</span> , yeast artificial chromosome ( YAC ) transgenic mice were generated in order to determine whether the <span style=""background-color: #FFFF00"">Fmr1</span> knockout mouse phenotype could be rescued .",1.5246062278747559," As a step toward understanding the function of FMR1 and the determination of the potential for therapeutic approaches to <span style=""background-color: #FFFF00"">fragile X syndrome</span> , yeast artificial chromosome ( YAC ) transgenic mice were generated in order to determine whether the Fmr1 knockout mouse phenotype could be rescued .",1.4062860012054443," As a step toward understanding the function of FMR1 and the determination of the potential for therapeutic approaches to <span style=""background-color: #FFFF00"">fragile X syndrome</span> , yeast artificial chromosome ( YAC ) transgenic mice were generated in order to determine whether the Fmr1 knockout mouse phenotype could be rescued .",1.562345027923584,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
232,"The locus for non - syndromic sensorineural hearing loss with EVA has been mapped to the same chromosomal region , 7q31 , as the Pendred syndrome locus .",O O O B I I I I I O B O O O O O O O O O O O O O B I O O,32," The locus for non - syndromic <span style=""background-color: #FFFF00"">sensorineural hearing loss</span> with <span style=""background-color: #FFFF00"">EVA</span> has been mapped to the same chromosomal region , 7q31 , as the <span style=""background-color: #FFFF00"">Pendred syndrome</span> locus .",1.2706949710845947," The locus for non - syndromic <span style=""background-color: #FFFF00"">sensorineural hearing loss</span> with EVA has been mapped to the same chromosomal region , 7q31 , as the <span style=""background-color: #FFFF00"">Pendred syndrome</span> locus .",1.1844940185546875," The locus for non - syndromic <span style=""background-color: #FFFF00"">sensorineural hearing loss</span> with EVA has been mapped to the same chromosomal region , 7q31 , as the <span style=""background-color: #FFFF00"">Pendred syndrome</span> locus .",1.2599029541015625," The locus for non - syndromic <span style=""background-color: #FFFF00"">sensorineural hearing loss</span> with EVA has been mapped to the same chromosomal region , 7q31 , as the <span style=""background-color: #FFFF00"">Pendred syndrome</span> locus .",1.5400819778442383,"['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']"
2003,The same residue is often mutated in the Brutons tyrosine kinase ( Btk ) gene in patients with an X - linked agammaglobulinemia .,O O O O O O O O O O O O O O O O O O O B I I I O,32," The same residue is often mutated in the <span style=""background-color: #FFFF00"">Brutons tyrosine kinase</span> ( <span style=""background-color: #FFFF00"">Btk</span> ) gene in patients with an <span style=""background-color: #FFFF00"">X - linked agammaglobulinemia</span> .",1.248589038848877," The same residue is often mutated in the <span style=""background-color: #FFFF00"">Brutons tyrosine kinase</span> ( <span style=""background-color: #FFFF00"">Btk</span> ) gene in patients with an X - linked <span style=""background-color: #FFFF00"">agammaglobulinemia</span> .",1.3498117923736572," The same residue is often mutated in the <span style=""background-color: #FFFF00"">Brutons tyrosine kinase ( Btk )</span> gene in patients with an X - linked <span style=""background-color: #FFFF00"">agammaglobulinemia</span> .",1.6972558498382568," The same residue is often mutated in the <span style=""background-color: #FFFF00"">Brutons tyrosine kinase</span> ( <span style=""background-color: #FFFF00"">Btk</span> ) gene in patients with an X - linked <span style=""background-color: #FFFF00"">agammaglobulinemia</span> .",1.6654987335205078,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
6803,"In addition , evidence for locus heterogeneity has been provided by the identification of other putative hereditary prostate cancer loci on Xq27 - 28 , 1q42 - 43 , and 1p36 .",O O O O O O O O O O O O O O O O B I I O O O O O O O O O O O O O,13," In addition , evidence for locus heterogeneity has been provided by the identification of other putative <span style=""background-color: #FFFF00"">hereditary prostate cancer</span> loci on <span style=""background-color: #FFFF00"">Xq27 - 28</span> , <span style=""background-color: #FFFF00"">1q42 - 43</span> , and <span style=""background-color: #FFFF00"">1p36</span> .",1.5972089767456055," In addition , evidence for locus heterogeneity has been provided by the identification of other putative <span style=""background-color: #FFFF00"">hereditary prostate cancer</span> loci on Xq27 - 28 , 1q42 - 43 , and 1p36 .",1.1107449531555176," In addition , evidence for locus heterogeneity has been provided by the identification of other putative <span style=""background-color: #FFFF00"">hereditary prostate cancer</span> loci on Xq27 - 28 , 1q42 - 43 , and 1p36 .",1.50508713722229," In addition , evidence for locus heterogeneity has been provided by the identification of other putative <span style=""background-color: #FFFF00"">hereditary prostate cancer</span> loci on Xq27 - 28 , 1q42 - 43 , and 1p36 .",1.4204130172729492,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
6081,"We describe seven Dutch patients from six families with a slowly progressive , mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis ( CTX ) .",O O O O O O O O O O O O O O B I I O O O O O O O O O B I O B O O,13," We describe seven Dutch patients from six families with a slowly progressive , mainly <span style=""background-color: #FFFF00"">spinal cord syndrome</span> that remained for many years the sole expression of <span style=""background-color: #FFFF00"">cerebrotendinous xanthomatosis</span> ( <span style=""background-color: #FFFF00"">CTX</span> ) .",1.302781105041504," We describe seven Dutch patients from six families with a slowly progressive , mainly spinal cord syndrome that remained for many years the sole expression of <span style=""background-color: #FFFF00"">cerebrotendinous xanthomatosis</span> ( <span style=""background-color: #FFFF00"">CTX</span> ) .",1.2303688526153564," We describe seven Dutch patients from six families with a slowly progressive , mainly spinal cord syndrome that remained for many years the sole expression of <span style=""background-color: #FFFF00"">cerebrotendinous xanthomatosis</span> ( <span style=""background-color: #FFFF00"">CTX</span> ) .",1.3425641059875488," We describe seven Dutch patients from six families with a slowly progressive , mainly <span style=""background-color: #FFFF00"">spinal cord syndrome</span> that remained for many years the sole expression of <span style=""background-color: #FFFF00"">cerebrotendinous xanthomatosis</span> ( <span style=""background-color: #FFFF00"">CTX</span> ) .",1.8067679405212402,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O']"
7861,We report here the result of a screening for germ - line mutations in the adenomatous polyposis coli ( APC ) gene in 61 new familial adenomatous polyposis ( FAP ) patients as well as a summary of the results of 150 patients .,O O O O O O O O O O O O O O O B I I O B O O O O O B I I O B O O O O O O O O O O O O O O,13," We report here the result of a screening for germ - line mutations in the <span style=""background-color: #FFFF00"">adenomatous polyposis coli</span> ( <span style=""background-color: #FFFF00"">APC</span> ) gene in 61 new <span style=""background-color: #FFFF00"">familial adenomatous polyposis</span> ( <span style=""background-color: #FFFF00"">FAP</span> ) patients as well as a summary of the results of 150 patients .",1.6965811252593994," We report here the result of a screening for germ - line mutations in the <span style=""background-color: #FFFF00"">adenomatous polyposis coli</span> ( <span style=""background-color: #FFFF00"">APC</span> ) gene in 61 new <span style=""background-color: #FFFF00"">familial adenomatous polyposis</span> ( <span style=""background-color: #FFFF00"">FAP</span> ) patients as well as a summary of the results of 150 patients .",1.7455720901489258," We report here the result of a screening for germ - line mutations in the <span style=""background-color: #FFFF00"">adenomatous polyposis coli</span> ( <span style=""background-color: #FFFF00"">APC</span> ) gene in 61 new <span style=""background-color: #FFFF00"">familial adenomatous polyposis</span> ( <span style=""background-color: #FFFF00"">FAP</span> ) patients as well as a summary of the results of 150 patients .",1.8599443435668945," We report here the result of a screening for germ - line mutations in the <span style=""background-color: #FFFF00"">adenomatous polyposis coli</span> ( <span style=""background-color: #FFFF00"">APC</span> ) gene in 61 new <span style=""background-color: #FFFF00"">familial adenomatous polyposis</span> ( <span style=""background-color: #FFFF00"">FAP</span> ) patients as well as a summary of the results of 150 patients .",2.2085628509521484,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
1933,"Affected individuals exhibit neonatal hypotonia , developmental delay and childhood - onset obesity .",O O O B I O B I O B I I I O,32," Affected individuals exhibit <span style=""background-color: #FFFF00"">neonatal hypotonia</span> , <span style=""background-color: #FFFF00"">developmental delay</span> and <span style=""background-color: #FFFF00"">childhood - onset obesity</span> .",1.0891730785369873," Affected individuals exhibit neonatal hypotonia , developmental delay and childhood - onset obesity .",0.5797297954559326," Affected individuals exhibit neonatal hypotonia , developmental delay and childhood - onset obesity .",0.6840848922729492," Affected individuals exhibit neonatal hypotonia , developmental delay and childhood - onset obesity .",0.9074528217315674,"['O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
6820,"We describe a recurrent large expansion of a maternal allele with 36 CAG repeats ( to 66 and 57 repeats , respectively , in two daughters ) associated with onset of Huntington disease ( HD ) in the second and third decade in a family without history of HD .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O B O O O O O O O O O O O O O B O,13," We describe a recurrent large expansion of a maternal allele with 36 <span style=""background-color: #FFFF00"">CAG repeats</span> ( to 66 and 57 repeats , respectively , in two daughters ) associated with onset of <span style=""background-color: #FFFF00"">Huntington disease</span> ( <span style=""background-color: #FFFF00"">HD</span> ) in the second and third decade in a family without history of <span style=""background-color: #FFFF00"">HD</span> .",1.8211970329284668," We describe a recurrent large expansion of a maternal allele with 36 CAG repeats ( to 66 and 57 repeats , respectively , in two daughters ) associated with onset of <span style=""background-color: #FFFF00"">Huntington disease</span> ( <span style=""background-color: #FFFF00"">HD</span> ) in the second and third decade in a family without history of <span style=""background-color: #FFFF00"">HD</span> .",1.6284139156341553," We describe a recurrent large expansion of a maternal allele with 36 CAG repeats ( to 66 and 57 repeats , respectively , in two daughters ) associated with onset of <span style=""background-color: #FFFF00"">Huntington disease</span> ( <span style=""background-color: #FFFF00"">HD</span> ) in the second and third decade in a family without history of <span style=""background-color: #FFFF00"">HD</span> .",1.7514429092407227," We describe a recurrent large expansion of a maternal allele with 36 CAG repeats ( to 66 and 57 repeats , respectively , in two daughters ) associated with onset of <span style=""background-color: #FFFF00"">Huntington disease</span> ( <span style=""background-color: #FFFF00"">HD</span> ) in the second and third decade in a family without history of <span style=""background-color: #FFFF00"">HD</span> .",1.975330114364624,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
12515,A genome - wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish .,O O O O O O O O O O O O O O O O O O O B I I O O O O O O,39," A genome - wide search for chromosomal loci linked to mental health wellness in relatives at high risk for <span style=""background-color: #FFFF00"">bipolar affective disorder</span> among the Old Order Amish .",0.8192219734191895," A genome - wide search for chromosomal loci linked to mental health wellness in relatives at high risk for <span style=""background-color: #FFFF00"">bipolar affective disorder</span> among the Old Order Amish .",0.920861005783081," A genome - wide search for chromosomal loci linked to <span style=""background-color: #FFFF00"">mental health wellness</span> in relatives at high risk for <span style=""background-color: #FFFF00"">bipolar affective disorder</span> among the Old Order Amish .",1.437124252319336," A genome - wide search for chromosomal loci linked to mental health wellness in relatives at high risk for <span style=""background-color: #FFFF00"">bipolar affective disorder</span> among the Old Order Amish .",1.4232490062713623,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']"
2106,"For this reason , we compared the incidence of death from malignant neoplasms in 2 families of patients with A - T to that expected in a random sample of the general population .",O O O O O O O O O O O B I O O O O O O B I I O O O O O O O O O O O O,32," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.1073729991912842," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.1690559387207031," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.3924148082733154," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.5696089267730713,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5654,A common human skin tumour is caused by activating mutations in beta - catenin .,O O O B I O O O O O O O O O O,13," A common human <span style=""background-color: #FFFF00"">skin tumour</span> is caused by activating mutations in <span style=""background-color: #FFFF00"">beta - catenin</span> .",0.8550689220428467," A common human skin tumour is caused by activating mutations in <span style=""background-color: #FFFF00"">beta - catenin</span> .",0.7541048526763916," A common human skin tumour is caused by activating mutations in <span style=""background-color: #FFFF00"">beta - catenin</span> .",1.0029470920562744," A common human <span style=""background-color: #FFFF00"">skin tumour</span> is caused by activating mutations in <span style=""background-color: #FFFF00"">beta - catenin</span> .",1.2465989589691162,"['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']","['O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']"
1893,"This effect , rather than depending on ligand - induced receptor oligomerization , was found to stem from ligand - independent interaction of wild - type and mutant Fas receptors through a specific region in the extracellular domain .",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,32," This effect , rather than depending on ligand - induced receptor oligomerization , was found to stem from ligand - independent interaction of wild - type and mutant <span style=""background-color: #FFFF00"">Fas</span> receptors through a specific region in the extracellular domain .",0.9878358840942383," This effect , rather than depending on ligand - induced receptor oligomerization , was found to stem from ligand - independent interaction of wild - type and mutant <span style=""background-color: #FFFF00"">Fas</span> receptors through a specific region in the extracellular domain .",1.0049858093261719," This effect , rather than depending on ligand - induced receptor oligomerization , was found to stem from ligand - independent interaction of wild - type and mutant <span style=""background-color: #FFFF00"">Fas</span> receptors through a specific region in the extracellular domain .",1.1064209938049316," This effect , rather than depending on ligand - induced receptor oligomerization , was found to stem from ligand - independent interaction of wild - type and mutant <span style=""background-color: #FFFF00"">Fas</span> receptors through a specific region in the extracellular domain .",1.418665885925293,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7507,"For this reason , we compared the incidence of death from malignant neoplasms in 2 families of patients with A - T to that expected in a random sample of the general population .",O O O O O O O O O O O B I O O O O O O B I I O O O O O O O O O O O O,13," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.1278269290924072," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.1482741832733154," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.4555017948150635," For this reason , we compared the incidence of death from <span style=""background-color: #FFFF00"">malignant neoplasms</span> in 2 families of patients with <span style=""background-color: #FFFF00"">A - T</span> to that expected in a random sample of the general population .",1.6234712600708008,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
83,"Loss of E - cadherin function has been implicated in the pathogenesis of sporadic colorectal and other cancers , and our findings provide evidence that germline CDH1 mutations predispose to early onset colorectal cancer .",O O O O O O O O O O O O O O B I I I O O O O O O O O O O O O O O B I O,32," Loss of <span style=""background-color: #FFFF00"">E - cadherin</span> function has been implicated in the pathogenesis of sporadic <span style=""background-color: #FFFF00"">colorectal</span> and other <span style=""background-color: #FFFF00"">cancers</span> , and our findings provide evidence that <span style=""background-color: #FFFF00"">germline CDH1 mutations</span> predispose to early onset <span style=""background-color: #FFFF00"">colorectal cancer</span> .",1.7614459991455078," Loss of <span style=""background-color: #FFFF00"">E - cadherin</span> function has been implicated in the pathogenesis of sporadic colorectal and other cancers , and our findings provide evidence that germline <span style=""background-color: #FFFF00"">CDH1</span> mutations predispose to early onset colorectal cancer .",1.2761149406433105," Loss of <span style=""background-color: #FFFF00"">E - cadherin</span> function has been implicated in the pathogenesis of sporadic colorectal and other cancers , and our findings provide evidence that germline <span style=""background-color: #FFFF00"">CDH1</span> mutations predispose to early onset colorectal cancer .",1.3419430255889893," Loss of E - <span style=""background-color: #FFFF00"">cadherin</span> function has been implicated in the pathogenesis of sporadic <span style=""background-color: #FFFF00"">colorectal</span> and other <span style=""background-color: #FFFF00"">cancers</span> , and our findings provide evidence that germline CDH1 mutations predispose to early onset <span style=""background-color: #FFFF00"">colorectal cancer</span> .",1.9376215934753418,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
7504,Ataxia - telangiectasia ( A - T ) is an autosomal recessive syndrome associated with a greatly increased incidence of malignant neoplasms in homozygous affected individuals .,B I I O B I I O O O B I I O O O O O O O B I O O O O O,13," <span style=""background-color: #FFFF00"">Ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) is an <span style=""background-color: #FFFF00"">autosomal recessive syndrome</span> associated with a greatly increased incidence of <span style=""background-color: #FFFF00"">malignant neoplasms</span> in <span style=""background-color: #FFFF00"">homozygous affected individuals</span> .",1.6411793231964111," <span style=""background-color: #FFFF00"">Ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) is an autosomal recessive syndrome associated with a greatly increased incidence of <span style=""background-color: #FFFF00"">malignant neoplasms</span> in homozygous affected individuals .",1.887951135635376," <span style=""background-color: #FFFF00"">Ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) is an autosomal recessive syndrome associated with a greatly increased incidence of <span style=""background-color: #FFFF00"">malignant neoplasms</span> in homozygous affected individuals .",1.5700428485870361," <span style=""background-color: #FFFF00"">Ataxia - telangiectasia</span> ( <span style=""background-color: #FFFF00"">A - T</span> ) is an autosomal recessive syndrome associated with a greatly increased incidence of <span style=""background-color: #FFFF00"">malignant neoplasms</span> in homozygous affected individuals .",1.6503229141235352,"['B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'I', 'O']","['B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']"
1725,"As ocular cataracts are a characteristic feature of DM , these results demonstrate that decreased SIX5 transcription is important in the aetiology of DM .",O O B O O O O O B O O O O O O O O O O O O O O B O,32," <span style=""background-color: #FFFF00"">As ocular cataracts</span> are a characteristic feature of <span style=""background-color: #FFFF00"">DM</span> , these results demonstrate that decreased <span style=""background-color: #FFFF00"">SIX5</span> transcription is important in the aetiology of <span style=""background-color: #FFFF00"">DM</span> .",1.3863391876220703," As ocular cataracts are a characteristic feature of <span style=""background-color: #FFFF00"">DM</span> , these results demonstrate that decreased SIX5 transcription is important in the aetiology of <span style=""background-color: #FFFF00"">DM</span> .",1.155609130859375," As <span style=""background-color: #FFFF00"">ocular cataracts</span> are a characteristic feature of <span style=""background-color: #FFFF00"">DM</span> , these results demonstrate that decreased SIX5 transcription is important in the aetiology of <span style=""background-color: #FFFF00"">DM</span> .",1.6545891761779785," As <span style=""background-color: #FFFF00"">ocular cataracts</span> are a characteristic feature of <span style=""background-color: #FFFF00"">DM</span> , these results demonstrate that decreased SIX5 transcription is important in the aetiology of <span style=""background-color: #FFFF00"">DM</span> .",1.5984561443328857,"['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
7897,"In this study , further segregation analysis has been performed using a newly identified WAS family as well as an additional marker probe , HOATL1 .",O O O O O O O O O O O O O O B O O O O O O O O O O O,13," In this study , further segregation analysis has been performed using a newly identified <span style=""background-color: #FFFF00"">WAS family</span> as well as an additional marker probe , <span style=""background-color: #FFFF00"">HOATL1</span> .",0.9846789836883545," In this study , further segregation analysis has been performed using a newly identified <span style=""background-color: #FFFF00"">WAS</span> family as well as an additional marker probe , HOATL1 .",0.8476667404174805," In this study , further segregation analysis has been performed using a newly identified WAS family as well as an additional marker probe , <span style=""background-color: #FFFF00"">HOATL1</span> .",1.3093068599700928," In this study , further segregation analysis has been performed using a newly identified <span style=""background-color: #FFFF00"">WAS</span> family as well as an additional marker probe , HOATL1 .",1.4669032096862793,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7774,"By screening nearly one - half of the coding region of the APC gene in 44 tumors , somatic mutations were detected in three tumors a missense mutation , a nonsense mutation , and a 5 - base pair deletion resulting in a frame shift which causes truncation of the gene product .",O O O O O O O O O O O O B O O O B O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O,13," By screening nearly one - half of the coding region of the <span style=""background-color: #FFFF00"">APC</span> gene in 44 tumors , somatic mutations were detected in three tumors a missense mutation , a nonsense mutation , and a 5 - base pair deletion resulting in a frame shift which causes truncation of the gene product .",1.1595268249511719," By screening nearly one - half of the coding region of the <span style=""background-color: #FFFF00"">APC</span> gene in 44 tumors , somatic mutations were detected in three tumors a missense mutation , a nonsense mutation , and a 5 - base pair deletion resulting in a frame shift which causes truncation of the gene product .",1.2078790664672852," By screening nearly one - half of the coding region of the <span style=""background-color: #FFFF00"">APC</span> gene in 44 tumors , somatic mutations were detected in three tumors a missense mutation , a nonsense mutation , and a 5 - base pair deletion resulting in a frame shift which causes truncation of the gene product .",1.4545788764953613," By screening nearly one - half of the coding region of the <span style=""background-color: #FFFF00"">APC</span> gene in 44 <span style=""background-color: #FFFF00"">tumors</span> , somatic mutations were detected in three <span style=""background-color: #FFFF00"">tumors</span> a missense mutation , a nonsense mutation , and a 5 - base pair deletion resulting in a frame shift which causes truncation of the gene product .",1.9546239376068115,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5267,BRCA1 mutations in a population - based sample of young women with breast cancer .,O O O O O O O O O O O O B I O,32," <span style=""background-color: #FFFF00"">BRCA1</span> mutations in a population - based sample of young women with <span style=""background-color: #FFFF00"">breast cancer</span> .",0.8765738010406494," <span style=""background-color: #FFFF00"">BRCA1</span> mutations in a population - based sample of young women with breast cancer .",0.7054338455200195," <span style=""background-color: #FFFF00"">BRCA1</span> mutations in a population - based sample of young women with breast cancer .",1.0273759365081787," <span style=""background-color: #FFFF00"">BRCA1</span> mutations in a population - based sample of young women with <span style=""background-color: #FFFF00"">breast cancer</span> .",1.312263011932373,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
5807,Oedemic buccal mucosa ( leucoedema ) and gingival overgrowths were more frequent in AGU patients than in controls ( p < 0 . 001 ) .,B I I O B O O B I O O O O B O O O O O O O O O O O O,13," <span style=""background-color: #FFFF00"">Oedemic buccal mucosa</span> ( <span style=""background-color: #FFFF00"">leucoedema</span> ) and <span style=""background-color: #FFFF00"">gingival overgrowths</span> were more frequent in AGU patients than in controls ( p < 0 . 001 ) .",1.3699150085449219," <span style=""background-color: #FFFF00"">Oedemic buccal mucosa</span> ( <span style=""background-color: #FFFF00"">leucoedema</span> ) and gingival overgrowths were more frequent in AGU patients than in controls ( p < 0 . 001 ) .",1.1351640224456787," <span style=""background-color: #FFFF00"">Oedemic buccal mucosa</span> ( <span style=""background-color: #FFFF00"">leucoedema</span> ) and gingival overgrowths were more frequent in AGU patients than in controls ( p < 0 . 001 ) .",1.426110029220581," <span style=""background-color: #FFFF00"">Oedemic buccal mucosa</span> ( <span style=""background-color: #FFFF00"">leucoedema</span> ) and gingival overgrowths were more frequent in AGU patients than in controls ( p < 0 . 001 ) .",1.574819803237915,"['B', 'I', 'I', 'O', 'B', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'B', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
955,Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile - onset diabetes mellitus and progressive optic atrophy .,B I O O B I I I O O B I I I I O O B I O,32," <span style=""background-color: #FFFF00"">Wolfram syndrome</span> is an <span style=""background-color: #FFFF00"">autosomal recessive neurodegenerative disorder</span> characterized by <span style=""background-color: #FFFF00"">juvenile - onset diabetes mellitus</span> and <span style=""background-color: #FFFF00"">progressive optic atrophy</span> .",1.3151819705963135," <span style=""background-color: #FFFF00"">Wolfram syndrome</span> is an autosomal recessive neurodegenerative disorder characterized by juvenile - onset <span style=""background-color: #FFFF00"">diabetes mellitus</span> and progressive optic atrophy .",1.0474350452423096," <span style=""background-color: #FFFF00"">Wolfram syndrome</span> is an autosomal recessive neurodegenerative disorder characterized by <span style=""background-color: #FFFF00"">juvenile - onset diabetes mellitus</span> and progressive optic atrophy .",1.176274299621582," <span style=""background-color: #FFFF00"">Wolfram syndrome</span> is an <span style=""background-color: #FFFF00"">autosomal recessive neurodegenerative disorder</span> characterized by <span style=""background-color: #FFFF00"">juvenile - onset diabetes mellitus</span> and <span style=""background-color: #FFFF00"">progressive optic atrophy</span> .",1.7671539783477783,"['B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'B', 'I', 'O']","['B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'O', 'O', 'O', 'O']","['B', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'O', 'B', 'I', 'I', 'O']"
1251,We report on a 4 - year - old boy with Knobloch syndrome .,O O O O O O O O O O O B I O,32," We report on a 4 - year - old boy with <span style=""background-color: #FFFF00"">Knobloch syndrome</span> .",0.7896261215209961," We report on a 4 - year - old boy with <span style=""background-color: #FFFF00"">Knobloch syndrome</span> .",0.7492978572845459," We report on a 4 - year - old boy with <span style=""background-color: #FFFF00"">Knobloch syndrome</span> .",0.8748998641967773," We report on a 4 - year - old boy with <span style=""background-color: #FFFF00"">Knobloch syndrome</span> .",1.0826539993286133,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']"
6540,The mutations found in our cases occurred in the same exon of the WT1 gene as detected in Denys - Drash syndrome ( DDS ) and could not be explained by the previously proposed mechanism .,O O O O O O O O O O O O O O O O O O B I I I O B O O O O O O O O O O O O,13," The mutations found in our cases occurred in the same exon of the <span style=""background-color: #FFFF00"">WT1 gene</span> as detected in <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> ( <span style=""background-color: #FFFF00"">DDS</span> ) and could not be explained by the previously proposed mechanism .",1.315234899520874," The mutations found in our cases occurred in the same exon of the <span style=""background-color: #FFFF00"">WT1</span> gene as detected in <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> ( <span style=""background-color: #FFFF00"">DDS</span> ) and could not be explained by the previously proposed mechanism .",1.41432785987854," The mutations found in our cases occurred in the same exon of the WT1 gene as detected in <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> ( <span style=""background-color: #FFFF00"">DDS</span> ) and could not be explained by the previously proposed mechanism .",1.2621698379516602," The mutations found in our cases occurred in the same exon of the WT1 gene as detected in <span style=""background-color: #FFFF00"">Denys - Drash syndrome</span> ( <span style=""background-color: #FFFF00"">DDS</span> ) and could not be explained by the previously proposed mechanism .",1.560915231704712,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
10621,"However , the mutant failed to bind factor VIII , demonstrating that the mutation was functionally related to the observed hemophilia phenotype .",O O O O O O O O O O O O O O O O O O O O B O O,13," However , the mutant failed to bind <span style=""background-color: #FFFF00"">factor VIII</span> , demonstrating that the mutation was functionally related to the observed <span style=""background-color: #FFFF00"">hemophilia</span> phenotype .",0.9423520565032959," However , the mutant failed to bind factor VIII , demonstrating that the mutation was functionally related to the observed <span style=""background-color: #FFFF00"">hemophilia</span> phenotype .",0.9504330158233643," However , the mutant failed to bind factor VIII , demonstrating that the mutation was functionally related to the observed <span style=""background-color: #FFFF00"">hemophilia</span> phenotype .",1.071911096572876," However , the mutant failed to bind factor VIII , demonstrating that the mutation was functionally related to the observed <span style=""background-color: #FFFF00"">hemophilia</span> phenotype .",1.1517388820648193,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']"
3156,Addition of purified human C9 to her plasma fully restored haemolysis .,O O O O O O O O O O O O,32," Addition of purified human <span style=""background-color: #FFFF00"">C9</span> to her plasma fully restored <span style=""background-color: #FFFF00"">haemolysis</span> .",0.9105098247528076, Addition of purified human C9 to her plasma fully restored haemolysis .,0.5248987674713135, Addition of purified human C9 to her plasma fully restored haemolysis .,0.6378240585327148," Addition of purified human C9 to her plasma fully restored <span style=""background-color: #FFFF00"">haemolysis</span> .",1.0363659858703613,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'B', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']"
7252,"A syndrome of microcephaly , progressive postnatal growth deficiency , and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent .",O O O B O O B I I O O B I O O O O O O O O O O O O O O O O O,13," A syndrome of <span style=""background-color: #FFFF00"">microcephaly</span> , progressive postnatal growth deficiency , and <span style=""background-color: #FFFF00"">mental retardation</span> was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent .",1.5260751247406006," A syndrome of <span style=""background-color: #FFFF00"">microcephaly</span> , progressive postnatal growth deficiency , and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent .",1.0512259006500244," A syndrome of <span style=""background-color: #FFFF00"">microcephaly</span> , progressive postnatal growth deficiency , and <span style=""background-color: #FFFF00"">mental retardation</span> was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent .",1.5158782005310059," A syndrome of <span style=""background-color: #FFFF00"">microcephaly</span> , progressive postnatal <span style=""background-color: #FFFF00"">growth deficiency</span> , and <span style=""background-color: #FFFF00"">mental retardation</span> was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent .",1.742870807647705,"['O', 'O', 'O', 'B', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3988,"From data collected in a North American Tay - Sachs disease ( TSD ) heterozygote screening program , the TSD carrier frequency among 46 , 304 Jewish individuals was found to be .",O O O O O O O B I I I O B O O O O O O B O O O O O O O O O O O O O,32," From data collected in a North American <span style=""background-color: #FFFF00"">Tay - Sachs disease</span> ( <span style=""background-color: #FFFF00"">TSD</span> ) <span style=""background-color: #FFFF00"">heterozygote screening</span> program , the <span style=""background-color: #FFFF00"">TSD carrier</span> frequency among 46 , 304 Jewish individuals was found to be .",1.6098828315734863," From data collected in a North American <span style=""background-color: #FFFF00"">Tay - Sachs disease</span> ( <span style=""background-color: #FFFF00"">TSD</span> ) heterozygote screening program , the <span style=""background-color: #FFFF00"">TSD</span> carrier frequency among 46 , 304 Jewish individuals was found to be .",1.7767577171325684," From data collected in a North American <span style=""background-color: #FFFF00"">Tay - Sachs disease</span> ( <span style=""background-color: #FFFF00"">TSD</span> ) heterozygote screening program , the <span style=""background-color: #FFFF00"">TSD</span> carrier frequency among 46 , 304 Jewish individuals was found to be .",1.4867050647735596," From data collected in a North American <span style=""background-color: #FFFF00"">Tay - Sachs disease</span> ( <span style=""background-color: #FFFF00"">TSD</span> ) heterozygote screening program , the <span style=""background-color: #FFFF00"">TSD</span> carrier frequency among 46 , 304 Jewish individuals was found to be .",1.835907220840454,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'B', 'I', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
